<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1707245591
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VIGAMOX 0.5% OPHTHALMIC SOLUTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MOXIFLOXACIN HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ocular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        26.6
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="S.A. Alcon Couvreur N.V" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            S.A. Alcon Couvreur N.V
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 439]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Novartis Saudi Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NOVARTIS PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01AX22
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Vigamox eye drops are used for the treatment of infections of the eye (conjunctivitis) when caused by bacteria. The active ingredient is moxifloxacin an ophthalmological anti-infective.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Vigamox</strong><br />&bull; If you are allergic ( hypersensitive ) to moxifloxacin, to other quinolones, or any of the other ingredients of this medicine.</p><p><strong>Warnings and Precautions</strong><br />&bull; If you experience an allergic reaction to Vigamox. Allergic reactions occur uncommonly and serious reactions occur rarely. If you experience any allergic (hypersensitivity) reaction or any side effect<br />please refer to section 4.<br />&bull; If you wear contact lenses &ndash; stop wearing your lenses if you have any signs or symptoms of an eye infection. Wear your glasses instead.<br />Do not start wearing your lenses again until the signs and symptoms of the infection have cleared and until you have stopped using the medicine.<br />&bull; Tendon swelling and rupture have happened in people taking oral or intravenous fluoroquinolones, particularly in older patients and in those treated concurrently with corticosteroids. Stop taking Vigamox if you develop pain or swelling of the tendons (tendinitis ).</p><p>As with any antibiotic, use of Vigamox for a long time may lead to other infections.</p><p><strong>Other medicines and Vigamox</strong><br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines,<br />including medicines obtained without a prescription.<br /><strong>Pregnancy, breast feeding and fertility</strong><br />Ask your doctor before using Vigamox eye drops.<br /><strong>Driving and using machines</strong><br />You may find that your vision is blurred for a short time just after you use Vigamox. Do not drive or<br />use machines until this has worn off.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you.<br />Check with your doctor or pharmacist if you are not sure.<br /><strong>The usual dose is&hellip;</strong><br />Adults, including the older, and children :<br />One drop in the affected eye or eyes, 3 times a day ( in the morning, in the afternoon and at night ).</p><p><br />Vigamox can be used in children, in patients over 65 years of age and patients with kidney or liver problems. There is only very limited information on the use of this medicine in the newborn and its use is not recommended in the newborn.</p><p>Only use the medicine in both eyes if your doctor told you to. Only use Vigamox for dropping in your eyes.</p><p>The infection normally improves within 5 days. If no improvement is seen, contact your doctor.<br />You should continue to use the drops for a further 2 - 3 days or as long as your doctor told you to.</p><p>&nbsp;</p><p><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAA94AAAFTCAYAAADP3NQEAAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAB3RJTUUH5AYPDSkJo2Ci3gAAIABJREFUeJzs3XlcTfn/B/DXvS1oI0tkbQZlHUOM+dnGDBqDIRJjyzZkl6xJpJBkZLIbWYdByjLGkmWy9bXUMMaQZAgtorTSdu/5/dF0pqsidO9peT0fj/t4OOee5X1u5L7O+SwyQRAEEBEREREREZFayKUugIiIiIiIiKgsY/AmIiIiIiIiUiMGbyIiIiIiIiI1YvAmIiIiIiIiUiMGbyIiIiIiIiI1YvAmIiIiIiIiUiMGbyIiIiIiIiI1YvAmIiIiIiIiUiMGbyIiIiIiIiI1YvAmIiIiIiIiUiMGbyIiIiIiIiI1emPwzg5diUYyGWRFejXCyIDHQHYoVjYq6j4yyEYGIEZTV0tERERERESkYW8M3tqWsxAhCBBS7sB/jlWB25jarcWV6AwIQgR2DKgHaFtiVoQAQUjCXX8ndC14J6y6Eg2FIEDYMQCmH34dpYASqaHrMDfgsdSFEBERERERkQYVram5QRMMcLCHXb43usJx2kh8ZqpbwE5GMB8wEVPtGuZ7x3TESIz9zLR8tXNPDcHGWRsRK3UdREREREREpFGSZF+9GpWhJ8WJJZOI0I1umB30SupCiIiIiIiISMPK1UNnaWQi5uyPmDX7N6kLISIiIiIiIgkweKuVEqlhv2DecFcESV0KERERERERSYLBW22USA3bhclfjcJODttORERERERUbpXg4J2M8LMB2Dr36zzTj7XEyJV7cDg0Bsp82z9GwMhGb5i6bAICYtIREzDh7VOioaCp1CYgICa7iLVnIubqhgJC933stKlfhGO+67UXRWGfz5uu+W11KpEaflalztojVyIgNAZKZSQCpqxD6Bs/skzEhB5Vvc7aI7HyQBDCU9/vKomIiIiIiEqakhm8U29h68iOsOhmg7FXLeF/NwmCIEARvQp1fpsF67aW6DY34LVwVg8D1h0teNozK1/cVWzEANOKMB2wHil3tsPu9TnMTCfD/8ntnCnRkDOVWnh0IJy6msLUbjvupKzHAFPtIhSvRPJZV1i2n/J+T7rf69qLoh4G7AhBiFfvQrfQtpyFiJQr8OpalAnelEgN/RHfWnTD2KsdcCY6A4KgQLhzS/zjYwUtLTPYnHjDYHKpYQiY+y1qt/0WC2KH4k6KAoLiCc6MisVs2y9h8a07zsZkvuM1EhERERERlTwlL3grIxEwfQjG7rwFwBJzXBwxwNwIACA37YZ5LqNgihgErbBB18m7EJY3gBo0wQAX9/zB8a8IPBG3k8OgyRAsWztZdf7wmDgkpqmGWXnNemik+yWWOA9GE4OiflRyGH21DNGCgKwQL6hOptYQdv6PIAjCv6+NqmH+Q669SKqg1ZddkX+CtzwMmuHL3hZvP1RqCDbO8kIQgIa9+6CLqS4AOQzMv8asdb/A165F4fsqIxEw3RY2KwIB2P73+crroOuowbACgCBXdBu6DqF88k1ERERERKVcCQvemYg65IUpW2/9u/wxLOoa5HlfDqO23THi38Qcs9MJ0/eHqza9NvgEfUd0Uj1szHZ4Hsi7nTYMqxi9dm4/LPANRnKeNcqIYAR8OhYDzSt+0FUVTTFcuwZl3z2PjUE5j/Tv/3YU5/M+nTZogVHOM1BA2wPku06rnujU6L/PV/5xK/TIvTMQ5IX5El4jERERERFRcfjA4B2E2W0N39Bnuj5sdt4v+uFSb+CXNQEQW2ibNoJZLV3VbfQqo4Y4CXgMAhfsRFBy3mhWEeYDJ2CO6uNsBO4LRoS4WQJCTt6ERVfVZ78xu04jRDxWOiIuXkXzrz/B6xFdLYrl2jUlG88iIyD+ZINc0c1yHLyv/tf/XG7eF3OHGuTfNfkifKasE6/T9FMz1Mr7t1DbBB93zP25vP5zIyIiIiIiKn0+MHh3hVdISp6m06+/HsHf7o0Nm/NQIvnqIawKytMxWq8qKuu9pcSYQJwMSVBdZ/QJvh5hqbou8AQuRqTn/Dn5Jk7+3Q+e8we91tw8z7GUD3ExwARft61axPo/RDFeu0bIoV+l6muf3U44trfC6JUn/+1/Xh1fuU2ApUq3eCWSQ05jV97LrFEZeniDwKu49bSog9oRERERERGVPCWoqXkmYh9G4N3HI4vGjYfPX2uOXBVtv7ZSDYa4iH0XH0IJJZJDgvD3gM5o2/6/pts5QrHr5E0k499m5s27oq2RJj6i4rx2TVBt9v6fW9g5uycsvl2AgPDkAvbLf533Z7eFzhtbSSQgMYXBm4iIiIiISq8SFLyzkZLw7D32i8H9hLTXwmdBwTC3afZzhJyMw4BOZpAX8GQ8p7n5S802My/Wa9cQo06Y9voAdbmCPGBjYYv5Z6Neq62A67TzR3ShLSYECMJ+jNFIH3siIiIiIiL1KEHBu5gZdcDYJbaq62ICcTLwJE7+/dm/A3pVxWeDhqHr69tcuarBZuallS7qDFiGIH8n1c9PFAiPbvZYFZr45sPEJiKFfbiJiIiIiKgMK0HBWxuGVWu8x36maFhVv4ALqYhGnXq+NrJ2KFbY/gg49oW5HADkMGj9DUZYmapss2uZB84NGIquGmlmDhT/tWuKEcwHLMGvd/0xp8C5v3/Dqv1/oKBG5yKVqd6IiIiIiIjKnhIUvHVRy6xRwU2X36g2PjWrXuCFyBt1wGCr145oaqX6JFtuhk6DVacfiwmqjC86mWnwwyn+a9ccOQzMB8Dz17Pwn5N/ArEY/z9wT+yiXRG1P35tjnDJBogjIiIiIiLSjBIUvAsbsOs1L5Pw7GWe5deDtMoh84dq0xHdXxswrYAn46/NLa1+arj2ws5kWBWq48y/RGziu/YTVyL57Dp4521GbtAEAzz9cLfQpucAoI2aLT7L1wph1+7ziCqwgExEHd4n0ZRpRERERERExaMEBW/k75d9PwKRz14b0TotEbH/TXaNro7W+KzQJuGvh2pLjChgwDTVJ+OmsBrcAY3U/cmkXkfA2aj/lov92gsmN6yCWiprVAdoU0YFYv2qoLcdBXqVX2Hr+rOvBWYjmA+Yg5VevcU1pjZt0DjPlGLyRt1gP6aFagVbF2HhocjXwr8SqWEHsR+fo4vGmvwTEREREREVP0kSzctnSXhZ4DsVYT5oIXztcoNZCK7cyTs4lxLJd0Jw6t8lUzsPbJjQFgZvOJdK0CvsCbHKk/FOGFxMzcy1G7eBjcpT7Ps49ds1RCkTEbpxLxLrVsvzXvFfe4FqNsMXrzW/v//befyZqgRSb2H7/EXYmm9es4Kn9Hq1dRHmb7+FVJW1Bqj9cd1//9wbjoPaqN7okDeAtdtijFEp4Ra22oyH046riFECQCZiQndj2c6KGPRtgxJ2d4iIiIiIiOgdCUWRckfwn2MlAMj3MrVbK1yJzihgpyThrr+T0LWAfWBqJ6y6Ei0oCjmdIvqisMquRc62XZ0E/7tJgiAohJS7/sKcrqZvOW++owlJZ5wEU0AwnXNGSCpsq7u+ghUgwMpXuFtYYe8sSbjjO0YwzfcZtBDsfP8SUgqqo1ivvSAKISVkVcE/F5gKXZ38BH+PrvnqHeP/UOXnlRXiJTTM3WeOr3DmbtJr9Rd+jYKQIURfWSvYmRZUQ+7fq+3CnZRi+0EQERERERFJ5o3B+79wVZRXQ8HO/5EgZIUIXg2Lug8E2PkL0QWePUm4e8Zf8FUJ/KZC1zmbBf8zdwsJdIVIOiPMMbUU5px59oaNngln5nQQrHzvFHpD4P0kCXcDV/0XMrvOEXzfWn8xXnuBFELK3ROCV27ABwRTOy/B78xdIUVIEUK8Xg/e+X9WWSFrhcn+DwWFIloIObQ7z7Fy6jwUUviNFbGK6BDhkJ+XSgD/rw4iIiIiIqKyQSYIgvDBj82JiIiIiIiIqEDsPktERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGqkLXUBmnL+/HkcPnxY6jKISpTly5dDR0dH6jKIiIiIiMq0chG8z507B1dXVwQFBUldClGJIpfL4e7ujooVK0pdChERERFRmSUTBEGQugh1W7FiBebOnSt1GYX6+uuv0alTJwQGBkImk6FHjx5Sl0RlmCAIWLhwobicmJiIypUrS1gREREREVHZVi6eeOdq3bo1+vTpI3UZ+fTq1Quff/45OnToAJlMhi+//FLqkqgMUygUKsGbiIiIiIjUq1wF7w4dOsDNzU3qMgr11VdfSV0CERERERERFTOOak5ERERERESkRuXqiTcRERVNSkoKbt68KXUZRBrVuHFjmJiYSF0GERGVQQzeRESkIiUlBf7+/hg9erTUpRBplK+vL8aMGSN1GURl1s6dO3Hq1Cmpy6ByaNiwYejZs6ekNTB4ExGRKCUlBQcOHMCYMWOgra2Npk2bSl0SkdpFRETg1atXUpdBVOZdvXoVP//8s9RlUDnUunVrBm8iIio5rl27Jj7xa9KkCZubU7kwaNAg+Pn5SV0GUbnQunVrhISESF0GlSMlZdpcBm8iIiIiItIImUwGubzkjO9848YNxMXFwcrKSupS6AOcOXMGVapUgaWlpdSlFIrBm4iIiIiIyqUdO3bgzJkzbOFVys2fPx+tW7dm8CYiotKhQoUKMDAwQGpqqiTnT0lJQUpKSoHvVapUCcbGxhquiIiIyrLvv/8e/fv3l7oM+kA//PADKleujMzMTAwcOBBz585Fx44dpS5LRclp50FERJLr2LEjTpw4Icm509LSsGzZMtSpU6fA17Bhw5CUlCRJbUREVDY1b94cXbp0kboM+kCdOnVCy5YtoVQqceLECTx+/Bjp6elSl6WiXATvunXrom7dulKXQUREb+Dp6Ynly5cX+v7x48cxZMgQDVb0frKyspCUlKTyKuwpPhERERWfihUrIjMzEwEBAbCxsZG6HBXloqn50KFDERcXh4iICKlLISKiMiQ7OxuZmZkq606ePIkBAwaorDM3N8f169dV1slkMlSqVEntNRIRUcF27twJS0tLNG/eXOpSqJhkZ2dj+/btiIiIQHp6OrZs2YKMjAypywJQToI3ERFRcVEqlVAqlQCADRs2YNq0aW/dJzw8HPr6+irrdHR08PLly3zbamvzv2YiIk2YMGECli9fzuBdhmRlZWHcuHHict4/S61cNDWPj49HbGys1GUQEVEZsGTJEujo6EBHR6dIobswWVlZ4nHyvhISEoqxWiIiIioJykXw9vX1haenp9RlEJUYZmZmUpdAVOrMnTsXMpkMixYtyveenZ2d+CS8qK/CBoqrVq0aZDIZZDIZ7t27p+7LIiIqt2rXrp2vNRKVbjKZDFWrVoWWlpbUpeRTLoK3kZER+9ER/UtLSwvnzp2DTCaTuhSiUmPWrFnw8vJSWefg4ID09HSkp6fD19dXDMtFfRkZGYn7533l/RLYpEkTaGtrq7zOnDmj6csnIiqTIiIiMHbsWKnLoGJUsWJFxMfH5xtrpSQoFx3JJkyYgPT0dA6uRgRAoVCgQYMGUpdBJdT58+fRrVs3Sc7t7OwMQRCwZMkSSc5fkEmTJmHLli1QKBQQBAEA4OTkBCcnJ+jq6qJChQofdPyC9o+NjRXP1bJlS0RGRqq837NnT/HG2S+//FLiRm0lIirp/vnnHxw6dAiTJk1CxYoVpS6H1KBv377i993Vq1dLXE2OcvHE+9WrV0hLS5O6DKISg82qqDDZ2dnIzs6W5NwVKlT44CBbnOzt7bF582ZkZWWJg6ktWLAALi4uMDQ0VFutBgYGMDQ0hKGhIW7cuIGEhASVgX+ys7ORlZWFrKwsDBkyBPr6+uJrw4YNaqmJiKgsuX37NmbOnFni5nmm4jN8+HB4eXnBy8urxNxcKRfBe9OmTQX2ySMqj7S0tJCamsqm5kRvMG7cOPj6+kKhUIjrFi1ahHnz5mm061KVKlVgbGyM8+fPIzY2VuXVq1cvZGVl4eXLl+Jr+vTpqFq1ar7X3LlzNVYzERER5Vcumpo7ODgAAJuaExGVYD/88APc3d0lrcHOzg6nTp3C8+fPVUK3m5sbHBwcJGstUrVq1Xzrdu7cqTId2cKFC7F9+3a8ePEi37be3t7YuXOnyrru3btj165dxV8sEVEJp6+vj48//hhyebl4BkklRLkI3kREVPKNGTMGUVFR8Pb2luT8w4cPx759+1Sa2nt6emLgwIGoVq0aDA0NJamrMNWqVUO1atXE5ZUrV8LFxUVc3rBhA1auXAkgZ+qy16fV3Lt3L86fPw8AaN26NQ4dOqSBqomIpPfll1/i/v37UpdB5QyDNxERlQjGxsYFPtnVhGHDhmH//v0qodvLywvjxo1D5cqVJanpXb0exJ2cnFRG6z106BCcnJzE5ezsbDx69AgAEBUVhcaNG+c7pqGhIf744w81Vk1EpFl+fn5QKpUYPHiw1KVQOcPgTURE5drQoUPh5+cnhm4fHx907doV9erVKzWhuyC5/btzTZgwAb1791bZ5tq1axg7diwUCkWB3bFkMpnKwG4FOXHiBOrVq1c8RRMRqdnevXuRlZXF4E0ax+BNRETl1uuhe82aNRg+fDiqVKkicWXFr0qVKvmuy8zMDK1atVJZFxMTg2+//RYAIAgCbt++/cbjWllZqQw45+vri9atWxdT1URERGUDgzcREZU7NjY2iIqKQmhoqBi6165di2HDhpXJ0F0YQ0NDWFpaqqzLyMhAcHBwoft06dJFpUl+WFiYyvtDhgwRP8MVK1agS5cuxVgxERFR6cTgTURE5crAgQNx+PBhcdTyTZs2oUmTJvjkk0/KVeguTIUKFfB///d/hb4fFBSkMuK7ra0t4uLixOW7d++Kfx4/fjxMTEywYMECWFlZqadgIiKiUoDBm4iIyo2BAwfi0KFDYnDcvHkzBg8eDCMjI4krKz06duyosnzw4EGVac2mT58uNk+/e/cu7t69i2nTpqFu3bpwcHBAnz59NFovERGQ05pn/vz5aNu2LVq2bCl1OVQOMXgTEVG5YGtri4MHD0KpVALICd3fffddiZsmrLTp0KGDyvLWrVuRkJAAAFi8eDGuXLkiBvAnT55g/fr1GDt2LGxsbKQol4jKqaysLKxatQoBAQG8AUiSYPDWADs7O1y6dCnf+hUrVvCLBxGRBtja2iIgIEAM3Zs2bcKQIUNgYGAgcWVlT/v27cU/V69eHTExMVi1ahXOnTsnBvD79+9DEAQMHDhQwkqJiIg0h8FbTWxsbHDnzh0AwL1791QGosk1YcIEuLi4qKybMmUKJk2apJEaiYjKg0GDBsHf3x+CIAAANm7ciGHDhkFfX1/iysq+du3aAQBMTU3x6NEjbNq0CadOnUJ4eDgWLFiAffv2oX///hg6dKikdc6cORMxMTGS1kBERGUbg3cx69u3Lx4/foxbt26JYXvz5s35Ro3N5eHhgQMHDojLLi4u+Omnn8RlW1tbzJ8/X71FExGVQQqFAiNHjoSfn5+4buPGjRgxYgT09PQkrKz8adeuHdq1a4cGDRpALpfj5MmT4tPvmzdvQqlUYvjw4ZLVFxISggcPHkh2fiIiKvsYvItBjx49kJycDAAIDQ2FQqHArl270KhRIwBAs2bNCh24x8vLCzNnzgSQ0/Rx+/btYt84AHj48CEOHz4sLnft2hWenp7quhQiojIhIyMD9vb22L17t7hu/fr1GDlyJCpWrChhZeVb27Zt4e7uju+++w4BAQH49ddfER4eDnd3dwiCgBEjRkhS17lz5xAVFSXJuYlI/YKCgvDLL7/A19cXbdq0kbocKqcYvD+QlZUVzp49C6VSCX9/f9SoUQMA0KZNmyI1YzQzM4OZmRmAnKZ4Y8aMybfN8ePH4eHhAQD4+++/882vamFhgS1btnzglRARSevIkSMICAgolmNlZ2djx44d4vK6deswduxY6OrqFsvxi+rBgwdYvnw56tatm69rUXmV+/S7ZcuWkMlkOHLkCMLDw7FkyRIAkCx8E1HZdfv2bWzbtg2bNm2SuhQqxxi834MgCOjevTsA4Pfff8fBgwdhYGCAjh07ftCTlAYNGqBBgwb51jdq1AjdunUDAAQHB2PhwoUq71+5ckVsImdqaoqff/75vWsgIpJKSEgIrl+//sHHefnypdiSCADWrFkDe3t7aGlpffCx39XTp0+xefNmNGnShMH7NZaWlli4cCFkMhkOHz6M8PBwuLm5QRAE2NnZSV0eERFRsWLwfgevXr0SRyE/e/Ysfv31V8yaNQvdu3eHjo6O2s5ramoKU1NTAEDLli3Rtm3bfNtERkZi4sSJ0NbWVmmqrqOjo9JUvSywt7fH48ePsWbNGjRs2FDqcoiohEhMTIS7uzvS09OxadMmyGQyrFq1CpMnT4ZMJpOsLhMTE47VUQhLS0vxhsThw4cREREBd3d3AGD4JqJicf78efz5559Sl0HE4F1UKSkpGDJkCI4fPw4g5wtCr169IJfLNVqHiYkJvvnmmwLrq127NgAgISEBo0ePBgDIZDJYW1sDAPz9/SV54lPcBg0ahBEjRmDMmDH46aefYG5uLnVJRPQeAgICcO3aNXH5999/f+s+f//9N5ycnMTl2rVrY+rUqQByfg+uWrUKACCXy+Hp6QkHB4dirrroHjx4gPXr16NWrVpsPv0GueFbJpPh0KFDiIiIgJubG2QyGT83Ivpgjo6OCA0NVetDMqKiYPB+i/j4eEycOBGZmZn47bffIJfLsW/fPvTt21fq0lQYGhqib9++eP78OWbOnAk/Pz+8fPkSI0eOFJ94Dx48GHK5HNu2bSvV0+h069YN27dvx9ixYzFhwgRUr14dLi4uaNmypdSllSp+fn4YNGiQ1GVQOfbbb79h69at77TPo0ePsHz5cnG5ZcuWmDp1KhISErBy5UoAgLa2NpYuXYpZs2YVa73v6vHjx9i1axc++eQTSesoDXLDtyAIOHz4MO7fvw8/Pz8GbyIqFj169MDkyZOlLoPKOQbvN4iLi4O9vT2OHz+OrVu3YtCgQdDS0sLAgQOlLq1QL1++xNGjR7Fjxw5kZWVBEASMGjVKHNk3t+lehQoV4OPjA2NjYynLfW9WVlb46aefkJCQgIULF2L69Onw9vZGq1at3uk4v//+O+7fv4/vv/9eTZWWXDY2NhpvsUFUnKpXr45Jkybh+fPnWLZsGXx8fADkdLGZM2eOxNXlMDExwcSJE6Uuo1Ro06YNFi1aBCCnVdnt27exb98+DB48WOLKiKi0Mzc3R79+/aQug8o5Bu9CxMTEYOrUqTh16hR27txZap4MVq1aFR4eHpg2bRpWrFghNt0cOnQoAECpVCI7Oxv29vbIzMyEvr4+li1bhlq1aklZ9nvp2bMngJxrdnBwwMyZM1G/fn1MnDgR7dq1K9Ix6tSpA11dXVy+fBk3btzAhAkT1FkyEeXRu3dvXLt2DX/99dc771uzZk0sWrQIAwYMgIeHB7y9vaGrqwtHR0dUqlRJDdW+m8jISOzevRtmZmYa+b1y8uRJ/Pnnn/jyyy+L/PuvJGrdujVcXV0hCAKOHDkCJycnyGSyUvN/MBERUWEYvAvw5MkTODo64tSpU9i8eXOp+g8/MzMTFy9eREBAAJYuXYpdu3apTJ0wfPhwAMD06dOxf/9+AEBaWhqMjY0xf/581K9fX5K6P0TPnj2xatUqPHnyBABw8OBB+Pr6ws7ODh06dHjjvubm5jA3N0dERASSkpKwadMm2Nvba6JsonJvwIABkMlkWLRo0TuF71q1asHFxQUTJ07EjRs3xH7duTcepfbgwQN4enri0KFDWLBggdrPFxgYCBcXF+jp6aF9+/ZqP5+6ffrpp7Czs8ORI0fw4MEDzJkzBzKZDLa2tlKXRkSlSFJSEo4cOYKnT59KXQoRAAZvFQ8ePIC3tzfi4uJw+vRprF27VnxS/DYLFixAcnJykc81YsQItTyVSE1Nxb59+7Bu3TpUqFABa9euxfjx49+4T24Af/HiBWrWrInp06eXutHCe/XqJf755MmTmD9/PsLDw9GiRQsMHDgQXbp0eeP+jRo1go2NDQ4cOIBp06aJ63L/TETq0b9/fwCAq6srbt68WaR9mjVrhkmTJiEuLg779u2Dnp4exowZg6pVq6qz1CK7ffs2Nm3ahM6dO4sDv6nLqVOn4OzsDH19fbi7u6Nz585qPZ+mNGzYEL169cKxY8cQGRkJR0dHyOVycWaR4tarVy+Ehoaq5dhEJI2YmBjOjkAlCoP3v+7fvw9nZ2ecO3cOs2fPxjfffPPWQV3mzZsHhUIBAFi9ejWys7OLfL7w8HCVwcB69+6Nrl27vlfteVWpUgU+Pj5in+Wi9C2cO3cuTExM4Onpibi4OMTGxmLp0qVo3LjxB9cjha+//hqCIIj9A2/evCne5LBPA/aXAAAgAElEQVSyskKPHj0K3K9Ro0awtbUV55NdunQpHj9+jDp16kg6MjJRWde/f39cvny5SMG7Vq1a6Nu3L2JjY+Hj44Ply5fDwsICa9as0UClb/fw4UNx9gtN2LZtG0JCQrB58+YyE7qBnKfeHh4eUCgUOHnyJJ48eYJp06ZBJpNhwIABxX6+UaNG4ezZs8V+XCKSno+PD7p37y51GUQM3gBw7949uLq64sKFC/D09Cz07lhGRgbc3NzE5RUrVkAQBACAs7MzvLy8kJmZCUdHR9SoUaPQ8+3atQsnT57EyZMnxXXXrl1Dx44d8dVXX6Fbt27vfS1GRkZFaiq9ZMkSzJo1C5mZmRg9ejQsLCxQrVo1zJs3D35+fpDL5WjYsCGGDRuGZs2avXc9UunZsyd69uyJFi1a4I8//sDRo0dx6dIlXLp0CUFBQejUqVOB07I1bNgQjo6OiIyMhCAIWLlyJYyNjfHs2TNUr14dM2bMkOBqiMq+zz77DM2bN8fff/9d6DampqaYO3cuBg0aBB8fH6xduxajR49GnTp1NFjpm924cQPr1q0DAERFReHYsWMqLXKKU1BQEO7du4f/+7//g4WFhVrOIaVPPvkEK1euhCAICAwMRHR0NBYuXKiW4E1EZdfnn3+Opk2bSl0GEYN3eHg43NzccO7cOSxdurTA0J2amooffvgBGRkZYv/BxYsXw9XVVdxm5syZqFGjBpycnJCeno4xY8bAxMSkwHNaWFiI/RkPHz6MP/74A+fOncO5c+dw/vx5XLx4EUDOF9GCwmFxmDp1KhQKBebPny+uGzlyJJRKJR4/fgxfX1/s27cP9+7dQ/PmzdG/f/9SOSWOlZUVrKys0LZtWwQHBwPI+bJ6+vRpXL16VdyuVatW4nznANCgQQM4OzuLX+ifPn2KH3/8EcnJyTA0NISjo6NmL4SojLOxsYFMJoOLiwtu375d4Dbt27eHra0t1qxZAw8PD7Rt2/adpyNTp8jISJw7d05c/ueffzBp0iQsW7YMQM6N0T59+hTLuc6dO4eZM2fijz/+wPbt29/anaa0atGiBVavXo1p06bh9OnTiI+Px9GjR4vtc8x16dIlREREFEvLMyIiooKU6+B99+5d7N+/Hx999BG6deuGUaNGAciZRmzLli3idqmpqfDy8sK8efPEgXIWLlwovu/t7Q0gZ8AypVKJhIQE8Ul4Qfr37y/2a2zTpg2uXLkivhcUFCQG+nbt2uH69evie82aNVMJhx/KwcEBSqUSBw4cgEwmw5gxYzB69GgAOcEzIiICe/bsgZ+fH/766y+4uLi883RdJUX37t3FZkZdu3bFqVOnkJ2djWvXruHkyZNo3rx5vi/79evXF3/OcXFxqFq1Kp49e4Zly5YhPT0dFSpUwMyZMzV+LURl1YABA3D79m24uLjke69mzZr46KOPsHbtWnh4eMDQ0BBff/21BFUWLDIyEqtXr8bq1avzrR82bBiAnMHfcge71NXVRd++fd/7fF5eXvjjjz/Qrl07mJmZvfdxSoOmTZvC1dUVp0+fRmxsLEaPHo2dO3cW643pkJAQPHz4sNiOR0TSunz5Mo4dOyZ1GUQqym3wDgsLw7Jly5CYmIgjR44AAKKjo7Fnzx5ER0fD29sblSpVEgfGWbBggTi/6OuSkpLEoP2uTZH79Omjcuf+zJkzCAwMBJDT/NzZ2Vl8r1mzZoiIiAAAmJmZFct84o6Ojli5ciXc3Nzw9OlTzJs3D6amphg5ciSAnFG/Fy9eDH9/f8hkMixYsKDUhu9cXbp0EZ8OXblyBa1atcKtW7dUPmsgZ6oxuVyOoUOHwsTEBO7u7khMTIS+vj6io6OxcePGfDdYHBwcoK1dbv9ZEX2wJk2aoF+/fggPD8edO3cA5ITuOXPmoGHDhrC2toahoSGmTZuGJUuWSFxtjsjISKxatQo+Pj6oVq0aOnXqBCDnht3//vc/cbuEhARxZG4dHR0cOHBA5Th9+vSBXC5/p3PPnDkTX3zxxQdeQclXrVo1dO7cGRcuXMDz588xdOhQ7Nu3D1ZWVsVy/I4dO5bacU2IKL8jR46UiFkuiPIqVwnhxo0b8PHxAZBzd/v8+fNwcXHBo0ePcOjQIdy/fx8+Pj4wNDSEg4MDqlevni+MFSRvk/MP1a1bN7GP98WLF+Hv74+//voLZ86cwe3btzF79mwAOcE7OjoaAGBiYoLvvvvuvc85a9YsCIKAZcuWQS6XY9asWWIT6xEjRkAQBLi7u4tfEstC+M7Vvn17tG/fHqGhoTA3NweQ0zz0yJEjiIqKwurVq1VGtq9SpQo8PT2RmpoKHR0dPHz4UOzPCQAymQw6OjoYN25ciZhLmKi0GThwIAYOHIgff/wRDg4OYugeOnQo1q1bByMjI0ydOrXEhG4gZ2Tx3P9bunTpgoCAAADArVu3MGfOHHG71NRUXLhwAQCQlZWFfv36qRzn8OHD0NHRKdI5Y2Nj8cknn8DU1LQ4LqFQ2dnZOHPmjOStC5o0aQJfX1+MHj0aly5dQmJiImxsbHDo0KEPGhcl14oVK3D+/HnxpjMRlX6mpqbw9/dn/24qMcpV8M4dXCtXy5YtkZWVBS8vL+zduxe2traYOHEi6tWrBycnJwkrzdGpUyd06tQJV65cEUMhkPN05dixY5g+fTqAnKdBiYmJAHL6EBZ1CrS8Zs+eDaVSicjISOzduxeDBw9G3bp1AQB2dnY4ffo0IiIicODAAXTu3LnMBO9clpaWsLS0BJAzFVCdOnUQFRWF0NBQbNy4EdWqVVOZQ9bAwADe3t7IysqCUqkU19+/fx+bNm1CZmYmDAwMAADfffcdqlSpotkLIirlGjRogG7duqFPnz747rvvsG7dOvj4+GDatGlwd3eXujzRkydPxG4qxsbGaN26tfheixYtVJo6RkVF5Qt2SqUSv//+OwDkC+JvExAQoNa+3VlZWTh+/DgGDBjwTrN2qEvjxo2xa9cuDBkyBFeuXEFqair69+//TlN5FubTTz/FmTNniqFKIpLakydPxBaK//d//yd1OUSichW8XxcfH4+QkBAAOVODldT+urlPZXP9/fffMDU1RWxsLH777Tc8ffpUnDZMX18f6enpAHKaMr5tSrS85s6dCwBYuXIl9u/frxIW7969K/45ODgYBgYGsLS0LHMBHMhp0r9+/Xrcu3cPnp6eOHHiBC5duoSUlBQAOZ/x4MGDAeR8xuvXr1fZX0tLC2FhYeJybn9+Iio6a2trWFtbIzY2FmvXrsWaNWswffp0lZklpBYVFYUffvgBq1evRpUqVeDo6CiOA1KQOnXq4PTp0yrrsrKyVJ7YXrx48Y1jhORq0qQJqlev/v7FF0FycjKsra3x1VdfqfU87+Kjjz6Cn58fBgwYgJCQEGRmZiI4OBgdOnT4oOPOnz9f5fc2EZVerVq1QkJCAho1aiR1KUQqyl3wNjMzE+c6/eyzzzBlyhSJK3p3zZs3x5YtW3Dv3j1UrVpVXJ+cnIzDhw9j7NixAHICoEwmE98fOnRokfoPtmrVCtOmTSv0S8i+ffuwb98+2NjYwNraGi1atMCnn376gVdV8jRu3BhbtmxBZGQkXFxcEBQUhNTUVJw4cQJZWVkAAG1t7XzN/EvKfMJEpd3Tp0/h4+MDDw8PDBo0SCOhOywsDDVr1oSxsfEbt4uOjoanpyfWrFmDKlWqYNasWUXqmvQ6HR0dnD9/Xlzu1q0b0tLSCt3++vXryMzMxMqVK9U6b3dmZiauXbsGHR2dfDcLpFavXj0cOXIEvXr1wo0bN9C1a1dcuHBB5QY1EZVvXbp04dSDVOKUu+Ddo0cPbN68WeoyikXjxo2xc+dOcfnp06eoWLEigJw5xw8dOqTyxFtbWxtyuRzW1tbQ1dUV1x8/flx8mgsALi4uCA8PR6dOnd44P+7169fh7+8PJyenMhm8czVo0ED8nJ8/f44pU6bgwIEDOHz4MORyeb6bGf379y9yP00iKlxAQAA8PDygr6+vkScX4eHhGDlyJFxcXN44XVVMTAyWLVsm9jmfPXu2ytSMH+JtzZ2/+OILlaCuLvHx8ejduzc6duyo9nO9D1NTUxw9ehR169ZFVlYWOnbsiKtXr6JNmzZSl0ZEJUCvXr3ELplEJUW5Ct5169Yt0/8p16xZE3v37gUApKSkiH0JBUHAoUOHMGTIEADArl27xP7HADBu3Dg8f/4cX3zxBapWrYrmzZujefPmWLBggcrndf36dURGRorLWVlZCA8PR1hYGG7duoUWLVpo4jIlVb16dezduxfJycni9HO5n/nBgwcBALt374aenh6AnBs9+vr6ktRKVJrFx8cjKioKenp6mDFjhkb6dY8fPx5Xr14t9P3Y2Fg8e/YMGzZswIYNG2BoaAgnJyfMmzdP7bVpUmZmJm7fvg09Pb23hvywsDB89NFHqFChgoaq+4+Ojg7Mzc0RHh4OhUKBtm3bqoy5QUREVJKUq+Ddr18/TJgwQeoyNMLQ0FAcWVcQBHz77bcAgGPHjhXY77tTp07w9fVFw4YNVdaHhoYiNjYWALB69eoCmxwePHgQH3/8MVauXFncl1FiGRkZiZ9vrr59+0KpVGLPnj04fvw4lEolfH19UbNmTXGbjh07cqA1ojeIj4/Hs2fPsHPnTqxevRqzZs3SaL/umjVrqtyYBHJaE7148QIrVqzAtm3bAOSM9bBgwQKVUcvLiujoaFhZWaFdu3Zv3C4iIgKdOnXC5cuXJelLaWJigsuXL8PS0hIPHjwAkHMjwMLCQqWbFRGVD6mpqXj48KHYHbA8unfvHoyMjFS+e+YVFRWFzMxMfPTRRxqujIByFrzLK5lMhqNHjwLICYevXr3C2bNnVZ4MrF+/XgzdISEhePHiBQBg4cKFSE5ORu3atQEA3bt3Vzl2eHg4Hj16hAcPHuDu3buwsLDQxCWVSLnzwQOAra0tEhMT8csvvwAAzp07h6ysLPz4449vnNaiadOm4mjyROXRhg0b4OLiAl1dXcyfPx+LFi3SyHmjo6Px8uVL7Ny5E127dgWQMw93amoqFixYIP5bBoBKlSph8eLFkgzIWbduXWhrayMmJgZpaWnF3qImKysLjx49grGxMS5fvlzodg8fPkSbNm1gYGAgadcaY2Nj/Pnnn2jWrBmePHmCpk2b4u7du2jcuDHDN1E587///Q9WVlZSlyGpXr16YeDAgYXOYb5w4UKEh4eLU1uSZjF4lzNHjhzBpUuXoKuri9TUVAQHByM7OxvXrl1DQkICAGD79u34559/AAC6urpYt26d+EX0de7u7li4cCECAgJQp04dcS7b8s7Pz09leezYsYiIiIC/vz8A4Nq1a3j16hUAwNzcHHFxcUhMTISjoyP69u0LIGf03vr162u2cCIJJSUlISkpCbq6uliwYAFcXFw0dm4bGxtcu3YNcXFxePz4MQBg6tSpOHz4sLhNhQoVYGxsjDlz5mDGjBkaqy2v3bt3Iy4uDuPGjUO1atWKfdaEBw8e4Msvv3zruB3NmzeHnp4eQkJCxBuzUjE0NER4eLjYxcfCwgJpaWniMhGVL87OzoV+by2roqKisG7dOowePbrQsTkWLFgAMzMzcSYNLy8vWFpalqiZK8o6Bu8yTKFQiP0Vc+cxvHLlClxcXBAQEIAqVarA1tYWjx8/hr29vThP67p16+Dt7V2kJtH16tWDqakpYmJi1HchZYCvr6/K8owZM7Bp0ya8evUKI0aMwNOnT3Ht2jVcunQJ27dvR0JCAuzt7TFy5EjUqVOHAZzKvJSUFCxevBje3t6YN2+eRkN3QkICMjMzAaDArji6urrQ19fHsmXLSlR3pRcvXiA9PV0cVPNDZWdn4/nz5zA1NUVoaGih28XFxaFmzZq4cuUKatSoUSzn/lAymQzGxsZia624uDhUqlQJNWrUKNJsHkRUdkyZMgW1atWSugyNio6OhoeHB+7cuYMmTZoUuI2Hhwe2bNmCoUOHAgB+/PFHjB8/nsFbg/i/URn28uVLdOjQAVOnTgWQ01+7Y8eOYugGcp7MXr58Gba2tmjTpg10dHQwefJk7N69G4mJiW89x6hRozhq5Hvw9vaGvb092rRpAw8PD5iYmOC3337D5cuX4ezsjDZt2uDatWuYMmUKtmzZgpCQEPEpHFFZ8/LlSzg7O8Pb2xva2toaf1LZvXt3/PHHH/nW6+joQE9PD5s3b0ZCQkKJCd1GRkaQy+UYO3Ysfv75Z2RkZBTLccPCwtCpUyeVaSoLUrduXYSGhpaY0A0AFStWxPPnz8W/Ox999BFq1aqF58+fS1wZEWnC9OnTMXDgQKnLKDbLli1Djx49AOQ0H69duzaaNWsGAPj+++9Ru3Zt1K5dG2lpaVi0aBGcnZ0RGRmJhg0bYuPGjbC0tASQczM5d9uIiAjY2tri6tWrqF27NgICAiAIAjp06CDZdZY3DN5lmFwuR+vWrRESEoKbN29i9OjRaNKkCbS0tPJtu2fPHoSGhmLIkCHQ0dHBlClTsHv3biQlJb31PCYmJqhWrRqeP3+OqKgodVxKmeTt7Y3Q0FBMmTIFHh4eWLduHRISEuDo6IjQ0FDxZWZmhlGjRqn0MSUqKzIyMjBr1iysWbMGADB//nyNPu1++fIlFAqFuKytrQ0dHR3o6Ohgz549SEtLE2eIKCn8/f3xzTffAMiZlWL79u0fPJiQQqFAWloaPvroI9y8ebPAbVJSUpCSkgJ9ff0S2X9aLpcjLS1NZYT11NRUCIIgYVVEpAnx8fHIyMjA559/rjJlbkmnVCoRHByM+Ph4cd21a9dw8+ZNhIeHIzg4GGFhYYiJiUFERASCg4Nx+/ZtJCcno0GDBrh69SpevXqFBg0aoH79+tDR0YGRkZE4HbCJiQkaNGggvm9gYIAKFSqIy/Xr1xe7C926dQv379+X5HMoN4RywtvbW5g8ebLUZUhCqVQKjRo1ErKysoq0vZ2dnaCtrS0AENasWSMkJSW9dZ9Vq1YJAAR7e/sPLbdcefLkiXDnzh2hT58+AgDB1dVVuHPnjhAfH6+R82trawuJiYkaOReVDmfOnBEACACEFi1aqPVcWVlZwvjx48XzyeVywc3NTa3nzCsjI0No2rSpeG4tLS0hMDBQY+d/FxkZGUJ6erqgUCgEQRAEa2trQSaTiZ/d+vXrhezs7Pc6tkKhEIKDgwUAQtOmTQvcRqlUiudKSUl57+vQlNz/wwAIjx8/LtI+I0aMEHx9fdVcGVH5NnnyZKFNmzbFftxhw4YJ3bt3L/bjqturV68EAIKfn5+4ztDQUPz9Vdirf//+giAIgo6OjrBu3bpiqaVjx47C2LFji+VYJY2BgYHwww8/SF2GwD7e5YBMJsO9e/eKvP2OHTsgk8nw+++/Y8aMGRAEAb1790b16tVhZGT0xn0TExPx7NmzEtUEsSSbPHmyyuBNrq6ucHV1hZOTE+bMmcOpx6hMs7e3x9atW8VlNzc3ODs7a+TcgiCgadOm4kCSFy5cKNHN7dq3b48bN24gKCgIX3zxBQ4ePIiBAweKAzZOmjQJCoUCkydPfuen0VeuXEGHDh3QtGlT3L59u8BthFL21DjvZ8C5vYnKLqVSialTpyI4ODjflLgl3aVLl7Br164C37O2tkbz5s2xdOlSODk5oV69eirvf/zxxwByZiX6/PPPi6We2bNno3LlyuLyjh07kJqaismTJxfL8YmDq1Ehtm/fDgAYP348HB0dMW3aNHh5eWHChAn55rgFckaVrVSpEvbt2wc9PT2VL9NUuBo1aqBmzZqIj48XB7cDcgbAUCqVcHJyUvklSETFo169emLXmJCQELE/XGly4MABDB06VOyGMnXqVGRlZRX7iOsZGRniAG6ZmZmSTh9WVJmZmdDT0xObYEZERJS6L+VE9HZKpRLr168HgFL3b/zvv//Gpk2bCnyvc+fOsLKywtKlSzFo0KBCZ5r4/vvvi62efv36qSwHBgYiLi6OwbsYsY83vdHmzZsxduxYVKlSBU5OTli/fj1evnyZb7vvv/8eK1askKDC0u2nn35CbGws7O3toa39330wHR0dbNq0CVu2bJGwOiL1GTVqFLZt2yYuL1++HE5OTho5d+3atcXQff36dbRp0+ad9l+yZAm0tLQwZ84cdZSXT8uWLXHjxg1cuHABXbp0UXlv165dyMrKEr98zZw5851+F58/fx4dO3bEp59+ir/++ivf+8nJyeKAZVlZWaUidOdKTk4WWw2Zm5sjLCxM4oqISF02b96MgwcPSl3GW/3zzz/Q09ODnp5eoYH20aNHmDRpEpo2bYoXL16gZcuWGq4yx+ufqZubGz777DNJaikr+MRbzVJSUqBQKKCvr1+qvrDktXHjRmzcuBHff/895s6dC6VSCQcHh0KnsMnIyEBaWhr09fU1XGnptXbtWsjlcqxfvx4KhQILFy7ErFmzim2aIKKSZMSIEdi9e7fYfHnlypWYPn26RqZ9MjU1RWxsLADgxo0baNmy5Ts3zVYqlZg5cyaWLl2qjhLzUSgUuHTpEj7//PN8teYOlrlu3Tpoa2tj48aNcHJygkKhKNKNDEEQIAgCZDJZgQNvAv811c57c7A0yFuvUqksUnP5cePGQalUFutTJCJSj6ioKPz5558AAH19/QJbZJY0SqUSr169AgDUrFlTfJJds2ZNcZu83Qyl7HL4+vf4+vXro3Xr1uLyo0ePEB4eju7du2u6tFKLT7zVrF+/fqhatSqOHz+O1NRUlebEpUV6erpK7U5OTli1apU4720uHR0daGlpYc+ePbC3t5ei1FLNx8cHU6dOhY6ODhYtWgRPT898nzGRunXp0gUnTpxQ2/GHDRuGPXv2iCFo1apVmDJlikZCXa1atRAbG4s7d+4gMTERLVu2fOewv2TJEri5uYmjn6tb69atERYWhooVK76xVl1dXaxatQqJiYlwcHCAi4sLlixZ8sZjnz179o1fmBISElCjRg1oaWkVaXrJkigyMhLVq1cHALRq1Qq3bt164/ZKpbJU/j9NVB4FBgaid+/eUpfx3qytrXHixAmcOHECnTt3lrqctxo1apRK0/ijR4+iV69eElZU+jB4q9nZs2fx1VdfwdraGoaGhjh06BAyMzNLxWAv2dnZyMzMxJgxY2BkZIQdO3aI7zk7O8PT01NlGh57e3uxnw29H29vb2RmZmLOnDlYvHgxli5dqvIZE6mbtra22p4afPfdd9i7d6/K779KlSqpTP+kDpUrV4aRkRGePn2KsLAwmJubo3Llyu/1hD09PR2Ojo4aGwQuKSmpyAObVapUCZUrV4abmxtiY2Mhl8thZGRUaK3Z2dnIzs5GmzZtcPbsWZX3nj59ivr160MQBDx9+rTUjjVhZGSEu3fvok6dOsjKysJnn32G69evF7r96tWrS9z0cURUOJlMhl27dpXowTHzqlmzJnbt2oVdu3ZhzJgxUpfzQbp3746ff/4ZALBmzRr8+OOPEldU8pWudmOl1OnTp9GjRw+cPn0atra2AICdO3dixIgRElf2Zv369cOxY8ewf/9+aGtr5xt5ceHChVAoFHB1dZWmwDLMw8MDWlpacHNzg0KheOuTK6KSbtCgQQgICFAJ3T/88INafw9mZ2fD1NQUycnJAICwsDA0btz4vZu0L1myBCtWrICzs7NGutK0a9cOkZGROHPmzDv18dPX14e+vj6mTp2KUaNGvbHW9u3b47fffsvXnFGpVCItLQ26urqoVq3ae19DSVC1alWxRcWrV6/eOOd57kChRFQ6yGQyDB8+XOoyiszQ0LBU1fsm5ubmMDc3BwD8/vvvUCgUmD59usRVlWx84i0ROzs7yGQybNiwQepSPsjixYsxf/58cXn8+PHYtm0bdu/eLd5koPezZMkSuLq6YunSpRobxInof//7H/r27Vvsx3327Fm+1hvGxsZqCbBJSUmoU6cOGjRogOfPn4vrTU1N3zt0u7m5wd3dHQ4ODhr7YhEdHQ2lUgkTE5P3atZuaGiI2rVrF/i0+uzZsxg8eDAqVKiQL1g/efIErVu3RqVKlRAREfHe9Zckly5dgpmZGQDgm2++QUhIiLQFEdEH+eKLLzB27Fipy6B/HThwoFQMbie1chW8169fj0mTJmn0nF26dIGWlhbOnDkjrtu9ezcyMjIwevRoTJ48GVpaWuLL3d1do/UVxXfffYfu3bsjIyNDfM2cOVN8f/ny5Zg3b16+/fz9/aGlpYVvv/1Wk+WWKQsWLIC7uztWrlyp8pkTqUurVq2KvcvI0KFDcfHixXzrHR0dsW/fvg8+/v379/Hxxx+Lr08++QTR0dGIjo4Wt/nrr78+qAl9fHw8MjMzYWxsLOlgN8UhMDAQgwYNKrDf9sOHD/H555/j1atXuHXrVr65Y0urOnXqICgoCI0aNUJCQgL69OmDy5cvS10WEb2jtLQ0HDhwANHR0ahduzYGDx4sdUkEQC6XF3pjOzAwEDdv3tRwRSWUUE54e3sLAAS5XC7o6OgU+urcuXOxnK9du3aCjo6OIJPJBADC4cOHhZSUFCElJUXIysoSBEEQ0tPTxXUzZswosL6pU6cWeo7g4GChS5cuxVJvQXr16iXs3btXpeZcGRkZwpw5cwQAYt2zZs0SBEEQtm3bJq4HIHz99ddqq7E8yMjIEJYtWybI5XLBwcGhWI+tra0tJCYmFusxqXS7cuWKUKdOHQGA0KJFi/c+Tp8+fQQLCwvBwsJC0NbWVvmdkPdVrVo1cbtNmzYVeKxff/1V3KagV4MGDQo9PgDhr7/+EpRK5Xtfi5ubm6Cvry8AEKpUqSJYWFgIq1evfu/jFcUXX3whyOVysf7iFBAQIAAQPv/8c+Hhw4fi+vDwcMHMzEz8uZRFLVq0EP9e1K5dW7hw4YL43ogRI4Tq1asL+/fvl7BCorJt8uTJQps2bd57/4cPH4r/hseMGVOMlZG6NG3aVDm75DMAACAASURBVJg9e7akNRgYGAg//PCDpDUIgiCUqz7eeeea9vf3x7hx4/Jtc+nSJbHpo7m5+RsHYSlMu3btEBoaKg6I8+uvv+Lrr7/O11SwQoUK4qBCS5cuhYuLC7y8vODh4SFus379evj6+orL1tbW2L17N4CcKWYuXryILl264Pz58+9cZ1FUrFixwKdEurq6cHV1xbx587B69Wq4ubnB29sbSqUyX1/EU6dOwdraGocOHVJLjWWdrq4uZsyYAblcDmdnZygUCvj4+EhdFpVRTZs2hbu7+wcN+vLtt9/i+PHjRRoYMD4+HvHx8QByZkxYu3Ztvm2eP3+OmJiY966nWbNm7zxlWK7Fixdj5cqVSEtLAwAkJiYiMTERrq6uKr+bAaBPnz5YtmzZe9eZ161bt9Q+CKehoSEaNGggLmdkZODhw4eoVq0azp07p9ZzS+XAgQOwtrZGWFgYoqOjkZKSovL+5MmT8dVXX0lUHRG9i2PHjqFfv3751u/YsQNHjx6Fn5+fyvqKFSsWSysrejfr16+HiYmJ1GWUCOUqeFeoUAHGxsYAgOHDhxfYj/H69evo2bMnAODPP/8Uty9IXFycGKabNm0qzg2bnJyMM2fOoHnz5gBy5uB7W/+8SpUqoVKlSpg/fz4cHBwAAFu3boWTkxNevnwpbrdv3z4cO3YMAMTR0S9duoTOnTvjwoULRfocimr37t2YPHkyZDJZgZ9Vbs16enoAIAbCMWPGqDTrVyqV4uBG9O7WrFmDhQsXYsyYMfDw8MD8+fOhVCoLDChEH8rQ0FAcLOV93bx5Uwzd27ZtQ7NmzYqjtCJLSUlRmSbrs88+Q3BwMHR1dd/pOK6urli1ahVSU1PzvZcbwPP6559/cOrUqfcr+jUvXrwoluO8LjAwEI6OjujYsaPK75CwsDAMGjQIpqamOH78OJo3b47ExET06NFD3ObatWtqqUmTLCws4O/vj8GDB+PWrVuYMmUKtm3bhi5dugDImae2tA8mR1RexMbG4siRI/nWp6en4/bt2/j111+hpaUFhUIBQRA0MgUk5de1a1epSygxylXwzqtixYqoWLFivvVffvklHj9+nG/9ixcv8Mknn6isy9v3LS4uTmXKFxsbGwQFBeXb520MDAzEJ8xTpkzJN/JhYGBgvsEklEolgoODiz18V6lSBS9fvkRGRsYbt5s4cSLS0tLg7u6O7OxsZGVl5RvM5/z587CxsYG/v3+x1VdejBw5EnFxcfD09MSECRPEPvVKpZLTt1GJM2DAAERFRYnLzZs3R7t27TRaQ3Z2Nk6dOiWGxtDQ0Hd6ejx//nwEBQXh1q1b+Z6IAsDo/2fvvqOiurqHj39nACsgCqKCFSxEkaIRwY41NlRijwXsveOD2LAX7LFFUcCa2LGDUTGWoGIJFhR7j6iICKKUmfcPftzXCSBtYFDPZy3XYm7dQ+I4+55z9nZ1TbOoz59//pnvuzxERkby8OFDLC0tpQcs169fp0ePHoSFhaGtrc3QoUMBSEhI4OrVqwQFBWkwYvWrXr0627Zto0+fPly9epX+/fuzbt06AGbNmoWhoWGao2iCIHxdzM3NuXPnDj/++COXLl3SdDiC8P0m3ukpUKAAZcuWTbW9TJky3Lt3T2VblSpV0v0y9/btW1q0aJFmcr969Wratm2bYSyfJ+EpjI2NadCggUpP7Zs3b9K+fftcSb7Xrl2Lh4cHBQoUSPeLiL6+PuPGjcPFxYXt27czY8aMVJUNk5KSePnypdri+p7o6+szfvx45HI58+fPZ8CAAdy+fZtTp05RoUIFWrRogbe3t6bDFAQAzp07pzLFfPDgwWzatAlLS8s8iyEuLo6ZM2dm69yU6e5pjXIPHjyYbt26UalSJalC9ueqVKkijZz+18OHD784ff+/fbTbt28vTW9Xl8DAQDw9PWnQoIE0Jf6ff/7BxcWF69evA8kPLf7++290dXXZv38/2tra1K9fX61x5Ac1a9bE19eXAQMGEBISwtChQ4mIiODt27c5WtYgCELuuXLlCoGBgam2DxgwQOV14cKFsbOzk0a4f/75Z2xtbaXlnYKgKSLxziQtLS3MzMxUtt28eVNllPtzbdu25f79+2nuc3FxSVUVd9KkSRmuqUwZ7baxsVGJxcTEhAMHDuRK8l2qVClmzZrFrFmzUCgUdOrUKc3jDAwMMDAwYPjw4cjlcpUWYynOnz9Pt27dxPqabDAwMMDIyIj4+Hg2bNiAnp4eHh4eODg45KhSM0CtWrW4dOnSV1+pWcifrly5gouLCyVKlMizeyYkJGTrM9Dd3Z1Vq1almXRDcmLt6OiY7vnGxsbprmOLiYnB1NQ03XP/e91ChQqpNfE+cuQI48aN4/bt27x8+VLqkvDmzRuuXr0KJFf+3rhxI5C8NKtx48Zqu39+ZG1tTcmSJQG4ffu2hqMRBCEjBw4cYPr06Srb5HI569evT3Vsx44d6dixI5D8HVsQ8gOReOdAtWrV0t139OhR4uLiUm0fM2YMJ0+eVOktC+Dm5saSJUuk1/369WPcuHEqx8TExBAREZHqmoUKFZIS8dyYdm5iYkJsbGym1hwaGBhQpkyZNPclJiam+zBCyFjPnj2JiIhg9uzZrFixAqVSyYIFC3J83fv372eqCJYgZNWKFSuoVKmSRu49YsQIOnfunKljJ0yYwO3btwkKCko36R40aFCaDx4PHz7MmjVr0jzHysqKOXPmAMkzmFq2bJnJ6FUNGzYMHx8fzM3Ns3Te7t278fX1BZL/nt+6dQtIXp9+7NgxatasqVIMTl9fP90R+2+Vp6cnr1+//ibWrwvCt65Pnz5UrVqVHj16sGzZMqytrbNdOFMQNEEk3rmkSpUqaW5fv359qgR2yZIlbN++ncjISGnbrFmz2Lp1K126dMHd3Z2AgADGjh2b6no3b96kd+/eKgXYUpJvdVY7nzlzJsuXL2fv3r3pjnqnp27duvTt2zfPe6h/awwNDRk9ejRyuZyZM2fy4MEDTYckCF/UuHHjLNe5UJfMjhZPmDCB1atXp/mgNMXgwYOZOHFiqllPABYWFiqzlYKDg6XuGUFBQdy6dYvKlStn6SGZq6urSuG206dP8+7du1THLV68mHPnzqV7nRs3bqQ5klunTh0mTZqEsbHxNzmNPCvs7OxYsWIFY8aM4fz585oORxCEL6hYsaKUaFeqVAlbW9tUNYUy69OnT0RFRVGyZMl0+08LgrqJxDuPpTViMXfuXEaMGAEkVwD29vYmKiqKy5cvc//+fRQKBWZmZjx+/BgHBweWLVvG5cuXGT58ONHR0dy8eRNInua4d+9eIiMjad++PWfOnKFx48ZqaQtTsWJFRowYwdq1a0lKSkpzJGnPnj14eXmlWh8XGhrK8uXLcxzD92737t0sWrRI+v0eOXIEDw+PHLcvCgwMRF9fXx0hCkK+1bt3bzZt2kThwoUBGD16NC9fvmTfvn0ZFpCsVatWmkk3gJmZmco+Ozs7ateuzT///MPcuXPZs2cPhQsX5tGjR0Dy5/SX2gH269ePzZs3p5qF8r///S9Vte2goKBM185wdHRkyJAhAJQtW5Z69epl6rzvgb29PUuXLsXNzY2zZ89qOhxBEDKhQ4cO9OvXL1Vbx8w6duwY7du35+3bt2KpnZBnROKdD1SsWJGKFSvi4+PDkSNH6NGjB4MHD2bPnj2sWLGCRYsWSevQrl27xpAhQ3jz5g03btwAoEKFCvj5+UnFJOLj4/H396dDhw6cPn2aJk2aqKUqrbm5ObGxsUyYMAGFQkHXrl2lfbt27cLNzQ1LS0saN26sMroTFxcn1s+pgb29PfXq1ZOWJMTExPDrr78C5Cj5njFjBnZ2dtl+aiwI+UVkZKQ0MygxMVFl365du9DS0pKK62zfvp2EhIRMXdfb2zvLCdnTp0+ln+Pi4qTaFjo6OmmOXqfYsmVLmkU7//zzzwzv2bt3b5X2X5+rWrUqdevWzfAa3ysHBwfMzMxE4i0I+VxKwdnNmzfn6DpmZmaMHz9eFFwT8pRIvPORBw8e0KRJEzw9PalcuTJmZmbI5XKWLVsmTU+PiYmRpo9bWFiwYsUK9PT0sLe3l65ToEABWrduLSXfp06dkr6MHThwIM1K65k1atQoOnXqxF9//YVSqaRbt27s3LkTd3d3Hj58yIcPH7h79y5NmjTBw8ODv//+O1UhDCF7TE1NGTt2LDKZjMWLFwPqSb7Pnj2bKkkRhPzq+vXrLFu2LM19MTExXyzemN3CjhcvXlTbGuCEhAQ2bdqUrXM9PDy+uM7bwcGBH374IbuhCYIg5HvFixdn0aJFOV4aUr16dRYtWqSmqAQhc0TinU/4+vqyefNm+vbtS+XKlYHkPuHjxo1DJpOxdOlS6VgbGxtmz55NiRIlcHBwSPN6Ojo6tGnThn379tGxY0dptKRjx47s3r2bokWLZitOCwsLLCwsKFeuHL///jvt2rXj1q1bUtG0iIgILC0tWbx4MbGxsezbty9b9xHSVrZsWcaMGQOgknyLtYnCt+rcuXNs2bJFev3w4UOOHDmSqXNlMpnGe90/ePBAWvMNUKRIEenvblZ16tSJUqVKqSs0QRCEr9qOHTsIDQ0VxRH/Y9OmTWk+oL548SJaWloaiEhIIRLvfOLWrVs4ODjQrVs3le3lypWTEq2lS5dSq1Ytfv3110ytz9PW1qZ9+/ZST21nZ2cCAgLo3r07Ojo6eHt7Z7vFj4WFBd26dcPGxibVvvLly/P+/XvGjRvHlStXsnV9IX1ly5Zl9OjRyGQy6WltSEgI06ZNy3bvYkHIT06cOMGBAweA5D7TJ0+eTPdYY2NjJk+enOY+uVwurWvWlH///VeljZi+vj4uLi6aC0gQBOEbUKFCBa5fv87ly5ezdX5MTAwvXrzA3Nz8qyiuFhUVRWRkZKp6I/fu3Uu1POnZs2cqBTr/Ky4uTmU5lI6ODhUrVlRrvELaROKdT/Ts2ZM9e/Zw8+bNVFMFy5cvj52dHZA83TgrRXHkcrnUx3DHjh10796dgwcPAslrIIsUKcLSpUvTbQH2JT/88EO60xq3bdtGSEiIyjZzc3PmzZvHo0ePWLVqFQsXLuT169dSYTlIniafMg3zl19+wcfHhwIFCmQ5tm9duXLlGDVqFACLFi0iOjqaZcuWIZPJmDFjhoajE4TsO378OJ6enpw5cybVPgsLCwYMGKCyzdjYmN69e+dVeFlWunRp6e+qIAiCoB5btmzBx8cn1b8JmRUUFPRVFVfbtGkT7u7uKl2MIPm7+H/rlbi7u3+xfW9ISIhK60hTU1OVRFzIPSLxziesrKxQKpUq/QiPHz/Opk2baNiwIbq6ujm+R+fOndmyZQsJCQkMGDBAGlGKi4vDwMCAGTNm5PiJV1BQED4+Pty5cyfVvlevXrF582Zev37N8ePHefnyJe/fv5dG5AG0tLTw8/PDxcWFbdu2Ackt2IoUKZKjuL5F5cqVY/To0SiVShYvXsz79+85evSoSLwFjZk3b16qdomZFRAQwOnTpzl16lSqpLtmzZr06NEDCwuLLLczFARBEL5dSqWSmTNn4uzsjKWlpabDybY9e/YQHx9P9+7dpW0RERGsXbsWSH6fnp6eQPJA2q1btwCYPHlyql7mGbWJrFChgsp3xa/hwcO34rtKvI8dO8bmzZvz7eiItbW1yuuUtdMDBgzg2bNnQPL6jOXLlzN69Ohs3SPlL7SWlhYDBgwgLi6O/fv3A0j9DCdOnEjVqlWzfO2TJ0/i4eFBcHBwmvujo6NVigqlVWBIoVAwcOBAad+2bdtYtWoVU6dO5d27dyxYsCBVS53vWdmyZWnWrJm0ZvTWrVvMnj2bKVOmaDgy4XuzYMECpk2blq1CfQEBAXh6eqb72aFQKIiPjyc0NJTQ0NBMX1dLSytX/y4EBwfz9u1bWrdunWv3EARBENKnVCqZPn06lStX/qoT799//52YmJhUiXdKgeIxY8ZIP2/ZskUaPHv//n2WB+fKly/PtGnT1BS5kBXfVeIdHh7O6dOn823i/bkTJ07w8uVL5syZQ8OGDbl79y4DBgzA29ubw4cPZzvxTtGzZ0+SkpKIjY1l0qRJREVFSQn4q1evpDWJgwcPTvVA4L8CAwPZt28fV69eTfeLc2YplcpUPRknTJiAn58fiYmJfPz4Ueo5PWnSJMqVK5ej+31roqOjWbhwITKZLN11r4Kgbl5eXkyePDlV7+nMOnr06Bc/O27cuEFCQgJdunTJ8FqxsbFSURmZTCYVknFzc0NbW73/5P39999s374dQEq+w8PDCQ0NpXPnzmq9lyAIgqDK2dn5q+/m8OnTJ3744QemTJnCTz/9JG1fuHCh9G+Zv78/9erVIzo6GhsbG2bOnCkNuIgZoV+X7yrxBjh9+rTU59Xa2jpfFrk5fvw4p0+fplmzZtIajMqVK9O6dWu8vb25du0aa9asYejQoTm6T8oDiKJFi/L27Vvmzp3Ly5cvpQQc4PHjx1SpUuWL1wkODs5ywl28eHE8PT2JjIzMcGr054n41q1bpZ+joqJUKvwOGjToq/7wza7q1aszdOhQ1qxZAyQ//dy6datIvIU8sWTJEtzd3VEoFAwbNoz169dnuj82JPen/rwqv52dHU2aNEl1nLW1NT179szweu/fv1epCxEVFSU9jBo7dqzae7ZevHiRvXv3Son3zZs38fX1FYm3IAhCLitWrBi6urrY2try7t077t69K3UG+loolUoePHiAvr4+JiYmAISGhnLt2jVevXqFra0tFhYWGBkZ8f79ewwMDKhQoUKG382F/Om7S7x1dXUxNTXlypUrzJw5k7CwMCC58NegQYM0HF0yPT09mjRpQuPGjVW2W1pa4uLigq+vLzt27Mhx4p0iJQEvUaIEEydO5MWLF9K+Q4cOZfo69vb2/Pzzz1y4cIGdO3dK283MzFLFamRkhIuLC+/evctwioy7u3uaI2kpI00pHj9+rPKB26VLF3788cdMx/+1qlChAu7u7iiVSmkt0JMnT1i0aBETJkzQcHTCt27ChAkolUqGDBnC/Pnz2b17Ny9fvszUucePH2fq1KkqD+5++umnHNUp0NPTY8GCBSrbEhIS8PDwQC6XM3LkSAoXLpzt6/9XjRo1aNGihdquJwiCIGSelpYWly9fplevXuzZs4djx45pOqQca9CgAe/fv+eHH35Qqdqup6eX7SruQv7wXSXederUYcaMGbRu3ZqbN29KPabDw8PZsmULT548kY4tWbKkxirRplQw/6+qVavy888/4+vrmyv37dWrFytXrlRJvD/XsWNH6tSpk+75derUoUWLFvj6+kqJd+XKlZkzZw5du3ZN85xixYplmBzK5XI+fvyoss3LyytVq4SiRYuyb98+wsPDAbh+/Tq1atWibdu22Nvbf/EeX7vy5cvTs2dPKfGOiYnB09MTuVzOuHHjNByd8C1SKpX89ttv0ut58+ahp6eXpWts27ZNSrrt7OyIj49Xa4wKhYJ169axePFikpKSmDRpEv369VNb4m1tbY2zszPGxsZquZ4gCIKQfTdu3GDChAlMmzZNWpaYFj8/P+7cucOSJUvU+iA2q4KDg6VBJB8fH+nfw7i4OCB5ECXlO3KjRo1wcnLSTKCC2nxXibednZ00HbB69epUr14dSO6BV6lSJQCePn2Kt7c3enp6REVFYWBgkC9bwdy5cwc/Pz/69u2b6/dydnbGysoKJycnbG1tMzzexsaGjh07sm/fPqpXr55u0p1ZaSWOxYsXJyIigtWrVxMREQEkf8n+vJfh4cOHOXz4MMbGxt984g3JI9/9+vVj48aNQPJa1yVLlojEW8gVCoVCmsni4uKS47Z/Xbp0ITo6Wh2hSZKSkhg6dCiDBg1i+fLl0oOpnLh06RJyuRxbW1uaNm3KrVu32Lp1a6oZSoIgCELeevHiBYsXL2bChAlfTLz3799PQkKCytJKTQgNDWXFihXA///O+rmYmBhpLXdSUpJIvL8B31XinR5zc3OpUuCzZ88wNjbm1atXTJ8+nYIFC6r0zNPS0sLNzU1ToUqePXvG+vXr1Z54u7q60qxZM/z8/KRK6t27d89UUaMUNjY2dOnShX379nHr1i127dql9vWOKV/4S5cuzePHj6Xt586dA6Bdu3Y8ePCAGzduEBAQQGxsLJA8fUdbW5u4uDgcHR3VGpOmlS9fHk9PT5RKJT4+PgBERkayatUqhg8fruHohG9JYmKiSr2F1atXZ3nU4OzZs9LslFq1avHx40euXr2aqYd7mY1x+/bt9OnTJ1WrlZzYu3cvOjo6aotTEARByLmVK1fSoUMHlcGeu3fvYmdnx4kTJ7CxsdFgdBlbt25duom1o6MjK1euxM/PD0iugN6yZcu8DE9QE5F4/4epqSlz5swhIiKCYsWKAfDo0SNppEQul0tVcgFGjhyJjo5OnsVnZmZGp06dVHpfq9PgwYMBqFixIjNnzuTp06dZvsaNGzekteHh4eF4e3vnWqGhlHhTVK1alevXr9OjRw9WrVolxZIST/PmzdHR0aFGjRrfXOINyb29R4wYISXecXFxeHp6isRbUJv4+Hh+//13qTBl165dVT4TM2vt2rVSv+6+fftibGzMzZs3sbKyUkucSUlJBAYGsmXLFpXte/fupVevXhk+KDh37hxly5alfPnyKtutra2z9X4FQRCE3GNgYICZmRmNGzcmJCQEXV1d3rx5g5WVlUank6fn8uXL3L59G5lMRqNGjahatapKweDPNWzYkLi4OB4+fAhASEgIpqam1KhRIw8jFtRBJN7pMDY2xsvLC0hu0ZSSXCclJTF+/HiVY1OmWLq4uGS5l15WVa9encGDB+da4p2iVKlSFC1aFEie/mJlZUW1atW+eM61a9c4deoUwcHBbNu2LVfjS8/nMwBatGghvQeAM2fO8OeffwLJCenKlSuB5N9p06ZN8zbQXGRsbEzPnj019t9A+LZ9+PBB5e/Ztm3b1JKIdu/eXaV/aU4VLFgwVdINyd0P2rZtm+EXsSVLluDs7JyqknpWZv8IgiAIead27doEBQVhaGhIZGQklStX5s6dO5oOK03Dhg3j/PnzaGlpERQU9MVjf/vtN1asWCG1Ep48eTIhISHs2bMnDyIV1Ekk3pmgr68vrcFITExUqbDt5uYmrSuOjY2lePHiAHTu3JkSJUrkfbA5sG/fPmm9tJeXF3fv3gXA19eXZs2apZt4X716lQsXLnD8+HF27NiRZ/Fm5L9f5Pfv38/hw4cJCQkhKChI+qBzdXWlfPnyPHz4kObNm2soWvUpW7YsXl5eJCYm5qv/HsLX79OnTwQGBmo6DEEQBEHIsk+fPjFixAjs7e01NvX81atXeHh4cPv2bRo0aED//v0zdV6zZs3w9vYGYOnSpZw/f56BAweycuVKtbfJFHKPSLyzSFtbW6VAj0wm49OnTwBMmTKFxMREAF6+fEm5cuWA5PY4pUuXVlsMpqamtGzZkvDwcA4dOkTbtm1zdL19+/YRFRXF5MmTef78ubS9adOmhIWF8eLFC06dOkXdunVT9Q38559/mDVr1hefuj1+/JiAgABatWqVozhzysnJCScnJw4fPsyuXbuA5J67t27dYuHChVy6dAkvL69vYvTbxMSEFStWoFAoOHToEH/88QfdunXTdFjCVy4uLk4tBcrSEh4ejra2NmZmZjm+VkJCAqdOnUr3QVpQUBCdOnXKl9MPBUEQhNyRkJCAt7c3e/bs0VgbyHfv3kkJdI0aNaRlWxmpUaOGNLXc39+fAwcO4O3tzdKlS0Xi/RURiXcOrVmzRvpZT0+PNWvWkJCQwLRp06TtkydPpnr16jRp0gQTE5Mc39PS0hJ3d3eaNm2Kp6dnthNvf39/YmNjGTVqFG/evAGSp2entMZxc3Pj1KlTzJ8/H29vbxwcHKTE+8qVK4SFhbF79+4Mp7qEhYWxYMECjSfeKdq0aUObNm0AOHnyJBs2bODatWtcvnyZFStWfBOJNyQvF1izZg2DBg1i4MCBIvEWcszAwID9+/fTtm1b/vrrLyA5iXV0dEQul+fo2qdOnaJo0aJqSbxjY2Np3bo1CQkJae7/9ddfadq0qUi8BUEQvnKJiYmpPstTBsHu3buXp3WYMjJr1ixmzpwJwIkTJ6hfv36mzrO3t6dx48YsWLAAgJ07d7J371569OhB8eLFWb16NQMHDsy1uAX1EYm3Gi1fvhylUsm///4rbTty5Ahz5swBwN3dndq1a0v7ateuLbUxy0v79+8nPj4eFxcXqdp38+bNKV68OHPmzFEZ1ba2tubs2bPs2LGDixcvSu0ZNm3axIEDB4DkqvCFChXixo0b0nmlS5emYcOGPHnyhODgYP7991+CgoJo0qRJ3r3RTHB0dMTR0ZEzZ86wYsUKypYty5kzZ2jQoIGmQ1MLIyMjVq5cSaVKlfD396dDhw6aDkn4yunq6nLkyBGpfkLz5s358OFDjpPYFi1aoK2tnn+StLS0vtjey93dHQMDgwyvc/v2bSIiIlT6dD969Ai5XC7NaDIxMVHpfCEIgiDkrZRE+7+USqXKPrlcjpOTE2XKlMmr0FTEx8dL8RQqVCjTbTg/fPhAfHy89LpgwYJUrFgRJycnDh48mO5DZiH/EYm3mqWsBU/h4eHBzZs3geTiCG/fvpX2DR8+nJYtW2JpaZnlUR4jIyPq168vTXPPjIMHD6JQKPj555+lv/jNmjVDV1eX5cuXU6FChS+ev3bt2jSnmVpbW1OsWDFu3LiBiYkJderUoUmTJnTt2pVVq1YRHBxMWFgYU6ZMkaoY5zcNGjSgQYMGXLhwgcDAwG8m8YbkD3dHR0c6d+7M3r17adeunaZDEr5ycrmc2rVrc+nSJSC5wmrBggVz1GLr0KFDFC1aNNPT7r5ET09PKqSYlqlTp2JnZ5fhl6+ZM2dSqVIllZjWr1+PgkwepAAAIABJREFUjo6O1IKyY8eO0r7IyEipRZogCIKQv2hpaeHv76/pMNTC3t4ef3//TCfvQv4gEu9cNnfuXOnnmTNnEhwcDMDFixdZtWoVq1atYtCgQbi7u2dp9LtmzZrMnz+fvn37cvbs2XSnqygUCgICAoDkNc5KpRJIHuktVKgQPj4+6bYvSFG7dm1OnDjB69ev09y/Z88eTE1Nad26NTVr1pRGtVetWqXy/r8GdnZ22NnZaToMtSpRogRbtmyhZMmSdOrUSTwZFXKsUKFCnD9/HltbW65du0ajRo0AOH78eJYeBn4uL1veHT16NFdGPEJCQlixYkW+7xcrCILwrdDS0mLnzp0sWbKEv//+O93jmjdvrtHWqsOGDeP48eMUL16cdevWUbVq1Uyfu3jxYkqWLJnu/t9++43nz58ze/ZsdYQq5CKReOehz9d9e3l5sXDhQl6/fs26detQKpV4eHhQsWLFLF3z/v37DB06lNDQ0FT7EhMTOXbsmLSeGaBx48ZoaWmxe/fuTE21BJg4cSLXr19n8+bN6R5jb2/P0KFDOXTokMr9UhQpUoS6detm6n6C+uno6NCoUSPOnTun6VCEb4SWlhahoaHUqFGDsLAwlEolzZo1Uznm3r176bYa+3z2T4qIiAhkMtkXv2DklLm5eaantBsbG2epO0XdunVxc3Pj2LFj2Q1PEARByAKZTEbnzp3Zv38/wcHB0gCTTCYDkF5Xq1ZNZYZSXtuzZw8vX76kYsWKdO7cOVPnKJVKFAoFzZs3l97Pf8lkMkJDQ9HR0RGJ91dAJN4a4ubmhkwmw9/fn1u3brF+/XoUCgVTp07NcMr3f71//55Lly5J68fj4+M5f/48Hz58UEmC69evz9GjRylUqJBa3wvA7t272b17t/RaX1+f0qVLEx4eTpEiRejWrRsdO3bk9OnTQHIi/vl6dyF3FStWjP3792NoaPhNrWEXNO/GjRsqyffnnJ2dKV26dLrrvwsUKEB8fDwRERG8ffuWlStXIpPJmDFjRo7jUigU3Lt3D0ClbkVwcDBGRkYZnm9qasqGDRuytDQjICAANzc3XF1dsx6wIAiCkG2bNm2id+/etGzZEoB58+bRoUMHfvjhBw1Hln03btygZs2aXLlyJd2ZVCkt0lJm1Ar5m0i8NWjChAlMmDCBcePGsXTpUjZs2IBSqcTT01Mq3PMl+vr6WFhYcOvWLX755ReuXr3KP//8w+vXr2nXrh0ymYw6depIxwcFBamteFFaihcvTuXKlQFo27YtlpaWdO7cGUtLS2rVqiVNR4XkXtMpLb0+J5PJvrmp3vmFlpYWNjY2NGrUiL///lv8ngW1SUm+o6Ki+Pfff1EoFAAYGhoSEBCAlZVVmuf179+fjRs3MmfOHAwMDDAwMMhxdfQUHz9+lJa9PHnyhKdPn6Z6MPAly5cvz9Z927Vrx2+//ZatcwVBEITsMzExoXfv3mzfvp1Lly5Jo8StWrXS2KzLly9fcuzYMd6/f5/lcw0MDOjdu3eWZl7llaNHj2JoaKiSZwgZE4l3PmFkZERSUhIbN26kVKlSmVobbWVlhZ+fH3Xr1iU2NpbAwECparVcLsfBwUFtxcwqVaqErq4uMTExqfYVL16cChUq8MsvvzBhwgRpe8oI+IULF7hy5QqVKlXiyZMnWFpaAjBkyBA+fvzIrVu3pHPkcjkXL14EwNbWNt2pNULW6erqcvbsWezs7LC3t+fixYtZSkQE4UtSuhrUqlWLf/75B4VCwYkTJ9JNuiG5/oC2tjaJiYm8e/eOiRMnAhAdHS11UMiuIkWK8OzZM+m1mZkZxYoVU1tin5ZChQphaGiYa9cXBEEQ0lejRg02bdrEoUOH2LlzJzt37gSS23hpKkG8efMmvXv3zta5ZcuWZdOmTWqOSD0mT56Mg4ODSLyzSCTeGvT8+XMiIyPR0dHBy8uL+/fvM2vWLCIiIvj3338pXbp0pq/19OlTOnTogFwup1q1ahgYGKi1gviMGTOQyWTs2LFD2vbs2TOio6MZMmRIhg8KrK2tGTlyJAsWLGDXrl2Ympry5MkTdHV1U60L7dWrFwC///67ypfkatWq5at+jF+jggULcvnyZbS1tcWHpZArLl++TIUKFXj8+DGRkZEkJiamO9PGy8uL2NhY1qxZw+zZs0lKSpIeBs2bN09tMaUUhnzw4EGOEvqYmBhkMhlFihRJc7+TkxNOTk7Zvr4gCIKQc7t27WL16tWcPn0aX1/fLBUyyy2bN2/m4MGDnD9/PlPHb9iwgUuXLrF69epcjixrnjx5wsCBA7l+/ToODg6aDuerk3uP/oUMrVmzhh9//BETExOVdjUbNmxg0aJFmbpG4cKFpeq8crmchg0bcvPmzVwpouXp6cnNmzelP6NGjQLgzZs36VY8TxESEkLfvn25efMmbdq04fjx4zRp0oSPHz+qXPPzP126dKFDhw506NABKysrgoODCQ8PJzw8PNuVk4VkWW1fJwhZoa+vj0wmw9HRkdOnT6fbYxWSR6YLFiyIlpYW8+bNY/78+Xz8+JGoqKh0/6Q18waS13WndbyxsXG6Rd6yYubMmRQpUgQ3N7ccX0sQBEHIHbVq1aJq1aqUK1eOn376iWLFimkkjtjYWGJjYwFo0qQJVlZWmSps/O7dO8LDw7ly5Upuh5hp7969IyoqiufPnxMQEIBSqaRo0aKaDuurIxJvDRozZgxDhw6VPhCKFy+ebhGi9NSsWZPDhw8DUL58eYKCgtQdZprevn0rVSVet24dkyZNIjIyUuWYIkWKpPkBEx4eTrt27Xj+/Dn29vY8efIkzXvcvn2be/fuce/ePWxsbOjRowc//PAD1apV4+TJkzx8+FAk4NmgpaXFvXv3xDR+Iddcu3YNc3NzAJo2bcqpU6dISkpK89hFixbx8eNHxo8fL21btmwZxYsXT/dPu3bt+PDhQ6o/d+/eTXVsyZIl0dLS4t27dzmevq6joyNm3QiCIORzZmZm6OvrS0sXNWX48OG0b99eeu3h4ZGpZLpcuXKUKlXqi+3R8lqlSpUoXrw49vb2AJw7d44FCxZoOKqvj5hqriFRUVGMHDmShg0b0qlTJ54/f063bt14/vx5pke7U+jo6GS6NZg6vHv3Dg8PD9auXStt8/b2pnDhwqxYsULa1rp1a/z8/KR152mJiIjAysqKGzduIJPJVHrrPn/+XPo5JCQEuVxO3bp1uX//vrReZsuWLdSsWRNIXi+aGxXbv1XGxsa8fPlS02EI36jPE9TmzZsTGBiIo6MjWlpaaT700dLSQi6Xo1QqU9UekMlkKuecPn0aPT29NO/7+fIUuVyu1r71c+bMUdu1BEEQBPV6+vQpBw4cSHdWlCYYGRnRtWtXdHV1uXDhAnfv3qVnz56pjjt27Bh3794FwNXVNd0q5nnpzz//5M6dOwDSyH3hwoVxdXXF2NhYk6F9tUTirSFTpkzh4MGD1KtXj4kTJ+Lj44NSqfzilMz01KhRg7Nnz9K2bdtciDQ1T09PlaQ7xYcPH3j//n2aX4jlcrnKlJSkpCQ+fPgAJD+EMDU1RUdHR0q2jYyMqFmzJgkJCbx//56wsDCMjIw4d+6cypTRNm3acObMGWJjY9m6dSvNmzdHT0+PggULqvttf3P+/fdfdHR0svX/nCBk5ObNm1haWkpF11JavPj7+6e5Dnru3LnMnTuX2bNnM3XqVJV9vXr1yrcFZgRBEIT8ISwsjGHDhmk6DBWWlpasWrUKgAMHDrBly5Y0E+/169dLxeBevXqVqbaXuc3Hx4dt27apbDM1NZXej5B13/1U84SEBOkpTl5auXIl0dHRPHr0CD8/PxYvXsykSZPyPI7sKFy4cJrrJTds2MCoUaP48OED8fHxREVFScl148aNiY6Olv6kNf0nISGBkiVLYmxsTFRUFG/evCE6OprSpUtjY2ODsbExN27cICoqSpq2evjwYaKjo2nfvj0uLi6ULVuW3bt3ExUVRXx8fO7+IgRB+KJr165Ru3btLJ0zefLkVNPXNm/eLI1659UDRkEQBOHrMWvWLEaOHAkkJ7gphXrzk0GDBrFnzx6VbfHx8Tg4OHDkyBHs7Ow4e/Zsttakh4aG4uDgIP3JbKFPHx8flfM+/3PgwAGVY4cOHSo9HBCy57sf8Q4ICGDZsmUcOnRII6OkXl5eeHl5ATBt2rQ8v392zJ07F7lcnurLsUKhwNfXl6SkJJo2bYqrqysymQxtbe1MTQFPaSukVCopXrw40dHR0nrkwoULU6lSJWrXrk1iYiIXL16kVq1a0rTSffv2Sdfp06cPffv2ZcOGDfTp00e9b14QhEyTyWT8/fffNGrUiODgYAA6derErl276NSpU7rnjB8/ntGjR7Nu3TqpiGOKI0eOpFkl3dzcnNu3b6v/TQiCIAj53u3bt7l79y5lypShbt26lCxZUqPxPH78OFXv7nLlylGuXDmVbUqlkkePHqGnp0f16tWpV69etu6XkJAg/TsLyUVOHz9+nOF5165dUznvv7S0tKRp5VZWVvliCvzX7LtPvGUyGSdOnKBVq1YcP35cLZVv1RFTVnrNKpXKdAsX5ZbZs2cze/ZslW0rV65k5MiRbN68mS1btgDQrl079u7d+8Xfq1wuR19fn0ePHlG8eHEUCgWASiGkFy9e8PDhQwAsLCyoW7cuwcHB2NraplozumnTJjEtVRDyCR0dHekz9vTp0ygUigw/r7S0tNDS0mLIkCG4uroCsGfPHvr27Zvu592dO3coUKCAyjZtbW1p1o0gCILwbXN0dOTYsWOaDgOAChUqAMnVzL+kYMGCKjWN1CU6OlqKISfy0+/0W/DdJ95t27blyJEj/PTTTzRs2DBX2nBllbu7e4Z9sT/3zz//YGtrS8WKFXMvqCxwdXWlefPm/PLLLxw4cIC2bdty9OjRNI81MTHh2bNn0uvY2Ng0K7uXKVOGp0+fYmpqyq1btwCwtbXl6tWrnDp1ikaNGuXOmxEEIcf+uzwlZX1b586dv3heShXxnTt3MmDAgC8eq1QqUxVSS0hI+GbanZw7dw5ra2tNhyEIgpCvKBQKvLy8MDc3p1mzZpoOR0WbNm1wdnbWdBhZJpPJcHd3B6BKlSoajubb8t0n3pBc9Of48eM0a9aMOnXqaLz9wNdo6dKljBs3LtPHV69endu3b+Po6KiyvVChQiQkJKTZsqdcuXLcv39fesBw6dIlIPlp3LRp0/LdB64gCNCqVSsuXrzIu3fvpG0JCQn88ssvDBo0KFPXiI2NzXZ18m9lxLt+/fqpRvT/a/HixdIMAUEQhO+BQqHA3d2drVu3plm0TJO6dev2VS55lMlkWRoAFDJPJN4k/w/WpEkTTpw4QbNmzfjxxx8JCQnRdFiZEhISQt26dalcuTLXr1/P8/vPmzePqVOnSu1/+vfvT7169aR2X23btmXo0KH89NNPqUa9q1Spwv3791NdU1tbm7i4OAD09PSkqttKpZLKlSsDyaP8NWrUAJJbMGhra9OxY0cOHjzIjh07vsonjILwLXrz5g1v375NtT0+Pl7tBRCNjIwy1SP1c46OjlILF3WrU6dOqkI6OdG+fXuuXr2a7v7hw4enKtI5cuRIJk+erLYYBEEQ8gt/f/98V5j44MGDTJw4UWP39/f35+TJk3h7e/P333/Tv39/Lly4kOnzO3bsyKxZs3Ixwu+bSLz/j1wup1GjRpw4cYKmTZtSsGBBqlatyrVr1zQd2hcpFAoUCgVaWloaKQ6XmJgorbccPHgwNjY2DBo0SFqnnbJW89ixY7Rq1YqAgADpXJlMphLz+/fvU7VP+G+rq5R72djYEBISgrW1tTQKtG3bNhITE9Ocqi4IwretTJkyBAcHU7Zs2SydFxQUxKdPn3J8/z179uDm5gYkd3HYuHEjhQsXpkyZMjm+dopDhw7x8ePHNPd5eHjwxx9/SA8tU8yaNYt169bRp08f8WVKEIRvxsOHDwkNDSUsLAwLCwsMDAw0HRIAkZGRhIWFaez+VatW5fXr19SuXRtLS0tsbGyIjo7O9PnW1tZYWlrmYoTfN5F4f0ZLS4uiRYuiVCqJj4/nxo0b6OnpYWJikmfVct3c3JgyZUqe3Esdxo8fL/VMLFSoEFu3bk1V+Khp06bs3r2bRYsWpXudt2/fUrZs2QxHwC5fvkynTp149OgRdevWRUdHh8DAQBwcHChSpEjO35AgCGq1e/duPn78SO/evaVlPMuWLeOnn37K0XUvXbrEL7/8AiQXsTlx4gTly5fP8nVMTU1zFEeKgQMHIpfLGT9+POfOnWPu3Ll4e3ur5dopTExM0t33efuZcePGMWjQIH777TeWLl3K48eP8fLyYvv27Tg7O7Nw4UK1xiUIgpDXevfuzZkzZ5DL5RpNdPOjfv360a9fPwB+++03DUcjfE4k3v/n3LlztG/fXiXxUyqVxMTEcOfOHQwNDdHX1+fBgwe5GkeRIkUynUBeuHCBZs2aYWFhwenTp3M1rvT8N95evXrx4cMHxo4dK20rUKAArVu3pmDBghgaGlKrVq1UFRKLFSvG1atXqVq1apr3uXbtGkZGRpQsWZKQkBAcHBy4e/cunz59okWLFhQsWJCdO3fStGnT3HmjgiBkS0pV1c+LnJmamlKtWrUcXTciIkL6uVChQpiZmeXoejlVrFgxabQ9ISFB6sKQF6ZNm8aWLVuYNGkSPXr0oHTp0pQsWZJJkyZJa7537drFzJkzWbFiBYcOHaJZs2asWLEiz2IUBEFQN1tbW7p166bpMNI0b948atWqlef3Xbp0KUZGRujp6UkF0oT847tKvNetW4e+vr5UMODo0aPSE6G4uDiioqKoUaMGhw8fVjkvIiKCOnXq8Pbt2y+OOFy+fJnSpUtnK7b58+ezYMGCTK9V+fvvv2nbti0VK1bk2LFjqaZoa0qRIkXSnO5TsGBB9PT0iIyM5OXLl6n2y+VyzM3NefToUZrXNTU1laoiGxkZ8ddff9GsWTPCwsKIjY0lNjaWTp06sXPnTlq2bKneNyUIgpAJLVq0wMvLCzc3N06fPs3gwYPzZLThyZMnjB07ltGjR6v0ri1ZsqT0ukyZMjg5OREQEMDkyZO5d+8eZ86cwc7OjrVr1+Z6jIIgCOpma2vL//73P02HkSZNJb3r1q0DoESJEiLxzoe+q8Q7ISGBxYsXs337diC5x11kZCT169fH19cXSB45+e8aQRMTE+7cuUNsbKxK4/iwsDC0tf//rzAnyW9UVFSWCg19/PiRt2/fYm5unu1kP7c4OzsTGRnJ+PHjs3SeXC7P9FTRMmXKEBAQwKdPn+jevTuXLl0iOjqaHj16oK+vz/Lly3FycspO+IIgCNlSvHhxqQBkfHw8vr6+KJVK6YtQbqpQoYJK0v1fRkZGGBkZUbFiRWQyGR4eHly5coUbN26gVCrFdERBEL4Kz549w87Ojt9++w0HBwdNh6OiZ8+eHDhwQCP3rlGjBocOHZJepwxW9enTh+PHjwPw+PFjldaeQt77rhJvSP4y9PkUwEaNGrF58+YvJnza2tpUrlyZ9+/fq2w3NzdPs+1Vbjt79iy9evXCysqKHTt25Pn9M6Kvr0///v2Ry+VMnDgRCwsLAGJiYtR6n3LlyvHLL7/wzz//4O3tja+vL2fOnCEyMpL+/fuzfv16OnbsqNZ7CoIgfEnDhg2ZP38+7u7uxMfH4+fnx61btzA3N8fHx0fT4XH16lXpQTP8/wcEYWFhVK5cmY0bN2ouOEEQhC94+vQpFy9e5Pnz5xQrVgxDQ0NNh6TixYsXyGQy6tatm+f3LlSokLS063NGRkaUK1cuz+MR0vbdJd6dOnVi2rRpABw/fpxTp05lqyCPpvz111/07t2b58+fU6lSJSpVqqTpkFI5ePAgHh4evHnzhoSEhFSF6cLCwujcuTO7du3K9j26dOnC7du3CQsLY+3atXTt2pWmTZuq9Ar+mv67CoLwbTA0NGTAgAHIZDL+97//ER8fz+nTpwkODubx48eUKVOGLVu2qPWebm5u+Pr6sn///gxn+rx69Yrw8HAgeZqml5cXN27cYPTo0QQHBwOI5FsQhHxp48aNTJ8+XdNhfJGzs7PKw01NW7JkiaZDED7z3SXeRkZG0nTx+/fvc+rUqUyd9+7dOxwdHVW22dvbc+bMmRy3r1q2bBnr16/P8LiTJ0/Sv39/Hj9+jK2tbabOyW0bN27k06dPDB06VNpmb29Ply5dmDZtGg0aNKBz586MGTMGS0tLNmzYQHh4OK6urtSpUwcAY2NjlekxX9KpUyeePn3K1atX2bBhAxYWFlhYWKCnp4eenl6uvEdBEISsMDQ0pH///gDS+sOEhAROnDiBtrY2kZGR6Onp8ccff6jlftWrV+fdu3dMnDgRpVJJhw4dMnWekZERzZo1o3bt2gCMHj2azZs3AyL5FgQhf5kxYwYHDhygaNGiLFiwQFrWIwhfk+8u8f5c48aNiYyMxM3NDS8vrzSPiYiIoGPHjiQmJnLlyhWVfZcvX8bR0ZFjx47lKOl7/PgxkZGRXzzmzz//ZMiQITx48IAff/wRHx8ffvjhh2zfU12ePXuWqm+skZER5ubmAFy5coVXr14BEB4ezsaNG1m0aBGVKlXi6dOndO/eHblcTr169dDV1SUwMDDVPVq1aiVN879w4QJJSUn4+fnh7OyMrq5uLr9DQRDyi/PnzzNv3jxAtar5/fv3GTZsGKtXr9ZUaKmkJN8WFhbcu3ePcePGAZCYmMiRI0eQy+WplsLs3Lkz28uXhg0bxpMnT3B3d8fHx4eePXvStWvXTJ1rYGBA/fr1pfg2b96MTCZjw4YN2YpFEARB3davX8+zZ88wMTFh+PDhmg5HELLlu068DQ0NKV26NDt37kxz//Pnz3F2dub8+fMUKFCAEydOqOxv3rw558+fT9W3OrtcXV3p27dvqu2BgYGMGjWKe/fuUbduXdatW5evmtv7+vpSoUIFBg8eLG1r1qwZ06dPZ8aMGejq6nLixAlCQ0OZOHEit2/fxszMjF9//VX6nUZHR+Ps7JxqVgEkT69XKBTs2LFDKmCXUlSjSpUqefMmBUHIc4GBgSoze548ecL58+dTHZeQkJCqG0V+YGhoiJOTE1FRUdLSl4iICIYNG4ZCocDf31/l+JQHkZD8JTOtDhHpsba2Zu7cuUyZMgV/f39u3bol/dvWtm1bXFxc0j03PDyciRMnSq8TExPZtGkTgEi+BUHQqODgYJo1a0ZcXBz/+9//8mWl7ufPn1OlShU+fvxI7969NR2OkI9914k3QN26dSlTpozKtvv37zN06FA+fPhAWFgYR48eRUdHJ1VSeOTIEdq0aYOzszM6Ojps3bo1R5XNzc3N01yz/eLFC2mdtLGxMVZWVtm+h7r17NmT+/fvc+fOHZXtpUqVombNmkDyl7r58+dTrlw5Fi5cyJgxYzh79ixPnz6Vjo+Pj0ehUBAUFJTqHnv27KFIkSI0btyYQoUKATB8+PBUxe4EQfg6bdmyhaNHj6baHhYWxuXLlzM838jIiJUrV+ZGaGphYGDAzz//DEBsbCzFihUjJiZG5WElJH/WpUhKSqJIkSLS69mzZ1OxYsUv3sfGxoZZs2bRs2dPaduhQ4eYNWsWf/75JwD37t0DwMrKikmTJhEWFsaoUaM4ceIEpUqVYsmSJbx69YoxY8bg5+eHXC7PF8uaBEH4PiUmJvLhwwcAChcunKUHknlFoVDw4cMHatWqleff0Y8fP55uK14h//nuE+/P+5ymeP/+PYGBgZQoUYLdu3fTvHnzNM9t2bIl+/fvp2PHjiQkJNC9e3e2bt1KqVKl1BZfYGAgixcvBpIfEkydOlVt11YHc3NzLCwspOnkn6tXrx4HDhwgJCSEGTNmULRoUQAOHDjAo0ePGDFixBevvW/fPrS0tGjVqhU6Ojr069eP169fs3btWtasWYOZmVmuvCdBEHLXr7/+qlLX4dy5c1LBr/TUrl2bkSNHSq9v374tTTt///49Z8+epV27drkTsBoVLVqUnj178unTJwoWLCht/++I9N69e1Vev3v3LtWD3REjRkjrs1PY2tpia2srvba2tiYkJARAKvIGycUnjY2NGTNmDH/++ScmJiasWbMGJycnYmJiUCqVjB07lo0bNyKTyfKkJZogCMLXbNGiRWnO3MxNrVu3JiEhIdW/BUL+9F0n3ufPn+fUqVPSFLvbt28zefJk3r59i7GxMZs2bUo36U7Rpk0b9uzZQ3x8PH369KFPnz74+PhgYmKSpVh69eoljYikCAgIYOLEiVy7do369euzePFiqSDZ16BMmTK0a9dOinnGjBls376dqKgooqKiANDT00u3+qOTkxO9evWS9vv7+5OYmMiiRYto3LhxXrwFQRDUYNGiRVy/fl16/ddff/HXX3+le3yLFi3o0qULJ0+eZPv27UByNe5z585Jxzx//lz6+dOnT2zfvl1KxL8GBQsWVFlaFB8fn+qYsWPHEhsbCyR3i/ivJ0+eSPU0MqNUqVL079+fDRs2cOnSJdzc3AgMDKR8+fKsWLFCqoiuq6vLwIEDUSqVjBs3Dm9vb2QyGQCrV68WfWAFQcgTGzdu5Pfffwdg8eLFGX4nF4T87rtOvJ89e8aZM2ekxPv169fs3r2bMmXK4OPjQ6tWrTJ1nZRRFm1tbT58+JClgl++vr74+/szZMgQqd81JE9jnzx5MqGhoTRo0ICFCxdqpC9gZu3btw8rKyv69OmTat/Lly+l6vEfPnxg9+7d0r64uDiV15/bvXs327dvR6lUStuWL19O6dKl1Ry9IAi5ac+ePbx+/VplW58+fbCzs1PZ5u/vz7Fjx3j58iWhoaEqy1EeP36c7qhriRIlmDt3rvoDz0MDBw5Mta1QoUJER0ene87atWs5fvx4pu9RuXJlabr6ixcvKFq0KCtXrsTExCRVJfSStKU8AAAgAElEQVSiRYsydOhQChQoQGJiImPGjAFAS0uLpUuXqozWC4Ig5IZz585x7NgxILlNV0bLbQQhv/uuE+/P3bp1i1mzZgHJBXHatGmT5Wtk1D/1v3x9fZk9ezb29vYq9zt8+DBTp07lypUrNGrUiLlz5+Lg4JDlePLSvXv3CAkJSTPxNjIywtXVFVdXV+7du8fMmTOlfYmJiWzbtu2L116zZo201rFTp06ibZggfGXGjRuHm5sbDx8+lLb9+++/3L9/X+W4t2/fAhAaGkpoaKjKPktLS6lFF8Ddu3dZtWoVkLxk6PN1zd+KjIr0VKxYMVV9jc8FBgZy5MgR6bW+vj5t27albdu20vn/raz+uUKFCjF8+HCSkpJQKBSMGzeONWvWoKWlRYECBZg+fTr6+vpZfFeCIAgZ09HRISkpCQcHB/766698O9Nm/vz5TJ48WaMx/PrrryptfYX8SyTe/+fFixcEBARgYmIiJeC57ezZs9y7d4+RI0dSo0YNILkQzvTp07l8+TKNGzdm9uzZUpuX/Oqnn36S1hCmxcTERErIX716Rbly5aR9b968Ydq0aSxYsIAJEyawdu1alEolgwYNYu3atWhpadGnTx8KFCiQ6+9DEITc8ebNGz59+qSyLTAwMM32gSkcHBxUksLq1aurrOE+ffq0lHh/r1IS6PTY29vTpEkTzpw5w4EDB7CyspJGrrNCS0uLsWPHkpCQAMCkSZNQKBR8+vSJ2bNn58tiR4IgfN0UCgVKpRK5XI62dv5NVxQKBXK5HGdnZ4yNjTUSg1wuz7cPJgRV+ff/ZA0pU6bMF0cA1GXLli389ddfdO3aVSrEkJJ0X7p0iSZNmjBz5kwaNGiQ67HklLW1NfXq1ePBgwcZHluyZEkGDBggvX7//j2lS5emW7du6OrqMmDAAJRKJQkJCQwcOFBqrSMIwtfLz8+PFy9eZOmchIQEatSoQZkyZdi3bx8XLlzgwoUL0n5RxTVj9vb22Nvb07RpUwAuXrzI7t27U9UTyazPW45NnjyZVatWIZfLMTAwYOTIkakKlQqCIHwPDA0N021NLAif+24T7ytXrrBx40b++ecf1q9fT+XKlfPkvn5+foSGhnLw4EHCw8MxMTHBz88PSC44dOnSJRwdHfH09KRhw4Z5EpO6nDx5Mstf6vT09KQCQykJuUwmY9iwYbkSoyAIeW/AgAE8fvyYZ8+eZfqckJAQpk+fjqmpKfv378/F6L59P/74I9OnT2fGjBlMmzYNmUyGs7Nztq83ceJEFAoF06ZN49dffwWSlwmUKlUKV1dXTE1N1RW6IAjfmdOnT7N48WIUCgXDhw+ne/fumg4p35k/f77UoSIpKUnD0QhZ8d0m3uHh4VI7m127duHu7p6r99u4cSN37tzhjz/+UBkZDgoKknpXN2/enAULFmBvb0+jRo1yNR51a9iwISdPnuTYsWPZHk0RBOHb1K9fP5RKJZ6enioF0zJy6dIlLl26lIuRfT9q166Np6cn06dPZ/LkychkMjp16pTt67m7u6NQKJgxYwbx8fFSH/UXL15QoUIFunXrRoUKFdQVviAI34lnz57h7+8PQK1atfL1zM+PHz9KS3Dy0rlz5zhw4ECe31fIue828f4vMzMzBgwYwN69e1mzZo3aihR4e3vz5MkTNm7cyNOnT+nWrRv9+vVL81hHR8d8v547PT/++CMtW7Zk/fr1+Pv7p6qQmx0zZsxAoVAwadIkChUqlOPrHT9+HLlcnuc9FgVBgP79+7Nz584sJd6Zoa+vr1J0TUhfrVq1mDlzJtOmTWPSpEk8fPiQ8uXLZ/thqYeHB0qlkrdv37J27VpiY2NZvXo1APfv36datWo4OTllqeWZIAjC1+KHH37g4cOHlCpVStOhCF8JkXj/nwoVKuDi4oK3tzerV6/OceK9fv16Xr58yapVq/j3339V9jk7O1O9evUcXT+/Cg0NzXbi/enTJ7y8vKTXM2bMQKlUkpSUJCXeI0aMyHYhn5MnT6KjoyMSb0HQkI4dO1KlShXpdWBgIOHh4dSvXx9bW9t0zwsLC5PaZpmYmKhMky5Xrhxubm65F/Q3xtbWltmzZ+Ph4cG4ceOoWLFijqaep1TzNTQ05Pnz52zdupW3b9/y22+/AXDz5k1sbGxo3rw51apVU9v7EATh2xMQEMCJEycAcHV1pWrVqhqOKGOWlpbZ6oSUE61atSImJoaTJ0/Sp0+fbzan+BZ914m3mZkZNjY2xMTEAFC2bFn69OnDoUOH2LhxY7oj01+ybt06oqKiWLBgAZGRkan2f/z4kcTExBzHnp9dvXqVQ4cOZVhxN0VMTAyrV6/m06dPTJs2LdX+OXPmqBxbokQJ+vXrh5GRUaZjCgoK4syZMyLpFgQNGjJkiMrr/v37S7UuBg4ciJWVVapzbt++zYIFC6TX1tbW0rpiIXusra2ZP38+SqWSI0eOMHbsWORyeY4Ki06aNAlIfhBy//599u7dS0REBN7e3gC4uLhIbTEdHByoWbNmzt+IIAjflEWLFvHnn38Cyd+n83M18xQdO3bMs25IKYYPH46pqSknT55k1apV6Orq5un9hezL//9Hq9nVq1dZtmwZHz58YNq0aRgaGkpf4ipUqMCIESPYtGkT48ePRy6X4+LikuE1165dy8ePHwGYMmUKsbGx6R7r4uKS5pfLb4GNjQ2Ojo6cPHmS7du3Z5h4R0VF4evrS3R0NNOnT8/UPVK+gL9584bx48dnunXD4cOH+fTpU77vhy4I35OGDRty6tQpdu7ciZ2dXZqfjWfOnMHHxwdI7jrRqlWrvA7zm1SzZk28vLxQKBQEBAQwfPhw5HI5Tk5OObpuSuXzqlWrsnDhQl6+fAmAr68vvr6+AHTr1o2ffvoJSH4I8KXZDoIgCILwrfjuEu+LFy8SGRnJ1KlT6du3L9evX1d5yl+qVCm6du3Kjh07GDVqFB8+fMjwmqNHj87UKHabNm2oVKlSjuLPb0JCQkhMTMTe3p4GDRowa9YspkyZQlhYGIGBgbRs2TLdc1+/fs3YsWOl13K5PMMp/uvXryc+Pp6FCxcik8kYO3Zshmtrzpw5Q0hICE5OTl+MRxCEvOXi4sKFCxdYs2YNISEh3Lhxgxo1aqR7fN26dRk9enQeRvhtq1GjBsuWLWPUqFEcO3aMQYMGIZfLVfqlZ9e4ceOA5A4ikDzrKGV9/x9//MEff/wBgJOTE926dVM5t2LFitSrVy/HMQiCIAhCfvLdJd4ADRo0kFpYWVpaYmlpKe0rX748ixcvplixYrx7947hw4dn6pq9evWicOHC+Pn5ER8fD0CHDh04deoUUVFRAAwbNgxra2s1vxvNOnLkCHFxcdjb2wNQv359+vbti6urK+vXr0830Y2KipK+eGlra+Pq6sr/a+/Oo5q4/jaAPyGssoiiFlBBiwoq+IrSUpRaBbU/RKqAO1UsrWtb34pVi9Xao7VYl2JR676AWsUVFdFKBVcsiOIKlKq1LoSfWxEQhUDy/kHNK64sGSYhz+ecnJNMJneeBE4y35k795qYmOCnn3565fbq16+PhQsXori4GD/88AP69+//2sJ727ZtKCgoQMeOHavxDomoNsTExMDFxeWVhTepn5OTE5YsWYJx48YhMTERI0eORHR0tFquWXxSfAPAzz//jMOHDyM1NbXCHOx79ux5bro4Dw+PCq9t3Lgx3nvvvRrnISIiEpPOFd4tW7Z87fzYzZo1w8qVK3H79m2YmJigqKgI27Ztq7DOk8L9icjISCQkJCAmJgYlJSXw8/PDokWLMGTIEKSkpKj9fWiSc+fOIS0tDW5ubgCAVq1aoWvXrrh69SqSkpJeeF11Tk4Opk+fDqC8mF65cmWltjVnzhxs2bIF7du3R2JiIuLj49GyZcvXFt9DhgyBj49PFd8ZEQmtY8eOsLOzw/Xr11+5XqNGjXipiEDatGmDlStXYtKkSSgoKMDQoUOxYcMGGBgYqO17c/z48Rg/fjxWrVqlmsrz4sWLuHLlynPrnjx5EgMHDlQ9btu2LebOnVul7fn6+kIqldYsNBHVOgcHB/Tr1w8SiUTsKC+UmJiI8+fPAyi/7JGoKnSu8O7Zs2elp55p0qQJ1q9fj7y8PBgYGFR47sm1ak/s3r0bwcHBePjwIfr06YOlS5eiefPmquffe+89NG3atMb5NVF8fDzatm2rKrw9PT0xfvx4BAUFITQ0FIsWLapwtiIvL0+146Wvr/9cN8PK+P777xETE4OIiAhIJBKMHz/+hcV3WloasrKyYGdnV813R0RCGj16NDIzM7Fo0aJXrufl5aW6fpjUz8HBAbGxscjOzoajoyP69esHQ0ND7N27V62X6IwaNQqjRo0CAPzyyy/YtGmT6rmrV68iKyvruddkZmZWeaaMXbt2wdDQ8Lnlnp6esLCwqGJqIqot7u7uWLhwodgxXmrr1q2qWRuIqkrnCu/qsLS0rLBz8Ky4uDgMGjQIJSUlqrmsbW1tK6zz9ddf18muzu3atYOTk9Nzy+3s7PDWW2/h1KlTCA8PVxXe//zzD9asWaPagW7SpAmWLl1a6e0dOHAADx48AADMnj0bBw8exKxZs/Duu+8+V3ifOXMGYWFhkMlknMaGSENlZWXh2rVrYsegf9WrVw/e3t4oLi7G8ePH4evri19//RVeXl5q39awYcMwbNgw1eN9+/YhIiJCLW0vWbIEQPk0kgqFQrV8+fLlFeYVd3V1hZWVlVq2SUR137Rp0+Du7l6tmY+IWHjX0P79+xEQEAC5XA5vb29ER0erCsBjx47V+W4ogYGBkEgkOHPmDC5evKi6Xt7T0xOLFi3C3LlzVWfCAeDPP/+s0Zy7n3zySYXPtEePHrh06dIL1126dCl+++03REZGqmWwICJSv8jISMTGxr7wOZlMhuzs7FpOpNuaNWuG3377Dffu3YOvry9SUlLQq1cv1dy63bp1E6wLqK+vb6Wnoawsf39/1dSeycnJz01p98MPP+Djjz9m8U1ElWJnZ4e2bdsCKJ9pg98dVBUsvGvg4MGD8PPzQ7du3WBgYIBNmzZVmFt6+/btuHHjBjp37lylOae1TUBAAP7++29MmzYNc+fORbt27QAAXbp0eW7QHHXo2rWras7CuXPnIjk5GWlpaejYsaPqc75w4QJu3LiBNm3awN7eXu0ZiEg9HBwc0LBhQ9y/fx/Xr1/HyZMnVc/t3LkTCxYsEDGd7rKyssKBAwfQq1cvpKWloXv37gCAo0ePokuXLlpz/fSuXbtU94OCgp67pnznzp3w8PB47dgvRETPOnr0KFq1aiV2DNIiLLyrKSkpCT4+PujatSt2794Nc3Pz59b56aefkJKSgsGDB6NFixa1H7IW2dnZoaCgAAcPHlQV3uqWnJyMR48eYe3atc99nmFhYejQoYNqJN74+HjI5XIsXLiQZ7uJNNikSZNw8+ZNLFq0CCtXrnzhQIumpqbcuRGBpaUlDh8+DE9PT5w9exZA+Rnvo0ePwsPDA/r62rUL8apLxohIM6Snp2P27Nn4+uuvoaenJ3YcjbR161bs2LFD7BhUDdr1q6kBFAoFkpOT4eXlhXfeeQcHDx6EsbHxK18TGhoKZ2dn9OrVq5ZS1r7AwEAEBga+cp38/HycPXsWBgYGcHNzw6NHj3D79u0K6ygUCtUZry5dulTo0ujv7w97e3uYmJi8Ns/UqVMxderUarwTIqpttra2qmnEcnJy8M8//8Dc3Fw1KKK/vz9mz54tZkSdZWpqipSUFHTq1AkAcOnSJXTr1g3Hjh2DhYUFnJycXjiIGRFRdWRmZuKbb75BWFgYC++X2LhxI/bu3St2DKoGFt5VUFZWht9//x3vvvsu3NzccOzYMa074i+m8+fPY8yYMXBxcUFycjIuX74Md3d3pKamAgCkUilcXFzwxRdfAAAWL15c4Uu3Q4cOiI6Oho2NjSj5iUgYkydPxuTJk3H37l3MmjULixcvhr+/P+bNm/faqQJJeIaGhrh48SKA8gE1s7KyVF2zDx06BE9PTxbfRKQTvv32W45qTtXGqrGSSktLkZqaCk9PT7i4uODUqVOVel3btm1x5swZXL58GW+//Tbq168vcFLtYWRkhMaNG8Pd3R1A+dRip06dwqpVqwAAnTp1glKpBFD+OR45cgSNGzcWLS8RCSsyMhKrV6+GqakpoqOjYWZmVqVZD0h4GRkZaNeuHR4+fIgbN27A29sbhw4dQosWLdC0aVMYGRmJHZGItJSjoyMyMzNx69YtpKen480339S4wctyc3Nx9+5ddOjQgd93VGXsw/EacrkcGRkZOHXqFDw9PeHs7Izz589X+vXr1q2Dh4cHxo8fj+PHjwuYVLM9fPgQf/31F/T19dGmTRsAQPPmzZGUlARHR0e8+eabKC0thaurq+qmVCrRqlUrODo64sSJE68tuq9fv478/PzaeDtEJJDJkydjwYIFlbqkhMSRkZGBv//+G//zP/8DPT09eHt7w8HBAYmJiSguLhY7HhFpqSVLlqgG1Hz77bexe/dukRO9WKdOnXDu3Dk0b95c7CikZXjG+yVKSkpw/fp15OTkoEePHrCzs0P79u1x4cKFKrdlZ2cHfX195OTkoLCwUDUi9+vk5eXh7t27FZaZmppqZVfrlJQUjBgxAm5ubti+fbtquY2NDbKyspCXlwdXV9fnXnfhwoXXXkP/xLhx42BjY4N+/fqpLTcR1Y6CggIAgJmZGcaOHYvi4mKcPXsWDx48YE8hDZWenq7aAVUoFOjTpw/27duHzp07w9LSkmeDiKjKOnbsiIULF+LLL79UW5uRkZG4ceOG6nFwcLBq+lui2sTC+wVKSkpw7Ngx9OzZE3p6eujYsSNOnz5d7fY2bNiA3NxcjB49GkqlEkFBQTA1NX3t6/bs2YOvvvpK9biwsBBvv/021q5dC6C8q7a6rn+UyWSwsrIS5Dq9Fw2i9ixLS0v89ddfat82EWmH7777DhYWFpg8ebJq2fr166Gvr6+6/IQ0z5kzZ9C5c2f88ccfePTokWoe7l27dqFbt24wMzPj9d9EVGlOTk5wcnKq8FtQU9HR0RX247t06cLCm0TBrubPkMvlOHr0qNqK7iesrKwglUoxZswYbNiwAY8ePXrta0aMGIGcnBzVbfPmzUhPT4erqyvatWuHvn37Ijc3V3W9SU307NmzWmfzK+PIkSMYOnSoIG0TUd1gZGTEM6Ra6vTp0ygsLIS7uzsMDAwgkUjg7+8PKysr7Ny5EwUFBSgoKIBcLhc7KhFpkfHjx8Pf37/G7fz666+QyWSqm4+PDxISEmBlZQUrKyusWbOmUu00a9as0usKzcfHBzKZrFIn8khzsPB+ilwux5EjR9CrVy9IJBK1Fd0AsGXLFgwePBh6enoYN25che7WleXr64t79+7h3r17OHDgADIzM2Fvbw8bGxu4u7vj/v37yMvLU0teIejp6cHS0lLsGESkYUpLSzFz5kxV18KysjJVkfb0fdJsycnJKCkpQY8ePVRTQQ4dOhQWFhawsLDAmjVrUFxcjLKyMpGTEpGme++992Bqaors7GwcOXIEjx8/rnZbVlZWsLa2Vt2MjY1hZmYGZ2dnODs74+7du5Xa38/NzUXz5s3x1ltvVTuLuhgbG8Pa2rrCtLuk+Vh4o3ynLz8/H4cPH0bv3r1haGgIV1dXtRXdT2zatAlDhw6Fnp4eHj16hPz8fJSUlFSrLU9PTxQWFiI5ORmGhoa4efMmrK2t4eTkhPz8fNX1kprEw8MDCQkJYscgIg0zefJkREREAACUSiUWLFig6ma4bt06fPzxx2LGoyo6dOgQvL29n9shHDduHIyNjREZGQmFQgGFQqGauYKI6GmJiYnw9/dHRkYGunfvjtzcXLW27+HhgSNHjuDIkSPIzc3FRx99VKnXffXVV1iyZIlas5Du0LnC+9kzKY8fP8aBAwdgaWkJHx8fvPPOOyguLlZ70f3Exo0bERQUhLFjx6J+/fpYsWJFjY7+d+7cGcXFxSguLkZmZibu3r2Lhg0bwsbGptKjyxYXF0OhUFQ7w6soFIpqH1wgIt0zZ86cCmNbkHZKSEiAQqFA//79n3suNDQUUqkUUqkU33zzjQjpiEgbBAcHY8qUKQDKC964uDhBtjN48GDMmjULADB79mzs3LlTkO0Q6VzhvXbtWowaNQpKpRKxsbEwMTGBn58funfvjtLSUiQnJwueITo6GiNGjIBEIsGECROwePFitRz5d3BwQGlpKW7evImioiKYm5tXqqBu3749srKyarTtl4mLi1ONMq6np3P/bkRUSVOmTEF4eDimTZsGuVyOhQsXAgBCQkKwfv16ccNRtW3fvh1yuRzDhw9/4fNz5sxRFeGffvppLacjIk327rvvws/PDwAQExMj2Emxd955R3WQcPPmzTh58qQg2yHS2Upo69atGDBgAACgd+/eSExMrNXtr1+/HgqFAuPHj8fEiRMhlUrx/fffq6Vta2tr3L17F3K5XGNGk+3RoweOHj0qdgwi0kDz5s3DxIkTMX36dBgZGcHExETV1VxPT48H7bSYVCqFvr4+Vq9ejaKiogq3adOmQalUqrqdL1++HGPHjhU7MhFpEA8PDxQUFMDW1hazZs2Ck5OToNtLS0uDtbU1bG1tVctiY2NhaGjI8SmoxnRybyYqKgpDhw6Fv78/5HI54uPjxY4EAJgxYwakUimmT59e47YaNmyIf/75p9LrP5mPtbZkZGSgdevWtbY9ItJcBgYGmDNnDiZNmoTS0lKUlpZCoVDgk08+QWRkpNjxSA0MDQ1hYmJS4TZjxgzk5eVh9uzZAMovTVq1ahWMjIwwcuRIcQMTkUaQSqUwMzODr68vWrRoAZlMhri4ONy/f1+Q7dWrVw+tW7eGp6cn4uLiEBcXh5MnT0Iul6NPnz6wt7cXZLuVIZfLERcXh5ycHNEyUM3oZOH94YcforCwEJs3b4a+vj6kUqloWSIiIlTd654c+Q8PD0dYWFiN265fv/5rB1lzdHTE1atXIZVK1T4yYmxsLAICAtCzZ0/s379ftfz8+fMYOnQoLly4gOvXr6N58+Zq3S4RaR9jY2PMnDkTd+7cUd0iIiJgYmIidjQSiLGxMerXr49Jkybhzp07WLBggWpckI0bN8LCwgKDBw8WOyYRaYCVK1ciODgY+fn58PPzw6VLlwTb1gcffIBly5bBz88Pfn5+mDdvHgBgx44deP/99wXb7us8fPgQfn5+gnW5J+HpXOEdHByMFStWoF69ehoxZ6yhoaGqO/j06dMxbdo0KBQKzJ8/H1OnTq1R2xKJ5JU7rY6Ojvjzzz+RmpqKdu3a1WhbL1JWVoaysjJIpdIKn3X79u1x/Phx5OTkoHXr1rh16xaLbyKCqakpGjVqpLqZmZmJHYlqgYmJCRo1aoSxY8fixx9/BFD++1FQUIAdO3Zg4MCBIickIk0QGBiImJgY1W3IkCEICgoSZFtmZmaIiYmBi4uLIO2TbtK5wtvQ0BD16tUTO8YLGRsbY9q0abhz5w5yc3PRtGlTWFhYYMKECWrdTosWLWBhYYE///wTSqUS5ubmtXLWPyUlBRYWFmjQoAF8fHxgb2+PW7du4fbt2zh79iyA8hHWn8z5WlpaKngmIiLSDKamphg1ahSuXbuGa9euYfXq1SgrK8OuXbtUY7IQkfZ70sOzqtq3b49BgwZh0KBBOHfuHGJiYrBlyxZBpiY0MjLCoEGD0KxZM7W2S7pN5wpvTff0GZ+QkBDMmDEDy5Ytw+eff662beTm5qKgoACnTp3CrVu34ODgoLa2n9i9ezdGjBhRYVnHjh3xyy+/oGnTpti5cyekUqnqvVpZWQEoPzCSkZGhkfOQExGRsMzMzGBvbw97e3sMGTIEa9asQVlZGXbv3o3AwECx4xGRGqSnp0MqlSIzM7PGbSkUCkilUmzevFkNyYiEpS92gNq2fv16WFpaqq7X0GRmZmYYO3YsBg4cqNYul9nZ2VAoFGjWrBn09YX5F3j48CGKiorg7e2NqKgoAOVHD3v16oVDhw6hSZMmuHbtGjw9PVWvsbCwQEZGBpo1a4a//vpL1GvviYhIXKamphg0aBAkEglCQkKwZ88eBAQEcI5dIqrgww8/RMuWLZGbm4vExET4+/tzfBDSSDpXeMvlcty+fVvsGJVmbm4Oc3NztbZpZ2en1vZexdTUFG+88YbqsZGRkWqKBltb2wrTuD09ZVCLFi1qLSMREWkmMzMzDBgwAK6ursjIyEBwcDA6dOgAOzs7xMXFiR2PiESmp6eHDRs2AAASEhIQFBQEmUzGwps0ks4V3iS8PXv2IDQ09LXrGRoaok2bNrWQiIiItJW5uTk6duyI1q1bIyoqCkFBQcjIyEDfvn1ZfBNpoZYtW2Lp0qVqH1i3U6dOiI+Px2effYaioiLY2dlh+fLlNW63a9eu+Prrr1WDIYtt5syZ6Nevn9gxqBp4jTep3f379/Hf//4XXl5eiIiIEDsOERHVAaampujXrx+OHz+OLVu24MCBA+jbt6/YsYioiszNzeHh4aH2s9JWVlbw8fFBeno6EhMTkZKSgry8PJSVlVW5LaVSiby8PMjlctja2sLHx6dCz0wxubm5wdXVVewYVA2a8R9EdVLDhg3x5ptvih2DiIjqCFNTU3Tt2hW+vr7YsmUL9u/fj+7du4s6ty4RVc358+fRoEEDZGdnC9L+lStX8PjxY2zevBkNGjTAmTNnqtzG/fv30aBBA/z2228CJCRdxa7mREREpFVMTEzQt29fxMTEYODAgZBIJPjPf/6DAwcOiB2NiDREgwYNMG7cODRp0kTsKDV24cIFJCQkiB2Dakjnznj7+PhgypQpYseos+Lj4xEeHo4ePXpg5syZYschIqI6ytjYGB988AG2bt0KpVKJX3/9FX5+ftXqVkpEdc8bb7yBn3/+Gfb29mJHqbGkpCvRWoMAAAyiSURBVCRMmjRJ7BhUQzpXeDdr1gzt2rUTO0addfPmTWRnZ8PW1hbOzs5ixyEiojrM0NAQ/fv3R0xMDAAgLi4OAwYMQHFxscjJiEhIP//8M8LCwsSOQVQlOld479u3D4sXLxY7RgUhISHo37+/2DFqLD4+vtY/27CwMKSnpwMAZsyYAXd391rdPhERicvAwACBgYHYsmULACA2NhZBQUF4+PChyMmISCguLi5o3bq14NsxNzdH48aNBd9OZXI0atRI7BhUQzp3jXdOTg5Onz4tdowKnJ2d4ejoKHaMGrt69SouXrwIADh06BAWLVqEL774QtBtJiYmorCwUHXfz88P1tbWgm6zOiZPnoy///5b7BjPYZdMepUrV64gLCwM4eHhYkdBamoqlixZInaMSnF1dcXEiRPxxx9/YM6cORWea9y4MRYuXChSMvWaMGEC8vLyxI7xQjt27IBUKoWRkVGlX5OUlCRgIiLSRjExMfDx8RE7Bj766CP4+/ujQYMGYkehGtC5whsoLwqHDx8udowKUlNTYWBggKysLLGjVFtGRobqfm5uLn744QfBD3JkZmaq7p84cQKhoaFo0aKFoNusjm3btrHrI2mdR48eISIiAnfu3BE7Ci5fvowjR46IHaNSDh48iEuXLiEnJwf79++v8JyBgQEePHggUjL1ioqKQmlpqdgxXmrr1q1iRyAiIlLRycL75s2b2Lhxo9gxXujSpUuvfN7Z2fm1gyvk5eVh4sSJkEqlWL16NZRKJUJCQgAAy5cvh5GREcaMGYPw8HB8++23KCgoUFv+p+Xm5qrlc166dCm++OILyOVyzJs3r0KXH29v7xq3Xxs0PaepqanYEUiDODg4YNmyZWLHqMDNzQ1DhgwRO0aVffDBB2JHEIybm5vYEQTRrVs3sSMQEVEdpDOFt7e3N1asWCF2jBqzt7d/7XylRUVFqFevHgwMDDBy5EgolUrI5XIA5deT6+vrQyqVIiAgAE2bNtX4sy8jR46Eubk5Hj16hCFDhsDCwkLsSER1mrW1NcaOHSt2DCIiIqI6Q2cKbxcXF7i4uIgdo1bUq1cPo0ePVj2WSCQVHgNQdbUfPHhwrWarLk27NICIiIiIiKiydG5UcyIiIiIiIqLaxMKbiIiIiIjoGevXr9e4gRqjoqJU0yeSdmHhTURERERE9IytW7di+/btYseoYPv27Rp3MIAqR2eu8SYiIiIiIqqsdevWwdfXV+wYVEfwjDcREREREdEz3njjjQrT2BLVBAtvIiIiIiIiIgGx8CYiIiIiIiISEAtvIiIiIiIiIgGx8CYiIiIiIq0ybNgw3LlzR+wYtaZ+/fq4d+8eevfuLXYUqiaOak5ERERERFrFyMgIRkZGYseoNRKJBA0bNtSp91zX8Iw3ERERERERkYBYeBMRERERkdZRKBQYOXIkfv/9d0Hanz9/PpYtWyZI26R7WHgTEREREZHWUSgUiIqKwtWrVwVpPykpCUlJSYK0TbqHhTcREREREdG/rKysUFJSgvfff1/sKFSHsPAmIiIiIiKtI5FIEBgYCDs7O7W3bWBgAD09lkqkPhzVnIiIiIiItI5UKsX27dvFjkFUKSy8iYiIiIhIY40bNw5eXl7o3r07Ro8e/cp1161bh/j4eGzbtq3CchMTE/zyyy8AgLS0NMyZM+e12/39998hlUrh7+9f/fBqduLECUgkEo3KpOmKiorEjgCAhTcREREREdUCQ0NDSKVSlJWVobi4GI8fP67U6/bs2YNGjRqhQ4cOiI2NfeW6EREROHv27HPrGRgYYO3atQCA69evv7adp1Vl3dqiiZno1SRKpVIpdggiIiIiIqr70tLS8NZbb4kdg3TMwoULERoaKmoGnvEmIiIiIqJa0ahRI4SEhIgdg3SMs7Oz2BF4xpuIiIiIiIhISBwjn4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLxJCyhQmH0YO9dORY9WC3C6VOw8REQ6ojAbidsXINhWAomk/GYbvADbd5+GTCF2OCIiHfCy7+HEbBSKnY2qRKJUKpVihyB6EYXsNPaeSMLOCZMRLft3ocN8pGV9ic76okYjIqrjFCjM2oBPvUb+//fvM2xGLEHs3FF428awdqMREekIhSwB04cFI/zwi7+IbUJ24NSqADTlqVStwD8TaSZFFtZP34F7em/CL3QEbMTOQ0SkQxS3YvG/ryi6AUAW/Rnchy3F6UKe+iYiUrvCVPw4LAy3fJcgLacYSqUSSuUD/HFoDaZ0L98zlq39DB/+mMoz31qChTdpJj0nhKz5HiEBARgQGobverP0JiKqHXdxOPJ7rJX1xpQ1e5/a4StGTtoOzB/h/P+rHp6PL5encaePiEitHiN76wpkfr4D674MQGdVzyILtPEKQfjGJQixAQAZDv8Yi9R8HgDVBiy8SfPpmcLSup7YKYiIdILi1lFs2mCN+Wkx+CGk71M7fIaw6RyAL9cdwKGw3v8uk+Hw8qP4g2NvEBGpT/7v2PNgDH4KsH9hsabXtA+mfjew/IHsPvIesvDWBiy8iYiI6F8KFP5xFv/9bgFCO1u+eBW9pvD6aiqmPOmIdOUy/r7DypuISG0s3sHYUZ1g9tIV9GFu2bD8rk1DWJqypNMG/CsRERHRv4rw57kGCB3Q5tU7CBYd8P7wzrUViohIxxjDzKwyIwnboPd3I9DdgiWdNuDY0ERERPQvM3SeOLES6xmjfmPz8rsOrWDfmLsTRES1Jw+ZKWmwGRGOnwa95kApaQz+UhIREVEVPcaDOwUAAJvATmjNvQkiolqiQGHWPkSd9cPG9UPhZMayW1vwp5KIiIiqRnEX187mAPBF6KBOsBA7DxGRTlCgMDsWs8fFwmXBOnipBr8kbcDCm4iIiKpAgcL0/dhwUAabkBAMdX3JIGxERKQmJZCd/g0nkmIwYXI0ZADgdhkXflyOuf/bFTY86a0VWHgTERFRFdxH6tZNOGzzKXbM6oum3OEjIhLQDewM7oHA6CvPLL+I6FBPJFzcgVOrAvhdrAX4JyIiIqJKUqDw9AbMnleMkCWT0b8puzkSEQmrOQKiLkOpLEZO2j5smz8CNk89K1s7E9/E/g3O5K35WHgTERFR5RSmYfmXS4GwH/Fdf3vuRBAR1RpD2HTugwFfrkP2HzswpfuT8vsi1q44hMusvDUefzOJiIioEvJwevks/Gg3A8umefOaQiIiUejBrE1/zFgwGd2fLLpwGTcLWXlrOv5sEhER0WuU4NbO6fDb5429S4dz+hoiIlHpwczVB8N7/3vWW3YfeQ9ZeGs6/nISERHRK5RAlhiODxc3xsZfPkVnFt1EROLTawHPwZ7l9x1awb4xx8zWdPwLERER0UsoUHh6KYZ9eAefn/qRc8YSEWkMfZhbNgQA2AR2QmtWdRqPh62JiIjoBRQozNqATwdfxPDE7xHw0hHMFSg8vQoLEu/WajoiIt1WioK8+wA6Y/j7HWAhdhx6LRbeRERE9Ix/i+6+R/FeXARCnF62S5eP7ISf8Ongv9DJrWGtJiQi0mmKazgecxw2IdMwoXsjsdNQJbDwJu1SdB8Pijh4BBGRcEogS12GT71GIvrKWnzctj4kEslLbvXh2DsUCYE94WbBXQoioppToPB0BHpIJLANjkBCdv4L1inBrdglmF4yBhu/64um/PrVCvwzkYZToDArEbsTrpQ/lO1F1PYMFIobioiojiofSG2Y+2eIllX2NezmSESkPiXIOXcShwHIokPR23EgpkalQvbkvFNhNhIWjENIihcO753BsTe0iESpVCrFDkH0vFLIdn4G28AVL19lxA7kRAXApvZCERHVbbKdCLYNRHRVXmMThkNZ38GLZ7yJiNRDIcPpDYvw5ch5OPz08u5TsObzLmjh3ANebXi4U9uw8CYiIiIiIiISEA9PExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgP4PwwUMk71kkfwAAAAASUVORK5CYII=" alt="" width="500" height="171" vspace="0" hspace="0" border="0" style="width:500px;height:171px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>&bull; Get the Vigamox bottle and stand in front of a mirror<br />&bull; Wash your hands<br />&bull; Twist off the cap<br />&bull; After cap is removed, if tamper evident snap collar is loose, remove before using the product<br />&bull; Hold the bottle, pointing down, between your thumb and fingers<br />&bull; Tilt your head back. Pull down your eyelid with a clean finger, until there is a &lsquo;pocket&rsquo; between the<br />eyelid and your eye. The drop will go in here ( picture 1 )<br />&bull; Bring the bottle tip close to the eye. Use the mirror if it helps<br />&bull; Don&rsquo;t touch your eye or eyelid, surrounding areas or other surfaces with the dropper. It could infect<br />the drops<br />&bull; Gently press the bottom of the bottle to release one drop of medicine at a time ( picture 2 )<br />&bull; After using Vigamox, press a finger into the corner of your eye, by the nose for 2 - 3 minutes<br />( picture 3 ). This helps to stop the medicine getting into the rest of the body and is important in young<br />children<br />&bull; If you are using the drops in both eyes, wash your hands before you repeat the steps for your other<br />eye. This will help prevent spreading the infection from one eye to the other<br />&bull; Close the bottle cap firmly immediately after use</p><p>&nbsp;</p><p><strong>If a drop misses your eye</strong>, try again.<br /><strong>If you use more medicine than you should,</strong> rinse it all out with warm water. Don&rsquo;t put in any more<br />drops until it&rsquo;s time for your next regular dose.<br /><strong>If you accidentally swallow Vigamox </strong>contact your doctor or pharmacist for advice.<br /><strong>If you forge</strong>t to use the medicine, continue with the next dose as planned. Do not use a double dose to<br />make up for a forgotten dose.<br /><strong>If you are using other eye drops, </strong>leave at least 5 minutes between putting in Vigamox<br />and the other drops.<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines Vigamox can cause side effects although not everybody gets them.<br />You can usually carry on taking the drops, unless the effects are serious or if you suffer a<br />severe allergic reaction.<br />If you experience a severe allergic reaction and any of the following happen, stop taking MOXIVIG<br />immediately and tell your doctor immediately : swelling of the hands, feet, ankles, face, lips, mouth or<br />throat which may cause difficulty in swallowing or breathing, rash or hives, large fluid - filled blisters,<br />sores and ulceration.</p><p>&nbsp;</p><p><strong>Common side effects</strong><br />( May affect up to 1 in 10 people )<br /><strong>Effects in the eye</strong> : eye pain, eye irritation<br /><strong>Uncommon side effects</strong><br />( May affect up to 1 in 100 people )<br />Effects in the eye : dry eye, itchy eye, redness of the eye, eye surface inflammation or scarring, broken<br />blood vessel in eye, abnormal eye sensation, eyelid abnormality, itching, redness or swelling<br /><strong>General side effects</strong> : headache and bad taste<br /><strong>Rare side effects</strong><br />( May affect up to 1 in 1000 people )<br />Effects in the eye : corneal disorder, blurred or reduced vision, inflammation or infection of the<br />conjunctiva, eye strain, eye swelling<br />General side effects : vomiting, nose discomfort, feeling of a lump in the throat, decreased iron in<br />blood, abnormal liver blood tests, abnormal skin sensation, pain, throat irritation<br /><strong>Not known</strong><br />( Frequency cannot be estimated from the available data )<br /><strong>Effects in the eye </strong>: infection in the eye, eye surface becomes cloudy, corneal swelling, deposits on the<br />eye surface, increased pressure in eye, scratch on surface of eye, eye allergy, eye discharge, increased<br />tear production, sensitivity to light<br />General side effects : shortness of breath, irregular heart rhythm, dizziness, increased allergic<br />symptoms, itching, rash, skin redness, nausea and urticarial</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the bottle and the carton after EXP.<br />The expiry date refers to the last day of that month.<br />Store below 30&deg;C.<br />Throw away the bottle 4 weeks after first opening to prevent infections, and use a new bottle. Write<br />down the date of opening on the bottle label and carton label in the space provided.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to<br />throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is moxifloxacin. One ml of eye drops contains 5 mg of moxifloxacin ( as moxifloxacin hydrochloride, 5.45 mg ).<br />One eye drop contains 190 micrograms of moxifloxacin.<br />The other ingredients are : sodium chloride, boric acid, purified water.<br />Tiny amounts of sodium hydroxide and hydrochloric acid may be added to keep acidity<br />levels ( pH levels ) normal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                The medicine is a liquid ( a clear, greenish – yellow solution ) supplied in a plastic (DROP-TAINER)
dispenser that contains 5 ml.
Carton containing 1 bottle
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Marketing Authorization Holder for this Product is Novartis Pharma AG.</p><p>www.Novartis.com&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                02/17
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يُستخدم عقار فيجاموكس قطرة للعين لعلاج عدوى العين (التهاب المُلْتَحِمَة) الناتجة عن البكتيريا.</p><p>&nbsp;المادة الفعالة هي موكسيفلوكساسين، وهو مضاد لعدوى العين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">لا تستخدم عقار فيجاموكس في الحالات التَّالية:</p><p dir="RTL">&bull; إذا كنت تعاني من الحساسية (فرط الحساسية) تجاه موكسيفلوكساسين أو الكينولونات الأخرى أو أيٍّ من المكونات الأخرى بهذا الدَّواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">&bull; إذا تعرَّضت لتفاعلات حساسية تجاه عقار فيجاموكس. تحدث تفاعلات الحساسية بشكل غير شائع، وتحدث التفاعلات الخطيرة بشكل نادر. إذا أصبت بأي تفاعل حساسية (فرط حساسية) أو أي أثر جانبي</p><p dir="RTL">يُرجى الرجوع إلى قسم: 4.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull; إذا كنت ترتدي عدسات لاصقة &ndash; فتوقف عن ارتدائها إذا كانت لديك أية علامات أو أعراض تدل على حدوث عدوى بالعين. ارتد نظارتك بدلًا من ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تبدأ في معاودة ارتداء العدسات اللاصقة الخاصَّة بك مجددًا حتى تزول علامات وأعراض العدوى وحتى تتوقف عن استخدام هذا الدَّواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull; حدث تورم بالأوتار وتمزقها في الأشخاص ممن يتناولون الفلوروكينولونات عن طريق الفم أو عن طريق الوريد، لا سيما في المرضى من كبار السن وفيمن يتم علاجهم بالتزامن بالكورتيكوستيرويدات. توقف عن استخدام عقار فيجاموكس إذا أصبت بألم في الأوتار أو تورم بها (التهاب الأوتار).</p><p dir="RTL">&nbsp;</p><p dir="RTL">مثل أي مضادات حيوية، قد يُؤدي الاستخدام طويل الأمد لعقار فيجاموكس إلى حدوث عدوى أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أدوية أخرى مع عقار فيجاموكس</strong></p><p dir="RTL">يُرجى إبلاغ الطبيب أو الصيدلي الخاص بك إذا كنت تتناول أو تناولت مؤخرًا أية أدوية أخرى، بما في ذلك الأدوية التي حصلت عليها دون وصفة طبية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">استشيري طبيبكِ قبل استخدام عقار فيجاموكس قطرة للعين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد تجد أنَّ الرؤية لديك غير واضحة لوقت قصير فقط بعد استخدام عقار فيجاموكس. فتجنب القيادة أو استخدام الآلات حتى يزول ذلك التأثير.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ناول دائمًا هذا الدَّواء كما أخبرك طبيبك بالضبط.</p><p dir="RTL">راجع طبيبك أو الصيدلي الخاص بك إذا لم تكن متأكدًا من كيفية الاستخدام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة المعتادة هي&hellip;</strong></p><p dir="RTL">البالغون، بما في ذلك كبار السن، والأطفال:</p><p dir="RTL">قطرة واحدة في العين المصابة أو العينين المصابتين ثلاث مرات يوميًّا (في الصباح وبعد الظهر وفي المساء).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن استخدام عقار فيجاموكس في الأطفال وفي المرضى الذين تزيد أعمارهم عن 65 عامًا والمرضى المصابين بمشاكل في الكُلى أو الكبد. هناك معلومات محدودة جدًّا حول استخدام هذا الدَّواء في حديثي الولادة ولا يُنصح باستخدامه في حديثي الولادة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">استخدم هذا الدَّواء في كلتا العينين فقط إذا أخبرك طبيبك بذلك. استخدم عقار فيجاموكس فقط للتقطير في عينيك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">تخف العدوى عادة في غضون 5 أيام. في حال عدم ملاحظة حدوث أي تحسن، اتصل بطبيبك.</p><p dir="RTL">يجب عليك مواصلة استخدام القطرة لمدة تتراوح من يومين إلى 3 أيام إضافية أو للمدة التي أخبرك بها طبيبك.</p><p dir="RTL"><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAA94AAAFTCAYAAADP3NQEAAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAB3RJTUUH5AYPDSkJo2Ci3gAAIABJREFUeJzs3XlcTfn/B/DXvS1oI0tkbQZlHUOM+dnGDBqDIRJjyzZkl6xJpJBkZLIbWYdByjLGkmWy9bXUMMaQZAgtorTSdu/5/dF0pqsidO9peT0fj/t4OOee5X1u5L7O+SwyQRAEEBEREREREZFayKUugIiIiIiIiKgsY/AmIiIiIiIiUiMGbyIiIiIiIiI1YvAmIiIiIiIiUiMGbyIiIiIiIiI1YvAmIiIiIiIiUiMGbyIiIiIiIiI1YvAmIiIiIiIiUiMGbyIiIiIiIiI1YvAmIiIiIiIiUiMGbyIiIiIiIiI1emPwzg5diUYyGWRFejXCyIDHQHYoVjYq6j4yyEYGIEZTV0tERERERESkYW8M3tqWsxAhCBBS7sB/jlWB25jarcWV6AwIQgR2DKgHaFtiVoQAQUjCXX8ndC14J6y6Eg2FIEDYMQCmH34dpYASqaHrMDfgsdSFEBERERERkQYVram5QRMMcLCHXb43usJx2kh8ZqpbwE5GMB8wEVPtGuZ7x3TESIz9zLR8tXNPDcHGWRsRK3UdREREREREpFGSZF+9GpWhJ8WJJZOI0I1umB30SupCiIiIiIiISMPK1UNnaWQi5uyPmDX7N6kLISIiIiIiIgkweKuVEqlhv2DecFcESV0KERERERERSYLBW22USA3bhclfjcJODttORERERERUbpXg4J2M8LMB2Dr36zzTj7XEyJV7cDg0Bsp82z9GwMhGb5i6bAICYtIREzDh7VOioaCp1CYgICa7iLVnIubqhgJC933stKlfhGO+67UXRWGfz5uu+W11KpEaflalztojVyIgNAZKZSQCpqxD6Bs/skzEhB5Vvc7aI7HyQBDCU9/vKomIiIiIiEqakhm8U29h68iOsOhmg7FXLeF/NwmCIEARvQp1fpsF67aW6DY34LVwVg8D1h0teNozK1/cVWzEANOKMB2wHil3tsPu9TnMTCfD/8ntnCnRkDOVWnh0IJy6msLUbjvupKzHAFPtIhSvRPJZV1i2n/J+T7rf69qLoh4G7AhBiFfvQrfQtpyFiJQr8OpalAnelEgN/RHfWnTD2KsdcCY6A4KgQLhzS/zjYwUtLTPYnHjDYHKpYQiY+y1qt/0WC2KH4k6KAoLiCc6MisVs2y9h8a07zsZkvuM1EhERERERlTwlL3grIxEwfQjG7rwFwBJzXBwxwNwIACA37YZ5LqNgihgErbBB18m7EJY3gBo0wQAX9/zB8a8IPBG3k8OgyRAsWztZdf7wmDgkpqmGWXnNemik+yWWOA9GE4OiflRyGH21DNGCgKwQL6hOptYQdv6PIAjCv6+NqmH+Q669SKqg1ZddkX+CtzwMmuHL3hZvP1RqCDbO8kIQgIa9+6CLqS4AOQzMv8asdb/A165F4fsqIxEw3RY2KwIB2P73+crroOuowbACgCBXdBu6DqF88k1ERERERKVcCQvemYg65IUpW2/9u/wxLOoa5HlfDqO23THi38Qcs9MJ0/eHqza9NvgEfUd0Uj1szHZ4Hsi7nTYMqxi9dm4/LPANRnKeNcqIYAR8OhYDzSt+0FUVTTFcuwZl3z2PjUE5j/Tv/3YU5/M+nTZogVHOM1BA2wPku06rnujU6L/PV/5xK/TIvTMQ5IX5El4jERERERFRcfjA4B2E2W0N39Bnuj5sdt4v+uFSb+CXNQEQW2ibNoJZLV3VbfQqo4Y4CXgMAhfsRFBy3mhWEeYDJ2CO6uNsBO4LRoS4WQJCTt6ERVfVZ78xu04jRDxWOiIuXkXzrz/B6xFdLYrl2jUlG88iIyD+ZINc0c1yHLyv/tf/XG7eF3OHGuTfNfkifKasE6/T9FMz1Mr7t1DbBB93zP25vP5zIyIiIiIiKn0+MHh3hVdISp6m06+/HsHf7o0Nm/NQIvnqIawKytMxWq8qKuu9pcSYQJwMSVBdZ/QJvh5hqbou8AQuRqTn/Dn5Jk7+3Q+e8we91tw8z7GUD3ExwARft61axPo/RDFeu0bIoV+l6muf3U44trfC6JUn/+1/Xh1fuU2ApUq3eCWSQ05jV97LrFEZeniDwKu49bSog9oRERERERGVPCWoqXkmYh9G4N3HI4vGjYfPX2uOXBVtv7ZSDYa4iH0XH0IJJZJDgvD3gM5o2/6/pts5QrHr5E0k499m5s27oq2RJj6i4rx2TVBt9v6fW9g5uycsvl2AgPDkAvbLf533Z7eFzhtbSSQgMYXBm4iIiIiISq8SFLyzkZLw7D32i8H9hLTXwmdBwTC3afZzhJyMw4BOZpAX8GQ8p7n5S802My/Wa9cQo06Y9voAdbmCPGBjYYv5Z6Neq62A67TzR3ShLSYECMJ+jNFIH3siIiIiIiL1KEHBu5gZdcDYJbaq62ICcTLwJE7+/dm/A3pVxWeDhqHr69tcuarBZuallS7qDFiGIH8n1c9PFAiPbvZYFZr45sPEJiKFfbiJiIiIiKgMK0HBWxuGVWu8x36maFhVv4ALqYhGnXq+NrJ2KFbY/gg49oW5HADkMGj9DUZYmapss2uZB84NGIquGmlmDhT/tWuKEcwHLMGvd/0xp8C5v3/Dqv1/oKBG5yKVqd6IiIiIiIjKnhIUvHVRy6xRwU2X36g2PjWrXuCFyBt1wGCr145oaqX6JFtuhk6DVacfiwmqjC86mWnwwyn+a9ccOQzMB8Dz17Pwn5N/ArEY/z9wT+yiXRG1P35tjnDJBogjIiIiIiLSjBIUvAsbsOs1L5Pw7GWe5deDtMoh84dq0xHdXxswrYAn46/NLa1+arj2ws5kWBWq48y/RGziu/YTVyL57Dp4521GbtAEAzz9cLfQpucAoI2aLT7L1wph1+7ziCqwgExEHd4n0ZRpRERERERExaMEBW/k75d9PwKRz14b0TotEbH/TXaNro7W+KzQJuGvh2pLjChgwDTVJ+OmsBrcAY3U/cmkXkfA2aj/lov92gsmN6yCWiprVAdoU0YFYv2qoLcdBXqVX2Hr+rOvBWYjmA+Yg5VevcU1pjZt0DjPlGLyRt1gP6aFagVbF2HhocjXwr8SqWEHsR+fo4vGmvwTEREREREVP0kSzctnSXhZ4DsVYT5oIXztcoNZCK7cyTs4lxLJd0Jw6t8lUzsPbJjQFgZvOJdK0CvsCbHKk/FOGFxMzcy1G7eBjcpT7Ps49ds1RCkTEbpxLxLrVsvzXvFfe4FqNsMXrzW/v//befyZqgRSb2H7/EXYmm9es4Kn9Hq1dRHmb7+FVJW1Bqj9cd1//9wbjoPaqN7okDeAtdtijFEp4Ra22oyH046riFECQCZiQndj2c6KGPRtgxJ2d4iIiIiIiOgdCUWRckfwn2MlAMj3MrVbK1yJzihgpyThrr+T0LWAfWBqJ6y6Ei0oCjmdIvqisMquRc62XZ0E/7tJgiAohJS7/sKcrqZvOW++owlJZ5wEU0AwnXNGSCpsq7u+ghUgwMpXuFtYYe8sSbjjO0YwzfcZtBDsfP8SUgqqo1ivvSAKISVkVcE/F5gKXZ38BH+PrvnqHeP/UOXnlRXiJTTM3WeOr3DmbtJr9Rd+jYKQIURfWSvYmRZUQ+7fq+3CnZRi+0EQERERERFJ5o3B+79wVZRXQ8HO/5EgZIUIXg2Lug8E2PkL0QWePUm4e8Zf8FUJ/KZC1zmbBf8zdwsJdIVIOiPMMbUU5px59oaNngln5nQQrHzvFHpD4P0kCXcDV/0XMrvOEXzfWn8xXnuBFELK3ROCV27ABwRTOy/B78xdIUVIEUK8Xg/e+X9WWSFrhcn+DwWFIloIObQ7z7Fy6jwUUviNFbGK6BDhkJ+XSgD/rw4iIiIiIqKyQSYIgvDBj82JiIiIiIiIqEDsPktERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGrE4E1ERERERESkRgzeRERERERERGqkLXUBmnL+/HkcPnxY6jKISpTly5dDR0dH6jKIiIiIiMq0chG8z507B1dXVwQFBUldClGJIpfL4e7ujooVK0pdChERERFRmSUTBEGQugh1W7FiBebOnSt1GYX6+uuv0alTJwQGBkImk6FHjx5Sl0RlmCAIWLhwobicmJiIypUrS1gREREREVHZVi6eeOdq3bo1+vTpI3UZ+fTq1Quff/45OnToAJlMhi+//FLqkqgMUygUKsGbiIiIiIjUq1wF7w4dOsDNzU3qMgr11VdfSV0CERERERERFTOOak5ERERERESkRuXqiTcRERVNSkoKbt68KXUZRBrVuHFjmJiYSF0GERGVQQzeRESkIiUlBf7+/hg9erTUpRBplK+vL8aMGSN1GURl1s6dO3Hq1Cmpy6ByaNiwYejZs6ekNTB4ExGRKCUlBQcOHMCYMWOgra2Npk2bSl0SkdpFRETg1atXUpdBVOZdvXoVP//8s9RlUDnUunVrBm8iIio5rl27Jj7xa9KkCZubU7kwaNAg+Pn5SV0GUbnQunVrhISESF0GlSMlZdpcBm8iIiIiItIImUwGubzkjO9848YNxMXFwcrKSupS6AOcOXMGVapUgaWlpdSlFIrBm4iIiIiIyqUdO3bgzJkzbOFVys2fPx+tW7dm8CYiotKhQoUKMDAwQGpqqiTnT0lJQUpKSoHvVapUCcbGxhquiIiIyrLvv/8e/fv3l7oM+kA//PADKleujMzMTAwcOBBz585Fx44dpS5LRclp50FERJLr2LEjTpw4Icm509LSsGzZMtSpU6fA17Bhw5CUlCRJbUREVDY1b94cXbp0kboM+kCdOnVCy5YtoVQqceLECTx+/Bjp6elSl6WiXATvunXrom7dulKXQUREb+Dp6Ynly5cX+v7x48cxZMgQDVb0frKyspCUlKTyKuwpPhERERWfihUrIjMzEwEBAbCxsZG6HBXloqn50KFDERcXh4iICKlLISKiMiQ7OxuZmZkq606ePIkBAwaorDM3N8f169dV1slkMlSqVEntNRIRUcF27twJS0tLNG/eXOpSqJhkZ2dj+/btiIiIQHp6OrZs2YKMjAypywJQToI3ERFRcVEqlVAqlQCADRs2YNq0aW/dJzw8HPr6+irrdHR08PLly3zbamvzv2YiIk2YMGECli9fzuBdhmRlZWHcuHHict4/S61cNDWPj49HbGys1GUQEVEZsGTJEujo6EBHR6dIobswWVlZ4nHyvhISEoqxWiIiIioJykXw9vX1haenp9RlEJUYZmZmUpdAVOrMnTsXMpkMixYtyveenZ2d+CS8qK/CBoqrVq0aZDIZZDIZ7t27p+7LIiIqt2rXrp2vNRKVbjKZDFWrVoWWlpbUpeRTLoK3kZER+9ER/UtLSwvnzp2DTCaTuhSiUmPWrFnw8vJSWefg4ID09HSkp6fD19dXDMtFfRkZGYn7533l/RLYpEkTaGtrq7zOnDmj6csnIiqTIiIiMHbsWKnLoGJUsWJFxMfH5xtrpSQoFx3JJkyYgPT0dA6uRgRAoVCgQYMGUpdBJdT58+fRrVs3Sc7t7OwMQRCwZMkSSc5fkEmTJmHLli1QKBQQBAEA4OTkBCcnJ+jq6qJChQofdPyC9o+NjRXP1bJlS0RGRqq837NnT/HG2S+//FLiRm0lIirp/vnnHxw6dAiTJk1CxYoVpS6H1KBv377i993Vq1dLXE2OcvHE+9WrV0hLS5O6DKISg82qqDDZ2dnIzs6W5NwVKlT44CBbnOzt7bF582ZkZWWJg6ktWLAALi4uMDQ0VFutBgYGMDQ0hKGhIW7cuIGEhASVgX+ys7ORlZWFrKwsDBkyBPr6+uJrw4YNaqmJiKgsuX37NmbOnFni5nmm4jN8+HB4eXnBy8urxNxcKRfBe9OmTQX2ySMqj7S0tJCamsqm5kRvMG7cOPj6+kKhUIjrFi1ahHnz5mm061KVKlVgbGyM8+fPIzY2VuXVq1cvZGVl4eXLl+Jr+vTpqFq1ar7X3LlzNVYzERER5Vcumpo7ODgAAJuaExGVYD/88APc3d0lrcHOzg6nTp3C8+fPVUK3m5sbHBwcJGstUrVq1Xzrdu7cqTId2cKFC7F9+3a8ePEi37be3t7YuXOnyrru3btj165dxV8sEVEJp6+vj48//hhyebl4BkklRLkI3kREVPKNGTMGUVFR8Pb2luT8w4cPx759+1Sa2nt6emLgwIGoVq0aDA0NJamrMNWqVUO1atXE5ZUrV8LFxUVc3rBhA1auXAkgZ+qy16fV3Lt3L86fPw8AaN26NQ4dOqSBqomIpPfll1/i/v37UpdB5QyDNxERlQjGxsYFPtnVhGHDhmH//v0qodvLywvjxo1D5cqVJanpXb0exJ2cnFRG6z106BCcnJzE5ezsbDx69AgAEBUVhcaNG+c7pqGhIf744w81Vk1EpFl+fn5QKpUYPHiw1KVQOcPgTURE5drQoUPh5+cnhm4fHx907doV9erVKzWhuyC5/btzTZgwAb1791bZ5tq1axg7diwUCkWB3bFkMpnKwG4FOXHiBOrVq1c8RRMRqdnevXuRlZXF4E0ax+BNRETl1uuhe82aNRg+fDiqVKkicWXFr0qVKvmuy8zMDK1atVJZFxMTg2+//RYAIAgCbt++/cbjWllZqQw45+vri9atWxdT1URERGUDgzcREZU7NjY2iIqKQmhoqBi6165di2HDhpXJ0F0YQ0NDWFpaqqzLyMhAcHBwoft06dJFpUl+WFiYyvtDhgwRP8MVK1agS5cuxVgxERFR6cTgTURE5crAgQNx+PBhcdTyTZs2oUmTJvjkk0/KVeguTIUKFfB///d/hb4fFBSkMuK7ra0t4uLixOW7d++Kfx4/fjxMTEywYMECWFlZqadgIiKiUoDBm4iIyo2BAwfi0KFDYnDcvHkzBg8eDCMjI4krKz06duyosnzw4EGVac2mT58uNk+/e/cu7t69i2nTpqFu3bpwcHBAnz59NFovERGQ05pn/vz5aNu2LVq2bCl1OVQOMXgTEVG5YGtri4MHD0KpVALICd3fffddiZsmrLTp0KGDyvLWrVuRkJAAAFi8eDGuXLkiBvAnT55g/fr1GDt2LGxsbKQol4jKqaysLKxatQoBAQG8AUiSYPDWADs7O1y6dCnf+hUrVvCLBxGRBtja2iIgIEAM3Zs2bcKQIUNgYGAgcWVlT/v27cU/V69eHTExMVi1ahXOnTsnBvD79+9DEAQMHDhQwkqJiIg0h8FbTWxsbHDnzh0AwL1791QGosk1YcIEuLi4qKybMmUKJk2apJEaiYjKg0GDBsHf3x+CIAAANm7ciGHDhkFfX1/iysq+du3aAQBMTU3x6NEjbNq0CadOnUJ4eDgWLFiAffv2oX///hg6dKikdc6cORMxMTGS1kBERGUbg3cx69u3Lx4/foxbt26JYXvz5s35Ro3N5eHhgQMHDojLLi4u+Omnn8RlW1tbzJ8/X71FExGVQQqFAiNHjoSfn5+4buPGjRgxYgT09PQkrKz8adeuHdq1a4cGDRpALpfj5MmT4tPvmzdvQqlUYvjw4ZLVFxISggcPHkh2fiIiKvsYvItBjx49kJycDAAIDQ2FQqHArl270KhRIwBAs2bNCh24x8vLCzNnzgSQ0/Rx+/btYt84AHj48CEOHz4sLnft2hWenp7quhQiojIhIyMD9vb22L17t7hu/fr1GDlyJCpWrChhZeVb27Zt4e7uju+++w4BAQH49ddfER4eDnd3dwiCgBEjRkhS17lz5xAVFSXJuYlI/YKCgvDLL7/A19cXbdq0kbocKqcYvD+QlZUVzp49C6VSCX9/f9SoUQMA0KZNmyI1YzQzM4OZmRmAnKZ4Y8aMybfN8ePH4eHhAQD4+++/882vamFhgS1btnzglRARSevIkSMICAgolmNlZ2djx44d4vK6deswduxY6OrqFsvxi+rBgwdYvnw56tatm69rUXmV+/S7ZcuWkMlkOHLkCMLDw7FkyRIAkCx8E1HZdfv2bWzbtg2bNm2SuhQqxxi834MgCOjevTsA4Pfff8fBgwdhYGCAjh07ftCTlAYNGqBBgwb51jdq1AjdunUDAAQHB2PhwoUq71+5ckVsImdqaoqff/75vWsgIpJKSEgIrl+//sHHefnypdiSCADWrFkDe3t7aGlpffCx39XTp0+xefNmNGnShMH7NZaWlli4cCFkMhkOHz6M8PBwuLm5QRAE2NnZSV0eERFRsWLwfgevXr0SRyE/e/Ysfv31V8yaNQvdu3eHjo6O2s5ramoKU1NTAEDLli3Rtm3bfNtERkZi4sSJ0NbWVmmqrqOjo9JUvSywt7fH48ePsWbNGjRs2FDqcoiohEhMTIS7uzvS09OxadMmyGQyrFq1CpMnT4ZMJpOsLhMTE47VUQhLS0vxhsThw4cREREBd3d3AGD4JqJicf78efz5559Sl0HE4F1UKSkpGDJkCI4fPw4g5wtCr169IJfLNVqHiYkJvvnmmwLrq127NgAgISEBo0ePBgDIZDJYW1sDAPz9/SV54lPcBg0ahBEjRmDMmDH46aefYG5uLnVJRPQeAgICcO3aNXH5999/f+s+f//9N5ycnMTl2rVrY+rUqQByfg+uWrUKACCXy+Hp6QkHB4dirrroHjx4gPXr16NWrVpsPv0GueFbJpPh0KFDiIiIgJubG2QyGT83Ivpgjo6OCA0NVetDMqKiYPB+i/j4eEycOBGZmZn47bffIJfLsW/fPvTt21fq0lQYGhqib9++eP78OWbOnAk/Pz+8fPkSI0eOFJ94Dx48GHK5HNu2bSvV0+h069YN27dvx9ixYzFhwgRUr14dLi4uaNmypdSllSp+fn4YNGiQ1GVQOfbbb79h69at77TPo0ePsHz5cnG5ZcuWmDp1KhISErBy5UoAgLa2NpYuXYpZs2YVa73v6vHjx9i1axc++eQTSesoDXLDtyAIOHz4MO7fvw8/Pz8GbyIqFj169MDkyZOlLoPKOQbvN4iLi4O9vT2OHz+OrVu3YtCgQdDS0sLAgQOlLq1QL1++xNGjR7Fjxw5kZWVBEASMGjVKHNk3t+lehQoV4OPjA2NjYynLfW9WVlb46aefkJCQgIULF2L69Onw9vZGq1at3uk4v//+O+7fv4/vv/9eTZWWXDY2NhpvsUFUnKpXr45Jkybh+fPnWLZsGXx8fADkdLGZM2eOxNXlMDExwcSJE6Uuo1Ro06YNFi1aBCCnVdnt27exb98+DB48WOLKiKi0Mzc3R79+/aQug8o5Bu9CxMTEYOrUqTh16hR27txZap4MVq1aFR4eHpg2bRpWrFghNt0cOnQoAECpVCI7Oxv29vbIzMyEvr4+li1bhlq1aklZ9nvp2bMngJxrdnBwwMyZM1G/fn1MnDgR7dq1K9Ix6tSpA11dXVy+fBk3btzAhAkT1FkyEeXRu3dvXLt2DX/99dc771uzZk0sWrQIAwYMgIeHB7y9vaGrqwtHR0dUqlRJDdW+m8jISOzevRtmZmYa+b1y8uRJ/Pnnn/jyyy+L/PuvJGrdujVcXV0hCAKOHDkCJycnyGSyUvN/MBERUWEYvAvw5MkTODo64tSpU9i8eXOp+g8/MzMTFy9eREBAAJYuXYpdu3apTJ0wfPhwAMD06dOxf/9+AEBaWhqMjY0xf/581K9fX5K6P0TPnj2xatUqPHnyBABw8OBB+Pr6ws7ODh06dHjjvubm5jA3N0dERASSkpKwadMm2Nvba6JsonJvwIABkMlkWLRo0TuF71q1asHFxQUTJ07EjRs3xH7duTcepfbgwQN4enri0KFDWLBggdrPFxgYCBcXF+jp6aF9+/ZqP5+6ffrpp7Czs8ORI0fw4MEDzJkzBzKZDLa2tlKXRkSlSFJSEo4cOYKnT59KXQoRAAZvFQ8ePIC3tzfi4uJw+vRprF27VnxS/DYLFixAcnJykc81YsQItTyVSE1Nxb59+7Bu3TpUqFABa9euxfjx49+4T24Af/HiBWrWrInp06eXutHCe/XqJf755MmTmD9/PsLDw9GiRQsMHDgQXbp0eeP+jRo1go2NDQ4cOIBp06aJ63L/TETq0b9/fwCAq6srbt68WaR9mjVrhkmTJiEuLg779u2Dnp4exowZg6pVq6qz1CK7ffs2Nm3ahM6dO4sDv6nLqVOn4OzsDH19fbi7u6Nz585qPZ+mNGzYEL169cKxY8cQGRkJR0dHyOVycWaR4tarVy+Ehoaq5dhEJI2YmBjOjkAlCoP3v+7fvw9nZ2ecO3cOs2fPxjfffPPWQV3mzZsHhUIBAFi9ejWys7OLfL7w8HCVwcB69+6Nrl27vlfteVWpUgU+Pj5in+Wi9C2cO3cuTExM4Onpibi4OMTGxmLp0qVo3LjxB9cjha+//hqCIIj9A2/evCne5LBPA/aXAAAgAElEQVSyskKPHj0K3K9Ro0awtbUV55NdunQpHj9+jDp16kg6MjJRWde/f39cvny5SMG7Vq1a6Nu3L2JjY+Hj44Ply5fDwsICa9as0UClb/fw4UNx9gtN2LZtG0JCQrB58+YyE7qBnKfeHh4eUCgUOHnyJJ48eYJp06ZBJpNhwIABxX6+UaNG4ezZs8V+XCKSno+PD7p37y51GUQM3gBw7949uLq64sKFC/D09Cz07lhGRgbc3NzE5RUrVkAQBACAs7MzvLy8kJmZCUdHR9SoUaPQ8+3atQsnT57EyZMnxXXXrl1Dx44d8dVXX6Fbt27vfS1GRkZFaiq9ZMkSzJo1C5mZmRg9ejQsLCxQrVo1zJs3D35+fpDL5WjYsCGGDRuGZs2avXc9UunZsyd69uyJFi1a4I8//sDRo0dx6dIlXLp0CUFBQejUqVOB07I1bNgQjo6OiIyMhCAIWLlyJYyNjfHs2TNUr14dM2bMkOBqiMq+zz77DM2bN8fff/9d6DampqaYO3cuBg0aBB8fH6xduxajR49GnTp1NFjpm924cQPr1q0DAERFReHYsWMqLXKKU1BQEO7du4f/+7//g4WFhVrOIaVPPvkEK1euhCAICAwMRHR0NBYuXKiW4E1EZdfnn3+Opk2bSl0GEYN3eHg43NzccO7cOSxdurTA0J2amooffvgBGRkZYv/BxYsXw9XVVdxm5syZqFGjBpycnJCeno4xY8bAxMSkwHNaWFiI/RkPHz6MP/74A+fOncO5c+dw/vx5XLx4EUDOF9GCwmFxmDp1KhQKBebPny+uGzlyJJRKJR4/fgxfX1/s27cP9+7dQ/PmzdG/f/9SOSWOlZUVrKys0LZtWwQHBwPI+bJ6+vRpXL16VdyuVatW4nznANCgQQM4OzuLX+ifPn2KH3/8EcnJyTA0NISjo6NmL4SojLOxsYFMJoOLiwtu375d4Dbt27eHra0t1qxZAw8PD7Rt2/adpyNTp8jISJw7d05c/ueffzBp0iQsW7YMQM6N0T59+hTLuc6dO4eZM2fijz/+wPbt29/anaa0atGiBVavXo1p06bh9OnTiI+Px9GjR4vtc8x16dIlREREFEvLMyIiooKU6+B99+5d7N+/Hx999BG6deuGUaNGAciZRmzLli3idqmpqfDy8sK8efPEgXIWLlwovu/t7Q0gZ8AypVKJhIQE8Ul4Qfr37y/2a2zTpg2uXLkivhcUFCQG+nbt2uH69evie82aNVMJhx/KwcEBSqUSBw4cgEwmw5gxYzB69GgAOcEzIiICe/bsgZ+fH/766y+4uLi883RdJUX37t3FZkZdu3bFqVOnkJ2djWvXruHkyZNo3rx5vi/79evXF3/OcXFxqFq1Kp49e4Zly5YhPT0dFSpUwMyZMzV+LURl1YABA3D79m24uLjke69mzZr46KOPsHbtWnh4eMDQ0BBff/21BFUWLDIyEqtXr8bq1avzrR82bBiAnMHfcge71NXVRd++fd/7fF5eXvjjjz/Qrl07mJmZvfdxSoOmTZvC1dUVp0+fRmxsLEaPHo2dO3cW643pkJAQPHz4sNiOR0TSunz5Mo4dOyZ1GUQqym3wDgsLw7Jly5CYmIgjR44AAKKjo7Fnzx5ER0fD29sblSpVEgfGWbBggTi/6OuSkpLEoP2uTZH79Omjcuf+zJkzCAwMBJDT/NzZ2Vl8r1mzZoiIiAAAmJmZFct84o6Ojli5ciXc3Nzw9OlTzJs3D6amphg5ciSAnFG/Fy9eDH9/f8hkMixYsKDUhu9cXbp0EZ8OXblyBa1atcKtW7dUPmsgZ6oxuVyOoUOHwsTEBO7u7khMTIS+vj6io6OxcePGfDdYHBwcoK1dbv9ZEX2wJk2aoF+/fggPD8edO3cA5ITuOXPmoGHDhrC2toahoSGmTZuGJUuWSFxtjsjISKxatQo+Pj6oVq0aOnXqBCDnht3//vc/cbuEhARxZG4dHR0cOHBA5Th9+vSBXC5/p3PPnDkTX3zxxQdeQclXrVo1dO7cGRcuXMDz588xdOhQ7Nu3D1ZWVsVy/I4dO5bacU2IKL8jR46UiFkuiPIqVwnhxo0b8PHxAZBzd/v8+fNwcXHBo0ePcOjQIdy/fx8+Pj4wNDSEg4MDqlevni+MFSRvk/MP1a1bN7GP98WLF+Hv74+//voLZ86cwe3btzF79mwAOcE7OjoaAGBiYoLvvvvuvc85a9YsCIKAZcuWQS6XY9asWWIT6xEjRkAQBLi7u4tfEstC+M7Vvn17tG/fHqGhoTA3NweQ0zz0yJEjiIqKwurVq1VGtq9SpQo8PT2RmpoKHR0dPHz4UOzPCQAymQw6OjoYN25ciZhLmKi0GThwIAYOHIgff/wRDg4OYugeOnQo1q1bByMjI0ydOrXEhG4gZ2Tx3P9bunTpgoCAAADArVu3MGfOHHG71NRUXLhwAQCQlZWFfv36qRzn8OHD0NHRKdI5Y2Nj8cknn8DU1LQ4LqFQ2dnZOHPmjOStC5o0aQJfX1+MHj0aly5dQmJiImxsbHDo0KEPGhcl14oVK3D+/HnxpjMRlX6mpqbw9/dn/24qMcpV8M4dXCtXy5YtkZWVBS8vL+zduxe2traYOHEi6tWrBycnJwkrzdGpUyd06tQJV65cEUMhkPN05dixY5g+fTqAnKdBiYmJAHL6EBZ1CrS8Zs+eDaVSicjISOzduxeDBw9G3bp1AQB2dnY4ffo0IiIicODAAXTu3LnMBO9clpaWsLS0BJAzFVCdOnUQFRWF0NBQbNy4EdWqVVOZQ9bAwADe3t7IysqCUqkU19+/fx+bNm1CZmYmDAwMAADfffcdqlSpotkLIirlGjRogG7duqFPnz747rvvsG7dOvj4+GDatGlwd3eXujzRkydPxG4qxsbGaN26tfheixYtVJo6RkVF5Qt2SqUSv//+OwDkC+JvExAQoNa+3VlZWTh+/DgGDBjwTrN2qEvjxo2xa9cuDBkyBFeuXEFqair69+//TlN5FubTTz/FmTNniqFKIpLakydPxBaK//d//yd1OUSichW8XxcfH4+QkBAAOVODldT+urlPZXP9/fffMDU1RWxsLH777Tc8ffpUnDZMX18f6enpAHKaMr5tSrS85s6dCwBYuXIl9u/frxIW7969K/45ODgYBgYGsLS0LHMBHMhp0r9+/Xrcu3cPnp6eOHHiBC5duoSUlBQAOZ/x4MGDAeR8xuvXr1fZX0tLC2FhYeJybn9+Iio6a2trWFtbIzY2FmvXrsWaNWswffp0lZklpBYVFYUffvgBq1evRpUqVeDo6CiOA1KQOnXq4PTp0yrrsrKyVJ7YXrx48Y1jhORq0qQJqlev/v7FF0FycjKsra3x1VdfqfU87+Kjjz6Cn58fBgwYgJCQEGRmZiI4OBgdOnT4oOPOnz9f5fc2EZVerVq1QkJCAho1aiR1KUQqyl3wNjMzE+c6/eyzzzBlyhSJK3p3zZs3x5YtW3Dv3j1UrVpVXJ+cnIzDhw9j7NixAHICoEwmE98fOnRokfoPtmrVCtOmTSv0S8i+ffuwb98+2NjYwNraGi1atMCnn376gVdV8jRu3BhbtmxBZGQkXFxcEBQUhNTUVJw4cQJZWVkAAG1t7XzN/EvKfMJEpd3Tp0/h4+MDDw8PDBo0SCOhOywsDDVr1oSxsfEbt4uOjoanpyfWrFmDKlWqYNasWUXqmvQ6HR0dnD9/Xlzu1q0b0tLSCt3++vXryMzMxMqVK9U6b3dmZiauXbsGHR2dfDcLpFavXj0cOXIEvXr1wo0bN9C1a1dcuHBB5QY1EZVvXbp04dSDVOKUu+Ddo0cPbN68WeoyikXjxo2xc+dOcfnp06eoWLEigJw5xw8dOqTyxFtbWxtyuRzW1tbQ1dUV1x8/flx8mgsALi4uCA8PR6dOnd44P+7169fh7+8PJyenMhm8czVo0ED8nJ8/f44pU6bgwIEDOHz4MORyeb6bGf379y9yP00iKlxAQAA8PDygr6+vkScX4eHhGDlyJFxcXN44XVVMTAyWLVsm9jmfPXu2ytSMH+JtzZ2/+OILlaCuLvHx8ejduzc6duyo9nO9D1NTUxw9ehR169ZFVlYWOnbsiKtXr6JNmzZSl0ZEJUCvXr3ELplEJUW5Ct5169Yt0/8p16xZE3v37gUApKSkiH0JBUHAoUOHMGTIEADArl27xP7HADBu3Dg8f/4cX3zxBapWrYrmzZujefPmWLBggcrndf36dURGRorLWVlZCA8PR1hYGG7duoUWLVpo4jIlVb16dezduxfJycni9HO5n/nBgwcBALt374aenh6AnBs9+vr6ktRKVJrFx8cjKioKenp6mDFjhkb6dY8fPx5Xr14t9P3Y2Fg8e/YMGzZswIYNG2BoaAgnJyfMmzdP7bVpUmZmJm7fvg09Pb23hvywsDB89NFHqFChgoaq+4+Ojg7Mzc0RHh4OhUKBtm3bqoy5QUREVJKUq+Ddr18/TJgwQeoyNMLQ0FAcWVcQBHz77bcAgGPHjhXY77tTp07w9fVFw4YNVdaHhoYiNjYWALB69eoCmxwePHgQH3/8MVauXFncl1FiGRkZiZ9vrr59+0KpVGLPnj04fvw4lEolfH19UbNmTXGbjh07cqA1ojeIj4/Hs2fPsHPnTqxevRqzZs3SaL/umjVrqtyYBHJaE7148QIrVqzAtm3bAOSM9bBgwQKVUcvLiujoaFhZWaFdu3Zv3C4iIgKdOnXC5cuXJelLaWJigsuXL8PS0hIPHjwAkHMjwMLCQqWbFRGVD6mpqXj48KHYHbA8unfvHoyMjFS+e+YVFRWFzMxMfPTRRxqujIByFrzLK5lMhqNHjwLICYevXr3C2bNnVZ4MrF+/XgzdISEhePHiBQBg4cKFSE5ORu3atQEA3bt3Vzl2eHg4Hj16hAcPHuDu3buwsLDQxCWVSLnzwQOAra0tEhMT8csvvwAAzp07h6ysLPz4449vnNaiadOm4mjyROXRhg0b4OLiAl1dXcyfPx+LFi3SyHmjo6Px8uVL7Ny5E127dgWQMw93amoqFixYIP5bBoBKlSph8eLFkgzIWbduXWhrayMmJgZpaWnF3qImKysLjx49grGxMS5fvlzodg8fPkSbNm1gYGAgadcaY2Nj/Pnnn2jWrBmePHmCpk2b4u7du2jcuDHDN1E587///Q9WVlZSlyGpXr16YeDAgYXOYb5w4UKEh4eLU1uSZjF4lzNHjhzBpUuXoKuri9TUVAQHByM7OxvXrl1DQkICAGD79u34559/AAC6urpYt26d+EX0de7u7li4cCECAgJQp04dcS7b8s7Pz09leezYsYiIiIC/vz8A4Nq1a3j16hUAwNzcHHFxcUhMTISjoyP69u0LIGf03vr162u2cCIJJSUlISkpCbq6uliwYAFcXFw0dm4bGxtcu3YNcXFxePz4MQBg6tSpOHz4sLhNhQoVYGxsjDlz5mDGjBkaqy2v3bt3Iy4uDuPGjUO1atWKfdaEBw8e4Msvv3zruB3NmzeHnp4eQkJCxBuzUjE0NER4eLjYxcfCwgJpaWniMhGVL87OzoV+by2roqKisG7dOowePbrQsTkWLFgAMzMzcSYNLy8vWFpalqiZK8o6Bu8yTKFQiP0Vc+cxvHLlClxcXBAQEIAqVarA1tYWjx8/hr29vThP67p16+Dt7V2kJtH16tWDqakpYmJi1HchZYCvr6/K8owZM7Bp0ya8evUKI0aMwNOnT3Ht2jVcunQJ27dvR0JCAuzt7TFy5EjUqVOHAZzKvJSUFCxevBje3t6YN2+eRkN3QkICMjMzAaDArji6urrQ19fHsmXLSlR3pRcvXiA9PV0cVPNDZWdn4/nz5zA1NUVoaGih28XFxaFmzZq4cuUKatSoUSzn/lAymQzGxsZia624uDhUqlQJNWrUKNJsHkRUdkyZMgW1atWSugyNio6OhoeHB+7cuYMmTZoUuI2Hhwe2bNmCoUOHAgB+/PFHjB8/nsFbg/i/URn28uVLdOjQAVOnTgWQ01+7Y8eOYugGcp7MXr58Gba2tmjTpg10dHQwefJk7N69G4mJiW89x6hRozhq5Hvw9vaGvb092rRpAw8PD5iYmOC3337D5cuX4ezsjDZt2uDatWuYMmUKtmzZgpCQEPEpHFFZ8/LlSzg7O8Pb2xva2toaf1LZvXt3/PHHH/nW6+joQE9PD5s3b0ZCQkKJCd1GRkaQy+UYO3Ysfv75Z2RkZBTLccPCwtCpUyeVaSoLUrduXYSGhpaY0A0AFStWxPPnz8W/Ox999BFq1aqF58+fS1wZEWnC9OnTMXDgQKnLKDbLli1Djx49AOQ0H69duzaaNWsGAPj+++9Ru3Zt1K5dG2lpaVi0aBGcnZ0RGRmJhg0bYuPGjbC0tASQczM5d9uIiAjY2tri6tWrqF27NgICAiAIAjp06CDZdZY3DN5lmFwuR+vWrRESEoKbN29i9OjRaNKkCbS0tPJtu2fPHoSGhmLIkCHQ0dHBlClTsHv3biQlJb31PCYmJqhWrRqeP3+OqKgodVxKmeTt7Y3Q0FBMmTIFHh4eWLduHRISEuDo6IjQ0FDxZWZmhlGjRqn0MSUqKzIyMjBr1iysWbMGADB//nyNPu1++fIlFAqFuKytrQ0dHR3o6Ohgz549SEtLE2eIKCn8/f3xzTffAMiZlWL79u0fPJiQQqFAWloaPvroI9y8ebPAbVJSUpCSkgJ9ff0S2X9aLpcjLS1NZYT11NRUCIIgYVVEpAnx8fHIyMjA559/rjJlbkmnVCoRHByM+Ph4cd21a9dw8+ZNhIeHIzg4GGFhYYiJiUFERASCg4Nx+/ZtJCcno0GDBrh69SpevXqFBg0aoH79+tDR0YGRkZE4HbCJiQkaNGggvm9gYIAKFSqIy/Xr1xe7C926dQv379+X5HMoN4RywtvbW5g8ebLUZUhCqVQKjRo1ErKysoq0vZ2dnaCtrS0AENasWSMkJSW9dZ9Vq1YJAAR7e/sPLbdcefLkiXDnzh2hT58+AgDB1dVVuHPnjhAfH6+R82trawuJiYkaOReVDmfOnBEACACEFi1aqPVcWVlZwvjx48XzyeVywc3NTa3nzCsjI0No2rSpeG4tLS0hMDBQY+d/FxkZGUJ6erqgUCgEQRAEa2trQSaTiZ/d+vXrhezs7Pc6tkKhEIKDgwUAQtOmTQvcRqlUiudKSUl57+vQlNz/wwAIjx8/LtI+I0aMEHx9fdVcGVH5NnnyZKFNmzbFftxhw4YJ3bt3L/bjqturV68EAIKfn5+4ztDQUPz9Vdirf//+giAIgo6OjrBu3bpiqaVjx47C2LFji+VYJY2BgYHwww8/SF2GwD7e5YBMJsO9e/eKvP2OHTsgk8nw+++/Y8aMGRAEAb1790b16tVhZGT0xn0TExPx7NmzEtUEsSSbPHmyyuBNrq6ucHV1hZOTE+bMmcOpx6hMs7e3x9atW8VlNzc3ODs7a+TcgiCgadOm4kCSFy5cKNHN7dq3b48bN24gKCgIX3zxBQ4ePIiBAweKAzZOmjQJCoUCkydPfuen0VeuXEGHDh3QtGlT3L59u8BthFL21DjvZ8C5vYnKLqVSialTpyI4ODjflLgl3aVLl7Br164C37O2tkbz5s2xdOlSODk5oV69eirvf/zxxwByZiX6/PPPi6We2bNno3LlyuLyjh07kJqaismTJxfL8YmDq1Ehtm/fDgAYP348HB0dMW3aNHh5eWHChAn55rgFckaVrVSpEvbt2wc9PT2VL9NUuBo1aqBmzZqIj48XB7cDcgbAUCqVcHJyUvklSETFo169emLXmJCQELE/XGly4MABDB06VOyGMnXqVGRlZRX7iOsZGRniAG6ZmZmSTh9WVJmZmdDT0xObYEZERJS6L+VE9HZKpRLr168HgFL3b/zvv//Gpk2bCnyvc+fOsLKywtKlSzFo0KBCZ5r4/vvvi62efv36qSwHBgYiLi6OwbsYsY83vdHmzZsxduxYVKlSBU5OTli/fj1evnyZb7vvv/8eK1askKDC0u2nn35CbGws7O3toa39330wHR0dbNq0CVu2bJGwOiL1GTVqFLZt2yYuL1++HE5OTho5d+3atcXQff36dbRp0+ad9l+yZAm0tLQwZ84cdZSXT8uWLXHjxg1cuHABXbp0UXlv165dyMrKEr98zZw5851+F58/fx4dO3bEp59+ir/++ivf+8nJyeKAZVlZWaUidOdKTk4WWw2Zm5sjLCxM4oqISF02b96MgwcPSl3GW/3zzz/Q09ODnp5eoYH20aNHmDRpEpo2bYoXL16gZcuWGq4yx+ufqZubGz777DNJaikr+MRbzVJSUqBQKKCvr1+qvrDktXHjRmzcuBHff/895s6dC6VSCQcHh0KnsMnIyEBaWhr09fU1XGnptXbtWsjlcqxfvx4KhQILFy7ErFmzim2aIKKSZMSIEdi9e7fYfHnlypWYPn26RqZ9MjU1RWxsLADgxo0baNmy5Ts3zVYqlZg5cyaWLl2qjhLzUSgUuHTpEj7//PN8teYOlrlu3Tpoa2tj48aNcHJygkKhKNKNDEEQIAgCZDJZgQNvAv811c57c7A0yFuvUqksUnP5cePGQalUFutTJCJSj6ioKPz5558AAH19/QJbZJY0SqUSr169AgDUrFlTfJJds2ZNcZu83Qyl7HL4+vf4+vXro3Xr1uLyo0ePEB4eju7du2u6tFKLT7zVrF+/fqhatSqOHz+O1NRUlebEpUV6erpK7U5OTli1apU4720uHR0daGlpYc+ePbC3t5ei1FLNx8cHU6dOhY6ODhYtWgRPT898nzGRunXp0gUnTpxQ2/GHDRuGPXv2iCFo1apVmDJlikZCXa1atRAbG4s7d+4gMTERLVu2fOewv2TJEri5uYmjn6tb69atERYWhooVK76xVl1dXaxatQqJiYlwcHCAi4sLlixZ8sZjnz179o1fmBISElCjRg1oaWkVaXrJkigyMhLVq1cHALRq1Qq3bt164/ZKpbJU/j9NVB4FBgaid+/eUpfx3qytrXHixAmcOHECnTt3lrqctxo1apRK0/ijR4+iV69eElZU+jB4q9nZs2fx1VdfwdraGoaGhjh06BAyMzNLxWAv2dnZyMzMxJgxY2BkZIQdO3aI7zk7O8PT01NlGh57e3uxnw29H29vb2RmZmLOnDlYvHgxli5dqvIZE6mbtra22p4afPfdd9i7d6/K779KlSqpTP+kDpUrV4aRkRGePn2KsLAwmJubo3Llyu/1hD09PR2Ojo4aGwQuKSmpyAObVapUCZUrV4abmxtiY2Mhl8thZGRUaK3Z2dnIzs5GmzZtcPbsWZX3nj59ivr160MQBDx9+rTUjjVhZGSEu3fvok6dOsjKysJnn32G69evF7r96tWrS9z0cURUOJlMhl27dpXowTHzqlmzJnbt2oVdu3ZhzJgxUpfzQbp3746ff/4ZALBmzRr8+OOPEldU8pWudmOl1OnTp9GjRw+cPn0atra2AICdO3dixIgRElf2Zv369cOxY8ewf/9+aGtr5xt5ceHChVAoFHB1dZWmwDLMw8MDWlpacHNzg0KheOuTK6KSbtCgQQgICFAJ3T/88INafw9mZ2fD1NQUycnJAICwsDA0btz4vZu0L1myBCtWrICzs7NGutK0a9cOkZGROHPmzDv18dPX14e+vj6mTp2KUaNGvbHW9u3b47fffsvXnFGpVCItLQ26urqoVq3ae19DSVC1alWxRcWrV6/eOOd57kChRFQ6yGQyDB8+XOoyiszQ0LBU1fsm5ubmMDc3BwD8/vvvUCgUmD59usRVlWx84i0ROzs7yGQybNiwQepSPsjixYsxf/58cXn8+PHYtm0bdu/eLd5koPezZMkSuLq6YunSpRobxInof//7H/r27Vvsx3327Fm+1hvGxsZqCbBJSUmoU6cOGjRogOfPn4vrTU1N3zt0u7m5wd3dHQ4ODhr7YhEdHQ2lUgkTE5P3atZuaGiI2rVrF/i0+uzZsxg8eDAqVKiQL1g/efIErVu3RqVKlRAREfHe9Zckly5dgpmZGQDgm2++QUhIiLQFEdEH+eKLLzB27Fipy6B/HThwoFQMbie1chW8169fj0mTJmn0nF26dIGWlhbOnDkjrtu9ezcyMjIwevRoTJ48GVpaWuLL3d1do/UVxXfffYfu3bsjIyNDfM2cOVN8f/ny5Zg3b16+/fz9/aGlpYVvv/1Wk+WWKQsWLIC7uztWrlyp8pkTqUurVq2KvcvI0KFDcfHixXzrHR0dsW/fvg8+/v379/Hxxx+Lr08++QTR0dGIjo4Wt/nrr78+qAl9fHw8MjMzYWxsLOlgN8UhMDAQgwYNKrDf9sOHD/H555/j1atXuHXrVr65Y0urOnXqICgoCI0aNUJCQgL69OmDy5cvS10WEb2jtLQ0HDhwANHR0ahduzYGDx4sdUkEQC6XF3pjOzAwEDdv3tRwRSWUUE54e3sLAAS5XC7o6OgU+urcuXOxnK9du3aCjo6OIJPJBADC4cOHhZSUFCElJUXIysoSBEEQ0tPTxXUzZswosL6pU6cWeo7g4GChS5cuxVJvQXr16iXs3btXpeZcGRkZwpw5cwQAYt2zZs0SBEEQtm3bJq4HIHz99ddqq7E8yMjIEJYtWybI5XLBwcGhWI+tra0tJCYmFusxqXS7cuWKUKdOHQGA0KJFi/c+Tp8+fQQLCwvBwsJC0NbWVvmdkPdVrVo1cbtNmzYVeKxff/1V3KagV4MGDQo9PgDhr7/+EpRK5Xtfi5ubm6Cvry8AEKpUqSJYWFgIq1evfu/jFcUXX3whyOVysf7iFBAQIAAQPv/8c+Hhw4fi+vDwcMHMzEz8uZRFLVq0EP9e1K5dW7hw4YL43ogRI4Tq1asL+/fvl7BCorJt8uTJQps2bd57/4cPH4r/hseMGVOMlZG6NG3aVDm75DMAACAASURBVJg9e7akNRgYGAg//PCDpDUIgiCUqz7eeeea9vf3x7hx4/Jtc+nSJbHpo7m5+RsHYSlMu3btEBoaKg6I8+uvv+Lrr7/O11SwQoUK4qBCS5cuhYuLC7y8vODh4SFus379evj6+orL1tbW2L17N4CcKWYuXryILl264Pz58+9cZ1FUrFixwKdEurq6cHV1xbx587B69Wq4ubnB29sbSqUyX1/EU6dOwdraGocOHVJLjWWdrq4uZsyYAblcDmdnZygUCvj4+EhdFpVRTZs2hbu7+wcN+vLtt9/i+PHjRRoYMD4+HvHx8QByZkxYu3Ztvm2eP3+OmJiY966nWbNm7zxlWK7Fixdj5cqVSEtLAwAkJiYiMTERrq6uKr+bAaBPnz5YtmzZe9eZ161bt9Q+CKehoSEaNGggLmdkZODhw4eoVq0azp07p9ZzS+XAgQOwtrZGWFgYoqOjkZKSovL+5MmT8dVXX0lUHRG9i2PHjqFfv3751u/YsQNHjx6Fn5+fyvqKFSsWSysrejfr16+HiYmJ1GWUCOUqeFeoUAHGxsYAgOHDhxfYj/H69evo2bMnAODPP/8Uty9IXFycGKabNm0qzg2bnJyMM2fOoHnz5gBy5uB7W/+8SpUqoVKlSpg/fz4cHBwAAFu3boWTkxNevnwpbrdv3z4cO3YMAMTR0S9duoTOnTvjwoULRfocimr37t2YPHkyZDJZgZ9Vbs16enoAIAbCMWPGqDTrVyqV4uBG9O7WrFmDhQsXYsyYMfDw8MD8+fOhVCoLDChEH8rQ0FAcLOV93bx5Uwzd27ZtQ7NmzYqjtCJLSUlRmSbrs88+Q3BwMHR1dd/pOK6urli1ahVSU1PzvZcbwPP6559/cOrUqfcr+jUvXrwoluO8LjAwEI6OjujYsaPK75CwsDAMGjQIpqamOH78OJo3b47ExET06NFD3ObatWtqqUmTLCws4O/vj8GDB+PWrVuYMmUKtm3bhi5dugDImae2tA8mR1RexMbG4siRI/nWp6en4/bt2/j111+hpaUFhUIBQRA0MgUk5de1a1epSygxylXwzqtixYqoWLFivvVffvklHj9+nG/9ixcv8Mknn6isy9v3LS4uTmXKFxsbGwQFBeXb520MDAzEJ8xTpkzJN/JhYGBgvsEklEolgoODiz18V6lSBS9fvkRGRsYbt5s4cSLS0tLg7u6O7OxsZGVl5RvM5/z587CxsYG/v3+x1VdejBw5EnFxcfD09MSECRPEPvVKpZLTt1GJM2DAAERFRYnLzZs3R7t27TRaQ3Z2Nk6dOiWGxtDQ0Hd6ejx//nwEBQXh1q1b+Z6IAsDo/2fvvqOiurqHj39nACsgCqKCFSxEkaIRwY41NlRijwXsveOD2LAX7LFFUcCa2LGDUTGWoGIJFhR7j6iICKKUmfcPftzXCSBtYFDPZy3XYm7dQ+I4+55z9nZ1TbOoz59//pnvuzxERkby8OFDLC0tpQcs169fp0ePHoSFhaGtrc3QoUMBSEhI4OrVqwQFBWkwYvWrXr0627Zto0+fPly9epX+/fuzbt06AGbNmoWhoWGao2iCIHxdzM3NuXPnDj/++COXLl3SdDiC8P0m3ukpUKAAZcuWTbW9TJky3Lt3T2VblSpV0v0y9/btW1q0aJFmcr969Wratm2bYSyfJ+EpjI2NadCggUpP7Zs3b9K+fftcSb7Xrl2Lh4cHBQoUSPeLiL6+PuPGjcPFxYXt27czY8aMVJUNk5KSePnypdri+p7o6+szfvx45HI58+fPZ8CAAdy+fZtTp05RoUIFWrRogbe3t6bDFAQAzp07pzLFfPDgwWzatAlLS8s8iyEuLo6ZM2dm69yU6e5pjXIPHjyYbt26UalSJalC9ueqVKkijZz+18OHD784ff+/fbTbt28vTW9Xl8DAQDw9PWnQoIE0Jf6ff/7BxcWF69evA8kPLf7++290dXXZv38/2tra1K9fX61x5Ac1a9bE19eXAQMGEBISwtChQ4mIiODt27c5WtYgCELuuXLlCoGBgam2DxgwQOV14cKFsbOzk0a4f/75Z2xtbaXlnYKgKSLxziQtLS3MzMxUtt28eVNllPtzbdu25f79+2nuc3FxSVUVd9KkSRmuqUwZ7baxsVGJxcTEhAMHDuRK8l2qVClmzZrFrFmzUCgUdOrUKc3jDAwMMDAwYPjw4cjlcpUWYynOnz9Pt27dxPqabDAwMMDIyIj4+Hg2bNiAnp4eHh4eODg45KhSM0CtWrW4dOnSV1+pWcifrly5gouLCyVKlMizeyYkJGTrM9Dd3Z1Vq1almXRDcmLt6OiY7vnGxsbprmOLiYnB1NQ03XP/e91ChQqpNfE+cuQI48aN4/bt27x8+VLqkvDmzRuuXr0KJFf+3rhxI5C8NKtx48Zqu39+ZG1tTcmSJQG4ffu2hqMRBCEjBw4cYPr06Srb5HI569evT3Vsx44d6dixI5D8HVsQ8gOReOdAtWrV0t139OhR4uLiUm0fM2YMJ0+eVOktC+Dm5saSJUuk1/369WPcuHEqx8TExBAREZHqmoUKFZIS8dyYdm5iYkJsbGym1hwaGBhQpkyZNPclJiam+zBCyFjPnj2JiIhg9uzZrFixAqVSyYIFC3J83fv372eqCJYgZNWKFSuoVKmSRu49YsQIOnfunKljJ0yYwO3btwkKCko36R40aFCaDx4PHz7MmjVr0jzHysqKOXPmAMkzmFq2bJnJ6FUNGzYMHx8fzM3Ns3Te7t278fX1BZL/nt+6dQtIXp9+7NgxatasqVIMTl9fP90R+2+Vp6cnr1+//ibWrwvCt65Pnz5UrVqVHj16sGzZMqytrbNdOFMQNEEk3rmkSpUqaW5fv359qgR2yZIlbN++ncjISGnbrFmz2Lp1K126dMHd3Z2AgADGjh2b6no3b96kd+/eKgXYUpJvdVY7nzlzJsuXL2fv3r3pjnqnp27duvTt2zfPe6h/awwNDRk9ejRyuZyZM2fy4MEDTYckCF/UuHHjLNe5UJfMjhZPmDCB1atXp/mgNMXgwYOZOHFiqllPABYWFiqzlYKDg6XuGUFBQdy6dYvKlStn6SGZq6urSuG206dP8+7du1THLV68mHPnzqV7nRs3bqQ5klunTh0mTZqEsbHxNzmNPCvs7OxYsWIFY8aM4fz585oORxCEL6hYsaKUaFeqVAlbW9tUNYUy69OnT0RFRVGyZMl0+08LgrqJxDuPpTViMXfuXEaMGAEkVwD29vYmKiqKy5cvc//+fRQKBWZmZjx+/BgHBweWLVvG5cuXGT58ONHR0dy8eRNInua4d+9eIiMjad++PWfOnKFx48ZqaQtTsWJFRowYwdq1a0lKSkpzJGnPnj14eXmlWh8XGhrK8uXLcxzD92737t0sWrRI+v0eOXIEDw+PHLcvCgwMRF9fXx0hCkK+1bt3bzZt2kThwoUBGD16NC9fvmTfvn0ZFpCsVatWmkk3gJmZmco+Ozs7ateuzT///MPcuXPZs2cPhQsX5tGjR0Dy5/SX2gH269ePzZs3p5qF8r///S9Vte2goKBM185wdHRkyJAhAJQtW5Z69epl6rzvgb29PUuXLsXNzY2zZ89qOhxBEDKhQ4cO9OvXL1Vbx8w6duwY7du35+3bt2KpnZBnROKdD1SsWJGKFSvi4+PDkSNH6NGjB4MHD2bPnj2sWLGCRYsWSevQrl27xpAhQ3jz5g03btwAoEKFCvj5+UnFJOLj4/H396dDhw6cPn2aJk2aqKUqrbm5ObGxsUyYMAGFQkHXrl2lfbt27cLNzQ1LS0saN26sMroTFxcn1s+pgb29PfXq1ZOWJMTExPDrr78C5Cj5njFjBnZ2dtl+aiwI+UVkZKQ0MygxMVFl365du9DS0pKK62zfvp2EhIRMXdfb2zvLCdnTp0+ln+Pi4qTaFjo6OmmOXqfYsmVLmkU7//zzzwzv2bt3b5X2X5+rWrUqdevWzfAa3ysHBwfMzMxE4i0I+VxKwdnNmzfn6DpmZmaMHz9eFFwT8pRIvPORBw8e0KRJEzw9PalcuTJmZmbI5XKWLVsmTU+PiYmRpo9bWFiwYsUK9PT0sLe3l65ToEABWrduLSXfp06dkr6MHThwIM1K65k1atQoOnXqxF9//YVSqaRbt27s3LkTd3d3Hj58yIcPH7h79y5NmjTBw8ODv//+O1UhDCF7TE1NGTt2LDKZjMWLFwPqSb7Pnj2bKkkRhPzq+vXrLFu2LM19MTExXyzemN3CjhcvXlTbGuCEhAQ2bdqUrXM9PDy+uM7bwcGBH374IbuhCYIg5HvFixdn0aJFOV4aUr16dRYtWqSmqAQhc0TinU/4+vqyefNm+vbtS+XKlYHkPuHjxo1DJpOxdOlS6VgbGxtmz55NiRIlcHBwSPN6Ojo6tGnThn379tGxY0dptKRjx47s3r2bokWLZitOCwsLLCwsKFeuHL///jvt2rXj1q1bUtG0iIgILC0tWbx4MbGxsezbty9b9xHSVrZsWcaMGQOgknyLtYnCt+rcuXNs2bJFev3w4UOOHDmSqXNlMpnGe90/ePBAWvMNUKRIEenvblZ16tSJUqVKqSs0QRCEr9qOHTsIDQ0VxRH/Y9OmTWk+oL548SJaWloaiEhIIRLvfOLWrVs4ODjQrVs3le3lypWTEq2lS5dSq1Ytfv3110ytz9PW1qZ9+/ZST21nZ2cCAgLo3r07Ojo6eHt7Z7vFj4WFBd26dcPGxibVvvLly/P+/XvGjRvHlStXsnV9IX1ly5Zl9OjRyGQy6WltSEgI06ZNy3bvYkHIT06cOMGBAweA5D7TJ0+eTPdYY2NjJk+enOY+uVwurWvWlH///VeljZi+vj4uLi6aC0gQBOEbUKFCBa5fv87ly5ezdX5MTAwvXrzA3Nz8qyiuFhUVRWRkZKp6I/fu3Uu1POnZs2cqBTr/Ky4uTmU5lI6ODhUrVlRrvELaROKdT/Ts2ZM9e/Zw8+bNVFMFy5cvj52dHZA83TgrRXHkcrnUx3DHjh10796dgwcPAslrIIsUKcLSpUvTbQH2JT/88EO60xq3bdtGSEiIyjZzc3PmzZvHo0ePWLVqFQsXLuT169dSYTlIniafMg3zl19+wcfHhwIFCmQ5tm9duXLlGDVqFACLFi0iOjqaZcuWIZPJmDFjhoajE4TsO378OJ6enpw5cybVPgsLCwYMGKCyzdjYmN69e+dVeFlWunRp6e+qIAiCoB5btmzBx8cn1b8JmRUUFPRVFVfbtGkT7u7uKl2MIPm7+H/rlbi7u3+xfW9ISIhK60hTU1OVRFzIPSLxziesrKxQKpUq/QiPHz/Opk2baNiwIbq6ujm+R+fOndmyZQsJCQkMGDBAGlGKi4vDwMCAGTNm5PiJV1BQED4+Pty5cyfVvlevXrF582Zev37N8ePHefnyJe/fv5dG5AG0tLTw8/PDxcWFbdu2Ackt2IoUKZKjuL5F5cqVY/To0SiVShYvXsz79+85evSoSLwFjZk3b16qdomZFRAQwOnTpzl16lSqpLtmzZr06NEDCwuLLLczFARBEL5dSqWSmTNn4uzsjKWlpabDybY9e/YQHx9P9+7dpW0RERGsXbsWSH6fnp6eQPJA2q1btwCYPHlyql7mGbWJrFChgsp3xa/hwcO34rtKvI8dO8bmzZvz7eiItbW1yuuUtdMDBgzg2bNnQPL6jOXLlzN69Ohs3SPlL7SWlhYDBgwgLi6O/fv3A0j9DCdOnEjVqlWzfO2TJ0/i4eFBcHBwmvujo6NVigqlVWBIoVAwcOBAad+2bdtYtWoVU6dO5d27dyxYsCBVS53vWdmyZWnWrJm0ZvTWrVvMnj2bKVOmaDgy4XuzYMECpk2blq1CfQEBAXh6eqb72aFQKIiPjyc0NJTQ0NBMX1dLSytX/y4EBwfz9u1bWrdunWv3EARBENKnVCqZPn06lStX/qoT799//52YmJhUiXdKgeIxY8ZIP2/ZskUaPHv//n2WB+fKly/PtGnT1BS5kBXfVeIdHh7O6dOn823i/bkTJ07w8uVL5syZQ8OGDbl79y4DBgzA29ubw4cPZzvxTtGzZ0+SkpKIjY1l0qRJREVFSQn4q1evpDWJgwcPTvVA4L8CAwPZt28fV69eTfeLc2YplcpUPRknTJiAn58fiYmJfPz4Ueo5PWnSJMqVK5ej+31roqOjWbhwITKZLN11r4Kgbl5eXkyePDlV7+nMOnr06Bc/O27cuEFCQgJdunTJ8FqxsbFSURmZTCYVknFzc0NbW73/5P39999s374dQEq+w8PDCQ0NpXPnzmq9lyAIgqDK2dn5q+/m8OnTJ3744QemTJnCTz/9JG1fuHCh9G+Zv78/9erVIzo6GhsbG2bOnCkNuIgZoV+X7yrxBjh9+rTU59Xa2jpfFrk5fvw4p0+fplmzZtIajMqVK9O6dWu8vb25du0aa9asYejQoTm6T8oDiKJFi/L27Vvmzp3Ly5cvpQQc4PHjx1SpUuWL1wkODs5ywl28eHE8PT2JjIzMcGr054n41q1bpZ+joqJUKvwOGjToq/7wza7q1aszdOhQ1qxZAyQ//dy6datIvIU8sWTJEtzd3VEoFAwbNoz169dnuj82JPen/rwqv52dHU2aNEl1nLW1NT179szweu/fv1epCxEVFSU9jBo7dqzae7ZevHiRvXv3Son3zZs38fX1FYm3IAhCLitWrBi6urrY2try7t077t69K3UG+loolUoePHiAvr4+JiYmAISGhnLt2jVevXqFra0tFhYWGBkZ8f79ewwMDKhQoUKG382F/Om7S7x1dXUxNTXlypUrzJw5k7CwMCC58NegQYM0HF0yPT09mjRpQuPGjVW2W1pa4uLigq+vLzt27Mhx4p0iJQEvUaIEEydO5MWLF9K+Q4cOZfo69vb2/Pzzz1y4cIGdO3dK283MzFLFamRkhIuLC+/evctwioy7u3uaI2kpI00pHj9+rPKB26VLF3788cdMx/+1qlChAu7u7iiVSmkt0JMnT1i0aBETJkzQcHTCt27ChAkolUqGDBnC/Pnz2b17Ny9fvszUucePH2fq1KkqD+5++umnHNUp0NPTY8GCBSrbEhIS8PDwQC6XM3LkSAoXLpzt6/9XjRo1aNGihdquJwiCIGSelpYWly9fplevXuzZs4djx45pOqQca9CgAe/fv+eHH35Qqdqup6eX7SruQv7wXSXederUYcaMGbRu3ZqbN29KPabDw8PZsmULT548kY4tWbKkxirRplQw/6+qVavy888/4+vrmyv37dWrFytXrlRJvD/XsWNH6tSpk+75derUoUWLFvj6+kqJd+XKlZkzZw5du3ZN85xixYplmBzK5XI+fvyoss3LyytVq4SiRYuyb98+wsPDAbh+/Tq1atWibdu22Nvbf/EeX7vy5cvTs2dPKfGOiYnB09MTuVzOuHHjNByd8C1SKpX89ttv0ut58+ahp6eXpWts27ZNSrrt7OyIj49Xa4wKhYJ169axePFikpKSmDRpEv369VNb4m1tbY2zszPGxsZquZ4gCIKQfTdu3GDChAlMmzZNWpaYFj8/P+7cucOSJUvU+iA2q4KDg6VBJB8fH+nfw7i4OCB5ECXlO3KjRo1wcnLSTKCC2nxXibednZ00HbB69epUr14dSO6BV6lSJQCePn2Kt7c3enp6REVFYWBgkC9bwdy5cwc/Pz/69u2b6/dydnbGysoKJycnbG1tMzzexsaGjh07sm/fPqpXr55u0p1ZaSWOxYsXJyIigtWrVxMREQEkf8n+vJfh4cOHOXz4MMbGxt984g3JI9/9+vVj48aNQPJa1yVLlojEW8gVCoVCmsni4uKS47Z/Xbp0ITo6Wh2hSZKSkhg6dCiDBg1i+fLl0oOpnLh06RJyuRxbW1uaNm3KrVu32Lp1a6oZSoIgCELeevHiBYsXL2bChAlfTLz3799PQkKCytJKTQgNDWXFihXA///O+rmYmBhpLXdSUpJIvL8B31XinR5zc3OpUuCzZ88wNjbm1atXTJ8+nYIFC6r0zNPS0sLNzU1ToUqePXvG+vXr1Z54u7q60qxZM/z8/KRK6t27d89UUaMUNjY2dOnShX379nHr1i127dql9vWOKV/4S5cuzePHj6Xt586dA6Bdu3Y8ePCAGzduEBAQQGxsLJA8fUdbW5u4uDgcHR3VGpOmlS9fHk9PT5RKJT4+PgBERkayatUqhg8fruHohG9JYmKiSr2F1atXZ3nU4OzZs9LslFq1avHx40euXr2aqYd7mY1x+/bt9OnTJ1WrlZzYu3cvOjo6aotTEARByLmVK1fSoUMHlcGeu3fvYmdnx4kTJ7CxsdFgdBlbt25duom1o6MjK1euxM/PD0iugN6yZcu8DE9QE5F4/4epqSlz5swhIiKCYsWKAfDo0SNppEQul0tVcgFGjhyJjo5OnsVnZmZGp06dVHpfq9PgwYMBqFixIjNnzuTp06dZvsaNGzekteHh4eF4e3vnWqGhlHhTVK1alevXr9OjRw9WrVolxZIST/PmzdHR0aFGjRrfXOINyb29R4wYISXecXFxeHp6isRbUJv4+Hh+//13qTBl165dVT4TM2vt2rVSv+6+fftibGzMzZs3sbKyUkucSUlJBAYGsmXLFpXte/fupVevXhk+KDh37hxly5alfPnyKtutra2z9X4FQRCE3GNgYICZmRmNGzcmJCQEXV1d3rx5g5WVlUank6fn8uXL3L59G5lMRqNGjahatapKweDPNWzYkLi4OB4+fAhASEgIpqam1KhRIw8jFtRBJN7pMDY2xsvLC0hu0ZSSXCclJTF+/HiVY1OmWLq4uGS5l15WVa9encGDB+da4p2iVKlSFC1aFEie/mJlZUW1atW+eM61a9c4deoUwcHBbNu2LVfjS8/nMwBatGghvQeAM2fO8OeffwLJCenKlSuB5N9p06ZN8zbQXGRsbEzPnj019t9A+LZ9+PBB5e/Ztm3b1JKIdu/eXaV/aU4VLFgwVdINyd0P2rZtm+EXsSVLluDs7JyqknpWZv8IgiAIead27doEBQVhaGhIZGQklStX5s6dO5oOK03Dhg3j/PnzaGlpERQU9MVjf/vtN1asWCG1Ep48eTIhISHs2bMnDyIV1Ekk3pmgr68vrcFITExUqbDt5uYmrSuOjY2lePHiAHTu3JkSJUrkfbA5sG/fPmm9tJeXF3fv3gXA19eXZs2apZt4X716lQsXLnD8+HF27NiRZ/Fm5L9f5Pfv38/hw4cJCQkhKChI+qBzdXWlfPnyPHz4kObNm2soWvUpW7YsXl5eJCYm5qv/HsLX79OnTwQGBmo6DEEQBEHIsk+fPjFixAjs7e01NvX81atXeHh4cPv2bRo0aED//v0zdV6zZs3w9vYGYOnSpZw/f56BAweycuVKtbfJFHKPSLyzSFtbW6VAj0wm49OnTwBMmTKFxMREAF6+fEm5cuWA5PY4pUuXVlsMpqamtGzZkvDwcA4dOkTbtm1zdL19+/YRFRXF5MmTef78ubS9adOmhIWF8eLFC06dOkXdunVT9Q38559/mDVr1hefuj1+/JiAgABatWqVozhzysnJCScnJw4fPsyuXbuA5J67t27dYuHChVy6dAkvL69vYvTbxMSEFStWoFAoOHToEH/88QfdunXTdFjCVy4uLk4tBcrSEh4ejra2NmZmZjm+VkJCAqdOnUr3QVpQUBCdOnXKl9MPBUEQhNyRkJCAt7c3e/bs0VgbyHfv3kkJdI0aNaRlWxmpUaOGNLXc39+fAwcO4O3tzdKlS0Xi/RURiXcOrVmzRvpZT0+PNWvWkJCQwLRp06TtkydPpnr16jRp0gQTE5Mc39PS0hJ3d3eaNm2Kp6dnthNvf39/YmNjGTVqFG/evAGSp2entMZxc3Pj1KlTzJ8/H29vbxwcHKTE+8qVK4SFhbF79+4Mp7qEhYWxYMECjSfeKdq0aUObNm0AOHnyJBs2bODatWtcvnyZFStWfBOJNyQvF1izZg2DBg1i4MCBIvEWcszAwID9+/fTtm1b/vrrLyA5iXV0dEQul+fo2qdOnaJo0aJqSbxjY2Np3bo1CQkJae7/9ddfadq0qUi8BUEQvnKJiYmpPstTBsHu3buXp3WYMjJr1ixmzpwJwIkTJ6hfv36mzrO3t6dx48YsWLAAgJ07d7J371569OhB8eLFWb16NQMHDsy1uAX1EYm3Gi1fvhylUsm///4rbTty5Ahz5swBwN3dndq1a0v7ateuLbUxy0v79+8nPj4eFxcXqdp38+bNKV68OHPmzFEZ1ba2tubs2bPs2LGDixcvSu0ZNm3axIEDB4DkqvCFChXixo0b0nmlS5emYcOGPHnyhODgYP7991+CgoJo0qRJ3r3RTHB0dMTR0ZEzZ86wYsUKypYty5kzZ2jQoIGmQ1MLIyMjVq5cSaVKlfD396dDhw6aDkn4yunq6nLkyBGpfkLz5s358OFDjpPYFi1aoK2tnn+StLS0vtjey93dHQMDgwyvc/v2bSIiIlT6dD969Ai5XC7NaDIxMVHpfCEIgiDkrZRE+7+USqXKPrlcjpOTE2XKlMmr0FTEx8dL8RQqVCjTbTg/fPhAfHy89LpgwYJUrFgRJycnDh48mO5DZiH/EYm3mqWsBU/h4eHBzZs3geTiCG/fvpX2DR8+nJYtW2JpaZnlUR4jIyPq168vTXPPjIMHD6JQKPj555+lv/jNmjVDV1eX5cuXU6FChS+ev3bt2jSnmVpbW1OsWDFu3LiBiYkJderUoUmTJnTt2pVVq1YRHBxMWFgYU6ZMkaoY5zcNGjSgQYMGXLhwgcDAwG8m8YbkD3dHR0c6d+7M3r17adeunaZDEr5ycrmc2rVrc+nSJSC5wmrBggVz1GLr0KFDFC1aNNPT7r5ET09PKqSYlqlTp2JnZ5fhl6+ZM2dSqVIllZjWr1+PgkwepAAAIABJREFUjo6O1IKyY8eO0r7IyEipRZogCIKQv2hpaeHv76/pMNTC3t4ef3//TCfvQv4gEu9cNnfuXOnnmTNnEhwcDMDFixdZtWoVq1atYtCgQbi7u2dp9LtmzZrMnz+fvn37cvbs2XSnqygUCgICAoDkNc5KpRJIHuktVKgQPj4+6bYvSFG7dm1OnDjB69ev09y/Z88eTE1Nad26NTVr1pRGtVetWqXy/r8GdnZ22NnZaToMtSpRogRbtmyhZMmSdOrUSTwZFXKsUKFCnD9/HltbW65du0ajRo0AOH78eJYeBn4uL1veHT16NFdGPEJCQlixYkW+7xcrCILwrdDS0mLnzp0sWbKEv//+O93jmjdvrtHWqsOGDeP48eMUL16cdevWUbVq1Uyfu3jxYkqWLJnu/t9++43nz58ze/ZsdYQq5CKReOehz9d9e3l5sXDhQl6/fs26detQKpV4eHhQsWLFLF3z/v37DB06lNDQ0FT7EhMTOXbsmLSeGaBx48ZoaWmxe/fuTE21BJg4cSLXr19n8+bN6R5jb2/P0KFDOXTokMr9UhQpUoS6detm6n6C+uno6NCoUSPOnTun6VCEb4SWlhahoaHUqFGDsLAwlEolzZo1Uznm3r176bYa+3z2T4qIiAhkMtkXv2DklLm5eaantBsbG2epO0XdunVxc3Pj2LFj2Q1PEARByAKZTEbnzp3Zv38/wcHB0gCTTCYDkF5Xq1ZNZYZSXtuzZw8vX76kYsWKdO7cOVPnKJVKFAoFzZs3l97Pf8lkMkJDQ9HR0RGJ91dAJN4a4ubmhkwmw9/fn1u3brF+/XoUCgVTp07NcMr3f71//55Lly5J68fj4+M5f/48Hz58UEmC69evz9GjRylUqJBa3wvA7t272b17t/RaX1+f0qVLEx4eTpEiRejWrRsdO3bk9OnTQHIi/vl6dyF3FStWjP3792NoaPhNrWEXNO/GjRsqyffnnJ2dKV26dLrrvwsUKEB8fDwRERG8ffuWlStXIpPJmDFjRo7jUigU3Lt3D0ClbkVwcDBGRkYZnm9qasqGDRuytDQjICAANzc3XF1dsx6wIAiCkG2bNm2id+/etGzZEoB58+bRoUMHfvjhBw1Hln03btygZs2aXLlyJd2ZVCkt0lJm1Ar5m0i8NWjChAlMmDCBcePGsXTpUjZs2IBSqcTT01Mq3PMl+vr6WFhYcOvWLX755ReuXr3KP//8w+vXr2nXrh0ymYw6depIxwcFBamteFFaihcvTuXKlQFo27YtlpaWdO7cGUtLS2rVqiVNR4XkXtMpLb0+J5PJvrmp3vmFlpYWNjY2NGrUiL///lv8ngW1SUm+o6Ki+Pfff1EoFAAYGhoSEBCAlZVVmuf179+fjRs3MmfOHAwMDDAwMMhxdfQUHz9+lJa9PHnyhKdPn6Z6MPAly5cvz9Z927Vrx2+//ZatcwVBEITsMzExoXfv3mzfvp1Lly5Jo8StWrXS2KzLly9fcuzYMd6/f5/lcw0MDOjdu3eWZl7llaNHj2JoaKiSZwgZE4l3PmFkZERSUhIbN26kVKlSmVobbWVlhZ+fH3Xr1iU2NpbAwECparVcLsfBwUFtxcwqVaqErq4uMTExqfYVL16cChUq8MsvvzBhwgRpe8oI+IULF7hy5QqVKlXiyZMnWFpaAjBkyBA+fvzIrVu3pHPkcjkXL14EwNbWNt2pNULW6erqcvbsWezs7LC3t+fixYtZSkQE4UtSuhrUqlWLf/75B4VCwYkTJ9JNuiG5/oC2tjaJiYm8e/eOiRMnAhAdHS11UMiuIkWK8OzZM+m1mZkZxYoVU1tin5ZChQphaGiYa9cXBEEQ0lejRg02bdrEoUOH2LlzJzt37gSS23hpKkG8efMmvXv3zta5ZcuWZdOmTWqOSD0mT56Mg4ODSLyzSCTeGvT8+XMiIyPR0dHBy8uL+/fvM2vWLCIiIvj3338pXbp0pq/19OlTOnTogFwup1q1ahgYGKi1gviMGTOQyWTs2LFD2vbs2TOio6MZMmRIhg8KrK2tGTlyJAsWLGDXrl2Ympry5MkTdHV1U60L7dWrFwC///67ypfkatWq5at+jF+jggULcvnyZbS1tcWHpZArLl++TIUKFXj8+DGRkZEkJiamO9PGy8uL2NhY1qxZw+zZs0lKSpIeBs2bN09tMaUUhnzw4EGOEvqYmBhkMhlFihRJc7+TkxNOTk7Zvr4gCIKQc7t27WL16tWcPn0aX1/fLBUyyy2bN2/m4MGDnD9/PlPHb9iwgUuXLrF69epcjixrnjx5wsCBA7l+/ToODg6aDuerk3uP/oUMrVmzhh9//BETExOVdjUbNmxg0aJFmbpG4cKFpeq8crmchg0bcvPmzVwpouXp6cnNmzelP6NGjQLgzZs36VY8TxESEkLfvn25efMmbdq04fjx4zRp0oSPHz+qXPPzP126dKFDhw506NABKysrgoODCQ8PJzw8PNuVk4VkWW1fJwhZoa+vj0wmw9HRkdOnT6fbYxWSR6YLFiyIlpYW8+bNY/78+Xz8+JGoqKh0/6Q18waS13WndbyxsXG6Rd6yYubMmRQpUgQ3N7ccX0sQBEHIHbVq1aJq1aqUK1eOn376iWLFimkkjtjYWGJjYwFo0qQJVlZWmSps/O7dO8LDw7ly5Upuh5hp7969IyoqiufPnxMQEIBSqaRo0aKaDuurIxJvDRozZgxDhw6VPhCKFy+ebhGi9NSsWZPDhw8DUL58eYKCgtQdZprevn0rVSVet24dkyZNIjIyUuWYIkWKpPkBEx4eTrt27Xj+/Dn29vY8efIkzXvcvn2be/fuce/ePWxsbOjRowc//PAD1apV4+TJkzx8+FAk4NmgpaXFvXv3xDR+Iddcu3YNc3NzAJo2bcqpU6dISkpK89hFixbx8eNHxo8fL21btmwZxYsXT/dPu3bt+PDhQ6o/d+/eTXVsyZIl0dLS4t27dzmevq6joyNm3QiCIORzZmZm6OvrS0sXNWX48OG0b99eeu3h4ZGpZLpcuXKUKlXqi+3R8lqlSpUoXrw49vb2AJw7d44FCxZoOKqvj5hqriFRUVGMHDmShg0b0qlTJ54/f063bt14/vx5pke7U+jo6GS6NZg6vHv3Dg8PD9auXStt8/b2pnDhwqxYsULa1rp1a/z8/KR152mJiIjAysqKGzduIJPJVHrrPn/+XPo5JCQEuVxO3bp1uX//vrReZsuWLdSsWRNIXi+aGxXbv1XGxsa8fPlS02EI36jPE9TmzZsTGBiIo6MjWlpaaT700dLSQi6Xo1QqU9UekMlkKuecPn0aPT29NO/7+fIUuVyu1r71c+bMUdu1BEEQBPV6+vQpBw4cSHdWlCYYGRnRtWtXdHV1uXDhAnfv3qVnz56pjjt27Bh3794FwNXVNd0q5nnpzz//5M6dOwDSyH3hwoVxdXXF2NhYk6F9tUTirSFTpkzh4MGD1KtXj4kTJ+Lj44NSqfzilMz01KhRg7Nnz9K2bdtciDQ1T09PlaQ7xYcPH3j//n2aX4jlcrnKlJSkpCQ+fPgAJD+EMDU1RUdHR0q2jYyMqFmzJgkJCbx//56wsDCMjIw4d+6cypTRNm3acObMGWJjY9m6dSvNmzdHT0+PggULqvttf3P+/fdfdHR0svX/nCBk5ObNm1haWkpF11JavPj7+6e5Dnru3LnMnTuX2bNnM3XqVJV9vXr1yrcFZgRBEIT8ISwsjGHDhmk6DBWWlpasWrUKgAMHDrBly5Y0E+/169dLxeBevXqVqbaXuc3Hx4dt27apbDM1NZXej5B13/1U84SEBOkpTl5auXIl0dHRPHr0CD8/PxYvXsykSZPyPI7sKFy4cJrrJTds2MCoUaP48OED8fHxREVFScl148aNiY6Olv6kNf0nISGBkiVLYmxsTFRUFG/evCE6OprSpUtjY2ODsbExN27cICoqSpq2evjwYaKjo2nfvj0uLi6ULVuW3bt3ExUVRXx8fO7+IgRB+KJr165Ru3btLJ0zefLkVNPXNm/eLI1659UDRkEQBOHrMWvWLEaOHAkkJ7gphXrzk0GDBrFnzx6VbfHx8Tg4OHDkyBHs7Ow4e/Zsttakh4aG4uDgIP3JbKFPHx8flfM+/3PgwAGVY4cOHSo9HBCy57sf8Q4ICGDZsmUcOnRII6OkXl5eeHl5ATBt2rQ8v392zJ07F7lcnurLsUKhwNfXl6SkJJo2bYqrqysymQxtbe1MTQFPaSukVCopXrw40dHR0nrkwoULU6lSJWrXrk1iYiIXL16kVq1a0rTSffv2Sdfp06cPffv2ZcOGDfTp00e9b14QhEyTyWT8/fffNGrUiODgYAA6derErl276NSpU7rnjB8/ntGjR7Nu3TqpiGOKI0eOpFkl3dzcnNu3b6v/TQiCIAj53u3bt7l79y5lypShbt26lCxZUqPxPH78OFXv7nLlylGuXDmVbUqlkkePHqGnp0f16tWpV69etu6XkJAg/TsLyUVOHz9+nOF5165dUznvv7S0tKRp5VZWVvliCvzX7LtPvGUyGSdOnKBVq1YcP35cLZVv1RFTVnrNKpXKdAsX5ZbZs2cze/ZslW0rV65k5MiRbN68mS1btgDQrl079u7d+8Xfq1wuR19fn0ePHlG8eHEUCgWASiGkFy9e8PDhQwAsLCyoW7cuwcHB2NraplozumnTJjEtVRDyCR0dHekz9vTp0ygUigw/r7S0tNDS0mLIkCG4uroCsGfPHvr27Zvu592dO3coUKCAyjZtbW1p1o0gCILwbXN0dOTYsWOaDgOAChUqAMnVzL+kYMGCKjWN1CU6OlqKISfy0+/0W/DdJ95t27blyJEj/PTTTzRs2DBX2nBllbu7e4Z9sT/3zz//YGtrS8WKFXMvqCxwdXWlefPm/PLLLxw4cIC2bdty9OjRNI81MTHh2bNn0uvY2Ng0K7uXKVOGp0+fYmpqyq1btwCwtbXl6tWrnDp1ikaNGuXOmxEEIcf+uzwlZX1b586dv3heShXxnTt3MmDAgC8eq1QqUxVSS0hI+GbanZw7dw5ra2tNhyEIgpCvKBQKvLy8MDc3p1mzZpoOR0WbNm1wdnbWdBhZJpPJcHd3B6BKlSoajubb8t0n3pBc9Of48eM0a9aMOnXqaLz9wNdo6dKljBs3LtPHV69endu3b+Po6KiyvVChQiQkJKTZsqdcuXLcv39fesBw6dIlIPlp3LRp0/LdB64gCNCqVSsuXrzIu3fvpG0JCQn88ssvDBo0KFPXiI2NzXZ18m9lxLt+/fqpRvT/a/HixdIMAUEQhO+BQqHA3d2drVu3plm0TJO6dev2VS55lMlkWRoAFDJPJN4k/w/WpEkTTpw4QbNmzfjxxx8JCQnRdFiZEhISQt26dalcuTLXr1/P8/vPmzePqVOnSu1/+vfvT7169aR2X23btmXo0KH89NNPqUa9q1Spwv3791NdU1tbm7i4OAD09PSkqttKpZLKlSsDyaP8NWrUAJJbMGhra9OxY0cOHjzIjh07vsonjILwLXrz5g1v375NtT0+Pl7tBRCNjIwy1SP1c46OjlILF3WrU6dOqkI6OdG+fXuuXr2a7v7hw4enKtI5cuRIJk+erLYYBEEQ8gt/f/98V5j44MGDTJw4UWP39/f35+TJk3h7e/P333/Tv39/Lly4kOnzO3bsyKxZs3Ixwu+bSLz/j1wup1GjRpw4cYKmTZtSsGBBqlatyrVr1zQd2hcpFAoUCgVaWloaKQ6XmJgorbccPHgwNjY2DBo0SFqnnbJW89ixY7Rq1YqAgADpXJlMphLz+/fvU7VP+G+rq5R72djYEBISgrW1tTQKtG3bNhITE9Ocqi4IwretTJkyBAcHU7Zs2SydFxQUxKdPn3J8/z179uDm5gYkd3HYuHEjhQsXpkyZMjm+dopDhw7x8ePHNPd5eHjwxx9/SA8tU8yaNYt169bRp08f8WVKEIRvxsOHDwkNDSUsLAwLCwsMDAw0HRIAkZGRhIWFaez+VatW5fXr19SuXRtLS0tsbGyIjo7O9PnW1tZYWlrmYoTfN5F4f0ZLS4uiRYuiVCqJj4/nxo0b6OnpYWJikmfVct3c3JgyZUqe3Esdxo8fL/VMLFSoEFu3bk1V+Khp06bs3r2bRYsWpXudt2/fUrZs2QxHwC5fvkynTp149OgRdevWRUdHh8DAQBwcHChSpEjO35AgCGq1e/duPn78SO/evaVlPMuWLeOnn37K0XUvXbrEL7/8AiQXsTlx4gTly5fP8nVMTU1zFEeKgQMHIpfLGT9+POfOnWPu3Ll4e3ur5dopTExM0t33efuZcePGMWjQIH777TeWLl3K48eP8fLyYvv27Tg7O7Nw4UK1xiUIgpDXevfuzZkzZ5DL5RpNdPOjfv360a9fPwB+++03DUcjfE4k3v/n3LlztG/fXiXxUyqVxMTEcOfOHQwNDdHX1+fBgwe5GkeRIkUynUBeuHCBZs2aYWFhwenTp3M1rvT8N95evXrx4cMHxo4dK20rUKAArVu3pmDBghgaGlKrVq1UFRKLFSvG1atXqVq1apr3uXbtGkZGRpQsWZKQkBAcHBy4e/cunz59okWLFhQsWJCdO3fStGnT3HmjgiBkS0pV1c+LnJmamlKtWrUcXTciIkL6uVChQpiZmeXoejlVrFgxabQ9ISFB6sKQF6ZNm8aWLVuYNGkSPXr0oHTp0pQsWZJJkyZJa7537drFzJkzWbFiBYcOHaJZs2asWLEiz2IUBEFQN1tbW7p166bpMNI0b948atWqlef3Xbp0KUZGRujp6UkF0oT847tKvNetW4e+vr5UMODo0aPSE6G4uDiioqKoUaMGhw8fVjkvIiKCOnXq8Pbt2y+OOFy+fJnSpUtnK7b58+ezYMGCTK9V+fvvv2nbti0VK1bk2LFjqaZoa0qRIkXSnO5TsGBB9PT0iIyM5OXLl6n2y+VyzM3NefToUZrXNTU1laoiGxkZ8ddff9GsWTPCwsKIjY0lNjaWTp06sXPnTlq2bKneNyUIgpAJLVq0wMvLCzc3N06fPs3gwYPzZLThyZMnjB07ltGjR6v0ri1ZsqT0ukyZMjg5OREQEMDkyZO5d+8eZ86cwc7OjrVr1+Z6jIIgCOpma2vL//73P02HkSZNJb3r1q0DoESJEiLxzoe+q8Q7ISGBxYsXs337diC5x11kZCT169fH19cXSB45+e8aQRMTE+7cuUNsbKxK4/iwsDC0tf//rzAnyW9UVFSWCg19/PiRt2/fYm5unu1kP7c4OzsTGRnJ+PHjs3SeXC7P9FTRMmXKEBAQwKdPn+jevTuXLl0iOjqaHj16oK+vz/Lly3FycspO+IIgCNlSvHhxqQBkfHw8vr6+KJVK6YtQbqpQoYJK0v1fRkZGGBkZUbFiRWQyGR4eHly5coUbN26gVCrFdERBEL4Kz549w87Ojt9++w0HBwdNh6OiZ8+eHDhwQCP3rlGjBocOHZJepwxW9enTh+PHjwPw+PFjldaeQt77rhJvSP4y9PkUwEaNGrF58+YvJnza2tpUrlyZ9+/fq2w3NzdPs+1Vbjt79iy9evXCysqKHTt25Pn9M6Kvr0///v2Ry+VMnDgRCwsLAGJiYtR6n3LlyvHLL7/wzz//4O3tja+vL2fOnCEyMpL+/fuzfv16OnbsqNZ7CoIgfEnDhg2ZP38+7u7uxMfH4+fnx61btzA3N8fHx0fT4XH16lXpQTP8/wcEYWFhVK5cmY0bN2ouOEEQhC94+vQpFy9e5Pnz5xQrVgxDQ0NNh6TixYsXyGQy6tatm+f3LlSokLS063NGRkaUK1cuz+MR0vbdJd6dOnVi2rRpABw/fpxTp05lqyCPpvz111/07t2b58+fU6lSJSpVqqTpkFI5ePAgHh4evHnzhoSEhFSF6cLCwujcuTO7du3K9j26dOnC7du3CQsLY+3atXTt2pWmTZuq9Ar+mv67CoLwbTA0NGTAgAHIZDL+97//ER8fz+nTpwkODubx48eUKVOGLVu2qPWebm5u+Pr6sn///gxn+rx69Yrw8HAgeZqml5cXN27cYPTo0QQHBwOI5FsQhHxp48aNTJ8+XdNhfJGzs7PKw01NW7JkiaZDED7z3SXeRkZG0nTx+/fvc+rUqUyd9+7dOxwdHVW22dvbc+bMmRy3r1q2bBnr16/P8LiTJ0/Sv39/Hj9+jK2tbabOyW0bN27k06dPDB06VNpmb29Ply5dmDZtGg0aNKBz586MGTMGS0tLNmzYQHh4OK6urtSpUwcAY2NjlekxX9KpUyeePn3K1atX2bBhAxYWFlhYWKCnp4eenl6uvEdBEISsMDQ0pH///gDS+sOEhAROnDiBtrY2kZGR6Onp8ccff6jlftWrV+fdu3dMnDgRpVJJhw4dMnWekZERzZo1o3bt2gCMHj2azZs3AyL5FgQhf5kxYwYHDhygaNGiLFiwQFrWIwhfk+8u8f5c48aNiYyMxM3NDS8vrzSPiYiIoGPHjiQmJnLlyhWVfZcvX8bR0ZFjx47lKOl7/PgxkZGRXzzmzz//ZMiQITx48IAff/wRHx8ffvjhh2zfU12ePXuWqm+skZER5ubmAFy5coVXr14BEB4ezsaNG1m0aBGVKlXi6dOndO/eHblcTr169dDV1SUwMDDVPVq1aiVN879w4QJJSUn4+fnh7OyMrq5uLr9DQRDyi/PnzzNv3jxAtar5/fv3GTZsGKtXr9ZUaKmkJN8WFhbcu3ePcePGAZCYmMiRI0eQy+WplsLs3Lkz28uXhg0bxpMnT3B3d8fHx4eePXvStWvXTJ1rYGBA/fr1pfg2b96MTCZjw4YN2YpFEARB3davX8+zZ88wMTFh+PDhmg5HELLlu068DQ0NKV26NDt37kxz//Pnz3F2dub8+fMUKFCAEydOqOxv3rw558+fT9W3OrtcXV3p27dvqu2BgYGMGjWKe/fuUbduXdatW5evmtv7+vpSoUIFBg8eLG1r1qwZ06dPZ8aMGejq6nLixAlCQ0OZOHEit2/fxszMjF9//VX6nUZHR+Ps7JxqVgEkT69XKBTs2LFDKmCXUlSjSpUqefMmBUHIc4GBgSoze548ecL58+dTHZeQkJCqG0V+YGhoiJOTE1FRUdLSl4iICIYNG4ZCocDf31/l+JQHkZD8JTOtDhHpsba2Zu7cuUyZMgV/f39u3bol/dvWtm1bXFxc0j03PDyciRMnSq8TExPZtGkTgEi+BUHQqODgYJo1a0ZcXBz/+9//8mWl7ufPn1OlShU+fvxI7969NR2OkI9914k3QN26dSlTpozKtvv37zN06FA+fPhAWFgYR48eRUdHJ1VSeOTIEdq0aYOzszM6Ojps3bo1R5XNzc3N01yz/eLFC2mdtLGxMVZWVtm+h7r17NmT+/fvc+fOHZXtpUqVombNmkDyl7r58+dTrlw5Fi5cyJgxYzh79ixPnz6Vjo+Pj0ehUBAUFJTqHnv27KFIkSI0btyYQoUKATB8+PBUxe4EQfg6bdmyhaNHj6baHhYWxuXLlzM838jIiJUrV+ZGaGphYGDAzz//DEBsbCzFihUjJiZG5WElJH/WpUhKSqJIkSLS69mzZ1OxYsUv3sfGxoZZs2bRs2dPaduhQ4eYNWsWf/75JwD37t0DwMrKikmTJhEWFsaoUaM4ceIEpUqVYsmSJbx69YoxY8bg5+eHXC7PF8uaBEH4PiUmJvLhwwcAChcunKUHknlFoVDw4cMHatWqleff0Y8fP55uK14h//nuE+/P+5ymeP/+PYGBgZQoUYLdu3fTvHnzNM9t2bIl+/fvp2PHjiQkJNC9e3e2bt1KqVKl1BZfYGAgixcvBpIfEkydOlVt11YHc3NzLCwspOnkn6tXrx4HDhwgJCSEGTNmULRoUQAOHDjAo0ePGDFixBevvW/fPrS0tGjVqhU6Ojr069eP169fs3btWtasWYOZmVmuvCdBEHLXr7/+qlLX4dy5c1LBr/TUrl2bkSNHSq9v374tTTt///49Z8+epV27drkTsBoVLVqUnj178unTJwoWLCht/++I9N69e1Vev3v3LtWD3REjRkjrs1PY2tpia2srvba2tiYkJARAKvIGycUnjY2NGTNmDH/++ScmJiasWbMGJycnYmJiUCqVjB07lo0bNyKTyfKkJZogCMLXbNGiRWnO3MxNrVu3JiEhIdW/BUL+9F0n3ufPn+fUqVPSFLvbt28zefJk3r59i7GxMZs2bUo36U7Rpk0b9uzZQ3x8PH369KFPnz74+PhgYmKSpVh69eoljYikCAgIYOLEiVy7do369euzePFiqSDZ16BMmTK0a9dOinnGjBls376dqKgooqKiANDT00u3+qOTkxO9evWS9vv7+5OYmMiiRYto3LhxXrwFQRDUYNGiRVy/fl16/ddff/HXX3+le3yLFi3o0qULJ0+eZPv27UByNe5z585Jxzx//lz6+dOnT2zfvl1KxL8GBQsWVFlaFB8fn+qYsWPHEhsbCyR3i/ivJ0+eSPU0MqNUqVL079+fDRs2cOnSJdzc3AgMDKR8+fKsWLFCqoiuq6vLwIEDUSqVjBs3Dm9vb2QyGQCrV68WfWAFQcgTGzdu5Pfffwdg8eLFGX4nF4T87rtOvJ89e8aZM2ekxPv169fs3r2bMmXK4OPjQ6tWrTJ1nZRRFm1tbT58+JClgl++vr74+/szZMgQqd81JE9jnzx5MqGhoTRo0ICFCxdqpC9gZu3btw8rKyv69OmTat/Lly+l6vEfPnxg9+7d0r64uDiV15/bvXs327dvR6lUStuWL19O6dKl1Ry9IAi5ac+ePbx+/VplW58+fbCzs1PZ5u/vz7Fjx3j58iWhoaEqy1EeP36c7qhriRIlmDt3rvoDz0MDBw5Mta1QoUJER0ene87atWs5fvx4pu9RuXJlabr6ixcvKFq0KCtXrsTExCRVJfSStKU8AAAgAElEQVSiRYsydOhQChQoQGJiImPGjAFAS0uLpUuXqozWC4Ig5IZz585x7NgxILlNV0bLbQQhv/uuE+/P3bp1i1mzZgHJBXHatGmT5Wtk1D/1v3x9fZk9ezb29vYq9zt8+DBTp07lypUrNGrUiLlz5+Lg4JDlePLSvXv3CAkJSTPxNjIywtXVFVdXV+7du8fMmTOlfYmJiWzbtu2L116zZo201rFTp06ibZggfGXGjRuHm5sbDx8+lLb9+++/3L9/X+W4t2/fAhAaGkpoaKjKPktLS6lFF8Ddu3dZtWoVkLxk6PN1zd+KjIr0VKxYMVV9jc8FBgZy5MgR6bW+vj5t27albdu20vn/raz+uUKFCjF8+HCSkpJQKBSMGzeONWvWoKWlRYECBZg+fTr6+vpZfFeCIAgZ09HRISkpCQcHB/766698O9Nm/vz5TJ48WaMx/PrrryptfYX8SyTe/+fFixcEBARgYmIiJeC57ezZs9y7d4+RI0dSo0YNILkQzvTp07l8+TKNGzdm9uzZUpuX/Oqnn36S1hCmxcTERErIX716Rbly5aR9b968Ydq0aSxYsIAJEyawdu1alEolgwYNYu3atWhpadGnTx8KFCiQ6+9DEITc8ebNGz59+qSyLTAwMM32gSkcHBxUksLq1aurrOE+ffq0lHh/r1IS6PTY29vTpEkTzpw5w4EDB7CyspJGrrNCS0uLsWPHkpCQAMCkSZNQKBR8+vSJ2bNn58tiR4IgfN0UCgVKpRK5XI62dv5NVxQKBXK5HGdnZ4yNjTUSg1wuz7cPJgRV+ff/ZA0pU6bMF0cA1GXLli389ddfdO3aVSrEkJJ0X7p0iSZNmjBz5kwaNGiQ67HklLW1NfXq1ePBgwcZHluyZEkGDBggvX7//j2lS5emW7du6OrqMmDAAJRKJQkJCQwcOFBqrSMIwtfLz8+PFy9eZOmchIQEatSoQZkyZdi3bx8XLlzgwoUL0n5RxTVj9vb22Nvb07RpUwAuXrzI7t27U9UTyazPW45NnjyZVatWIZfLMTAwYOTIkakKlQqCIHwPDA0N021NLAif+24T7ytXrrBx40b++ecf1q9fT+XKlfPkvn5+foSGhnLw4EHCw8MxMTHBz88PSC44dOnSJRwdHfH09KRhw4Z5EpO6nDx5Mstf6vT09KQCQykJuUwmY9iwYbkSoyAIeW/AgAE8fvyYZ8+eZfqckJAQpk+fjqmpKfv378/F6L59P/74I9OnT2fGjBlMmzYNmUyGs7Nztq83ceJEFAoF06ZN49dffwWSlwmUKlUKV1dXTE1N1RW6IAjfmdOnT7N48WIUCgXDhw+ne/fumg4p35k/f77UoSIpKUnD0QhZ8d0m3uHh4VI7m127duHu7p6r99u4cSN37tzhjz/+UBkZDgoKknpXN2/enAULFmBvb0+jRo1yNR51a9iwISdPnuTYsWPZHk0RBOHb1K9fP5RKJZ6enioF0zJy6dIlLl26lIuRfT9q166Np6cn06dPZ/LkychkMjp16pTt67m7u6NQKJgxYwbx8fFSH/UXL15QoUIFunXrRoUKFdQVviAI34lnz57h7+8PQK1atfL1zM+PHz9KS3Dy0rlz5zhw4ECe31fIue828f4vMzMzBgwYwN69e1mzZo3aihR4e3vz5MkTNm7cyNOnT+nWrRv9+vVL81hHR8d8v547PT/++CMtW7Zk/fr1+Pv7p6qQmx0zZsxAoVAwadIkChUqlOPrHT9+HLlcnuc9FgVBgP79+7Nz584sJd6Zoa+vr1J0TUhfrVq1mDlzJtOmTWPSpEk8fPiQ8uXLZ/thqYeHB0qlkrdv37J27VpiY2NZvXo1APfv36datWo4OTllqeWZIAjC1+KHH37g4cOHlCpVStOhCF8JkXj/nwoVKuDi4oK3tzerV6/OceK9fv16Xr58yapVq/j3339V9jk7O1O9evUcXT+/Cg0NzXbi/enTJ7y8vKTXM2bMQKlUkpSUJCXeI0aMyHYhn5MnT6KjoyMSb0HQkI4dO1KlShXpdWBgIOHh4dSvXx9bW9t0zwsLC5PaZpmYmKhMky5Xrhxubm65F/Q3xtbWltmzZ+Ph4cG4ceOoWLFijqaep1TzNTQ05Pnz52zdupW3b9/y22+/AXDz5k1sbGxo3rw51apVU9v7EATh2xMQEMCJEycAcHV1pWrVqhqOKGOWlpbZ6oSUE61atSImJoaTJ0/Sp0+fbzan+BZ914m3mZkZNjY2xMTEAFC2bFn69OnDoUOH2LhxY7oj01+ybt06oqKiWLBgAZGRkan2f/z4kcTExBzHnp9dvXqVQ4cOZVhxN0VMTAyrV6/m06dPTJs2LdX+OXPmqBxbokQJ+vXrh5GRUaZjCgoK4syZMyLpFgQNGjJkiMrr/v37S7UuBg4ciJWVVapzbt++zYIFC6TX1tbW0rpiIXusra2ZP38+SqWSI0eOMHbsWORyeY4Ki06aNAlIfhBy//599u7dS0REBN7e3gC4uLhIbTEdHByoWbNmzt+IIAjflEWLFvHnn38Cyd+n83M18xQdO3bMs25IKYYPH46pqSknT55k1apV6Orq5un9hezL//9Hq9nVq1dZtmwZHz58YNq0aRgaGkpf4ipUqMCIESPYtGkT48ePRy6X4+LikuE1165dy8ePHwGYMmUKsbGx6R7r4uKS5pfLb4GNjQ2Ojo6cPHmS7du3Z5h4R0VF4evrS3R0NNOnT8/UPVK+gL9584bx48dnunXD4cOH+fTpU77vhy4I35OGDRty6tQpdu7ciZ2dXZqfjWfOnMHHxwdI7jrRqlWrvA7zm1SzZk28vLxQKBQEBAQwfPhw5HI5Tk5OObpuSuXzqlWrsnDhQl6+fAmAr68vvr6+AHTr1o2ffvoJSH4I8KXZDoIgCILwrfjuEu+LFy8SGRnJ1KlT6du3L9evX1d5yl+qVCm6du3Kjh07GDVqFB8+fMjwmqNHj87UKHabNm2oVKlSjuLPb0JCQkhMTMTe3p4GDRowa9YspkyZQlhYGIGBgbRs2TLdc1+/fs3YsWOl13K5PMMp/uvXryc+Pp6FCxcik8kYO3Zshmtrzpw5Q0hICE5OTl+MRxCEvOXi4sKFCxdYs2YNISEh3Lhxgxo1aqR7fN26dRk9enQeRvhtq1GjBsuWLWPUqFEcO3aMQYMGIZfLVfqlZ9e4ceOA5A4ikDzrKGV9/x9//MEff/wBgJOTE926dVM5t2LFitSrVy/HMQiCIAhCfvLdJd4ADRo0kFpYWVpaYmlpKe0rX748ixcvplixYrx7947hw4dn6pq9evWicOHC+Pn5ER8fD0CHDh04deoUUVFRAAwbNgxra2s1vxvNOnLkCHFxcdjb2wNQv359+vbti6urK+vXr0830Y2KipK+eGlra+Pq6sr/a+/Oo5q4/jaAPyGssoiiFlBBiwoq+IrSUpRaBbU/RKqAO1UsrWtb34pVi9Xao7VYl2JR676AWsUVFdFKBVcsiOIKlKq1LoSfWxEQhUDy/kHNK64sGSYhz+ecnJNMJneeBE4y35k795qYmOCnn3565fbq16+PhQsXori4GD/88AP69+//2sJ727ZtKCgoQMeOHavxDomoNsTExMDFxeWVhTepn5OTE5YsWYJx48YhMTERI0eORHR0tFquWXxSfAPAzz//jMOHDyM1NbXCHOx79ux5bro4Dw+PCq9t3Lgx3nvvvRrnISIiEpPOFd4tW7Z87fzYzZo1w8qVK3H79m2YmJigqKgI27Ztq7DOk8L9icjISCQkJCAmJgYlJSXw8/PDokWLMGTIEKSkpKj9fWiSc+fOIS0tDW5ubgCAVq1aoWvXrrh69SqSkpJeeF11Tk4Opk+fDqC8mF65cmWltjVnzhxs2bIF7du3R2JiIuLj49GyZcvXFt9DhgyBj49PFd8ZEQmtY8eOsLOzw/Xr11+5XqNGjXipiEDatGmDlStXYtKkSSgoKMDQoUOxYcMGGBgYqO17c/z48Rg/fjxWrVqlmsrz4sWLuHLlynPrnjx5EgMHDlQ9btu2LebOnVul7fn6+kIqldYsNBHVOgcHB/Tr1w8SiUTsKC+UmJiI8+fPAyi/7JGoKnSu8O7Zs2elp55p0qQJ1q9fj7y8PBgYGFR47sm1ak/s3r0bwcHBePjwIfr06YOlS5eiefPmquffe+89NG3atMb5NVF8fDzatm2rKrw9PT0xfvx4BAUFITQ0FIsWLapwtiIvL0+146Wvr/9cN8PK+P777xETE4OIiAhIJBKMHz/+hcV3WloasrKyYGdnV813R0RCGj16NDIzM7Fo0aJXrufl5aW6fpjUz8HBAbGxscjOzoajoyP69esHQ0ND7N27V62X6IwaNQqjRo0CAPzyyy/YtGmT6rmrV68iKyvruddkZmZWeaaMXbt2wdDQ8Lnlnp6esLCwqGJqIqot7u7uWLhwodgxXmrr1q2qWRuIqkrnCu/qsLS0rLBz8Ky4uDgMGjQIJSUlqrmsbW1tK6zz9ddf18muzu3atYOTk9Nzy+3s7PDWW2/h1KlTCA8PVxXe//zzD9asWaPagW7SpAmWLl1a6e0dOHAADx48AADMnj0bBw8exKxZs/Duu+8+V3ifOXMGYWFhkMlknMaGSENlZWXh2rVrYsegf9WrVw/e3t4oLi7G8ePH4evri19//RVeXl5q39awYcMwbNgw1eN9+/YhIiJCLW0vWbIEQPk0kgqFQrV8+fLlFeYVd3V1hZWVlVq2SUR137Rp0+Du7l6tmY+IWHjX0P79+xEQEAC5XA5vb29ER0erCsBjx47V+W4ogYGBkEgkOHPmDC5evKi6Xt7T0xOLFi3C3LlzVWfCAeDPP/+s0Zy7n3zySYXPtEePHrh06dIL1126dCl+++03REZGqmWwICJSv8jISMTGxr7wOZlMhuzs7FpOpNuaNWuG3377Dffu3YOvry9SUlLQq1cv1dy63bp1E6wLqK+vb6Wnoawsf39/1dSeycnJz01p98MPP+Djjz9m8U1ElWJnZ4e2bdsCKJ9pg98dVBUsvGvg4MGD8PPzQ7du3WBgYIBNmzZVmFt6+/btuHHjBjp37lylOae1TUBAAP7++29MmzYNc+fORbt27QAAXbp0eW7QHHXo2rWras7CuXPnIjk5GWlpaejYsaPqc75w4QJu3LiBNm3awN7eXu0ZiEg9HBwc0LBhQ9y/fx/Xr1/HyZMnVc/t3LkTCxYsEDGd7rKyssKBAwfQq1cvpKWloXv37gCAo0ePokuXLlpz/fSuXbtU94OCgp67pnznzp3w8PB47dgvRETPOnr0KFq1aiV2DNIiLLyrKSkpCT4+PujatSt2794Nc3Pz59b56aefkJKSgsGDB6NFixa1H7IW2dnZoaCgAAcPHlQV3uqWnJyMR48eYe3atc99nmFhYejQoYNqJN74+HjI5XIsXLiQZ7uJNNikSZNw8+ZNLFq0CCtXrnzhQIumpqbcuRGBpaUlDh8+DE9PT5w9exZA+Rnvo0ePwsPDA/r62rUL8apLxohIM6Snp2P27Nn4+uuvoaenJ3YcjbR161bs2LFD7BhUDdr1q6kBFAoFkpOT4eXlhXfeeQcHDx6EsbHxK18TGhoKZ2dn9OrVq5ZS1r7AwEAEBga+cp38/HycPXsWBgYGcHNzw6NHj3D79u0K6ygUCtUZry5dulTo0ujv7w97e3uYmJi8Ns/UqVMxderUarwTIqpttra2qmnEcnJy8M8//8Dc3Fw1KKK/vz9mz54tZkSdZWpqipSUFHTq1AkAcOnSJXTr1g3Hjh2DhYUFnJycXjiIGRFRdWRmZuKbb75BWFgYC++X2LhxI/bu3St2DKoGFt5VUFZWht9//x3vvvsu3NzccOzYMa074i+m8+fPY8yYMXBxcUFycjIuX74Md3d3pKamAgCkUilcXFzwxRdfAAAWL15c4Uu3Q4cOiI6Oho2NjSj5iUgYkydPxuTJk3H37l3MmjULixcvhr+/P+bNm/faqQJJeIaGhrh48SKA8gE1s7KyVF2zDx06BE9PTxbfRKQTvv32W45qTtXGqrGSSktLkZqaCk9PT7i4uODUqVOVel3btm1x5swZXL58GW+//Tbq168vcFLtYWRkhMaNG8Pd3R1A+dRip06dwqpVqwAAnTp1glKpBFD+OR45cgSNGzcWLS8RCSsyMhKrV6+GqakpoqOjYWZmVqVZD0h4GRkZaNeuHR4+fIgbN27A29sbhw4dQosWLdC0aVMYGRmJHZGItJSjoyMyMzNx69YtpKen480339S4wctyc3Nx9+5ddOjQgd93VGXsw/EacrkcGRkZOHXqFDw9PeHs7Izz589X+vXr1q2Dh4cHxo8fj+PHjwuYVLM9fPgQf/31F/T19dGmTRsAQPPmzZGUlARHR0e8+eabKC0thaurq+qmVCrRqlUrODo64sSJE68tuq9fv478/PzaeDtEJJDJkydjwYIFlbqkhMSRkZGBv//+G//zP/8DPT09eHt7w8HBAYmJiSguLhY7HhFpqSVLlqgG1Hz77bexe/dukRO9WKdOnXDu3Dk0b95c7CikZXjG+yVKSkpw/fp15OTkoEePHrCzs0P79u1x4cKFKrdlZ2cHfX195OTkoLCwUDUi9+vk5eXh7t27FZaZmppqZVfrlJQUjBgxAm5ubti+fbtquY2NDbKyspCXlwdXV9fnXnfhwoXXXkP/xLhx42BjY4N+/fqpLTcR1Y6CggIAgJmZGcaOHYvi4mKcPXsWDx48YE8hDZWenq7aAVUoFOjTpw/27duHzp07w9LSkmeDiKjKOnbsiIULF+LLL79UW5uRkZG4ceOG6nFwcLBq+lui2sTC+wVKSkpw7Ngx9OzZE3p6eujYsSNOnz5d7fY2bNiA3NxcjB49GkqlEkFBQTA1NX3t6/bs2YOvvvpK9biwsBBvv/021q5dC6C8q7a6rn+UyWSwsrIS5Dq9Fw2i9ixLS0v89ddfat82EWmH7777DhYWFpg8ebJq2fr166Gvr6+6/IQ0z5kzZ9C5c2f88ccfePTokWoe7l27dqFbt24wMzPj9d9EVGlOTk5wcnKq8FtQU9HR0RX247t06cLCm0TBrubPkMvlOHr0qNqK7iesrKwglUoxZswYbNiwAY8ePXrta0aMGIGcnBzVbfPmzUhPT4erqyvatWuHvn37Ijc3V3W9SU307NmzWmfzK+PIkSMYOnSoIG0TUd1gZGTEM6Ra6vTp0ygsLIS7uzsMDAwgkUjg7+8PKysr7Ny5EwUFBSgoKIBcLhc7KhFpkfHjx8Pf37/G7fz666+QyWSqm4+PDxISEmBlZQUrKyusWbOmUu00a9as0usKzcfHBzKZrFIn8khzsPB+ilwux5EjR9CrVy9IJBK1Fd0AsGXLFgwePBh6enoYN25che7WleXr64t79+7h3r17OHDgADIzM2Fvbw8bGxu4u7vj/v37yMvLU0teIejp6cHS0lLsGESkYUpLSzFz5kxV18KysjJVkfb0fdJsycnJKCkpQY8ePVRTQQ4dOhQWFhawsLDAmjVrUFxcjLKyMpGTEpGme++992Bqaors7GwcOXIEjx8/rnZbVlZWsLa2Vt2MjY1hZmYGZ2dnODs74+7du5Xa38/NzUXz5s3x1ltvVTuLuhgbG8Pa2rrCtLuk+Vh4o3ynLz8/H4cPH0bv3r1haGgIV1dXtRXdT2zatAlDhw6Fnp4eHj16hPz8fJSUlFSrLU9PTxQWFiI5ORmGhoa4efMmrK2t4eTkhPz8fNX1kprEw8MDCQkJYscgIg0zefJkREREAACUSiUWLFig6ma4bt06fPzxx2LGoyo6dOgQvL29n9shHDduHIyNjREZGQmFQgGFQqGauYKI6GmJiYnw9/dHRkYGunfvjtzcXLW27+HhgSNHjuDIkSPIzc3FRx99VKnXffXVV1iyZIlas5Du0LnC+9kzKY8fP8aBAwdgaWkJHx8fvPPOOyguLlZ70f3Exo0bERQUhLFjx6J+/fpYsWJFjY7+d+7cGcXFxSguLkZmZibu3r2Lhg0bwsbGptKjyxYXF0OhUFQ7w6soFIpqH1wgIt0zZ86cCmNbkHZKSEiAQqFA//79n3suNDQUUqkUUqkU33zzjQjpiEgbBAcHY8qUKQDKC964uDhBtjN48GDMmjULADB79mzs3LlTkO0Q6VzhvXbtWowaNQpKpRKxsbEwMTGBn58funfvjtLSUiQnJwueITo6GiNGjIBEIsGECROwePFitRz5d3BwQGlpKW7evImioiKYm5tXqqBu3749srKyarTtl4mLi1ONMq6np3P/bkRUSVOmTEF4eDimTZsGuVyOhQsXAgBCQkKwfv16ccNRtW3fvh1yuRzDhw9/4fNz5sxRFeGffvppLacjIk327rvvws/PDwAQExMj2Emxd955R3WQcPPmzTh58qQg2yHS2Upo69atGDBgAACgd+/eSExMrNXtr1+/HgqFAuPHj8fEiRMhlUrx/fffq6Vta2tr3L17F3K5XGNGk+3RoweOHj0qdgwi0kDz5s3DxIkTMX36dBgZGcHExETV1VxPT48H7bSYVCqFvr4+Vq9ejaKiogq3adOmQalUqrqdL1++HGPHjhU7MhFpEA8PDxQUFMDW1hazZs2Ck5OToNtLS0uDtbU1bG1tVctiY2NhaGjI8SmoxnRybyYqKgpDhw6Fv78/5HI54uPjxY4EAJgxYwakUimmT59e47YaNmyIf/75p9LrP5mPtbZkZGSgdevWtbY9ItJcBgYGmDNnDiZNmoTS0lKUlpZCoVDgk08+QWRkpNjxSA0MDQ1hYmJS4TZjxgzk5eVh9uzZAMovTVq1ahWMjIwwcuRIcQMTkUaQSqUwMzODr68vWrRoAZlMhri4ONy/f1+Q7dWrVw+tW7eGp6cn4uLiEBcXh5MnT0Iul6NPnz6wt7cXZLuVIZfLERcXh5ycHNEyUM3oZOH94YcforCwEJs3b4a+vj6kUqloWSIiIlTd654c+Q8PD0dYWFiN265fv/5rB1lzdHTE1atXIZVK1T4yYmxsLAICAtCzZ0/s379ftfz8+fMYOnQoLly4gOvXr6N58+Zq3S4RaR9jY2PMnDkTd+7cUd0iIiJgYmIidjQSiLGxMerXr49Jkybhzp07WLBggWpckI0bN8LCwgKDBw8WOyYRaYCVK1ciODgY+fn58PPzw6VLlwTb1gcffIBly5bBz88Pfn5+mDdvHgBgx44deP/99wXb7us8fPgQfn5+gnW5J+HpXOEdHByMFStWoF69ehoxZ6yhoaGqO/j06dMxbdo0KBQKzJ8/H1OnTq1R2xKJ5JU7rY6Ojvjzzz+RmpqKdu3a1WhbL1JWVoaysjJIpdIKn3X79u1x/Phx5OTkoHXr1rh16xaLbyKCqakpGjVqpLqZmZmJHYlqgYmJCRo1aoSxY8fixx9/BFD++1FQUIAdO3Zg4MCBIickIk0QGBiImJgY1W3IkCEICgoSZFtmZmaIiYmBi4uLIO2TbtK5wtvQ0BD16tUTO8YLGRsbY9q0abhz5w5yc3PRtGlTWFhYYMKECWrdTosWLWBhYYE///wTSqUS5ubmtXLWPyUlBRYWFmjQoAF8fHxgb2+PW7du4fbt2zh79iyA8hHWn8z5WlpaKngmIiLSDKamphg1ahSuXbuGa9euYfXq1SgrK8OuXbtUY7IQkfZ70sOzqtq3b49BgwZh0KBBOHfuHGJiYrBlyxZBpiY0MjLCoEGD0KxZM7W2S7pN5wpvTff0GZ+QkBDMmDEDy5Ytw+eff662beTm5qKgoACnTp3CrVu34ODgoLa2n9i9ezdGjBhRYVnHjh3xyy+/oGnTpti5cyekUqnqvVpZWQEoPzCSkZGhkfOQExGRsMzMzGBvbw97e3sMGTIEa9asQVlZGXbv3o3AwECx4xGRGqSnp0MqlSIzM7PGbSkUCkilUmzevFkNyYiEpS92gNq2fv16WFpaqq7X0GRmZmYYO3YsBg4cqNYul9nZ2VAoFGjWrBn09YX5F3j48CGKiorg7e2NqKgoAOVHD3v16oVDhw6hSZMmuHbtGjw9PVWvsbCwQEZGBpo1a4a//vpL1GvviYhIXKamphg0aBAkEglCQkKwZ88eBAQEcI5dIqrgww8/RMuWLZGbm4vExET4+/tzfBDSSDpXeMvlcty+fVvsGJVmbm4Oc3NztbZpZ2en1vZexdTUFG+88YbqsZGRkWqKBltb2wrTuD09ZVCLFi1qLSMREWkmMzMzDBgwAK6ursjIyEBwcDA6dOgAOzs7xMXFiR2PiESmp6eHDRs2AAASEhIQFBQEmUzGwps0ks4V3iS8PXv2IDQ09LXrGRoaok2bNrWQiIiItJW5uTk6duyI1q1bIyoqCkFBQcjIyEDfvn1ZfBNpoZYtW2Lp0qVqH1i3U6dOiI+Px2effYaioiLY2dlh+fLlNW63a9eu+Prrr1WDIYtt5syZ6Nevn9gxqBp4jTep3f379/Hf//4XXl5eiIiIEDsOERHVAaampujXrx+OHz+OLVu24MCBA+jbt6/YsYioiszNzeHh4aH2s9JWVlbw8fFBeno6EhMTkZKSgry8PJSVlVW5LaVSiby8PMjlctja2sLHx6dCz0wxubm5wdXVVewYVA2a8R9EdVLDhg3x5ptvih2DiIjqCFNTU3Tt2hW+vr7YsmUL9u/fj+7du4s6ty4RVc358+fRoEEDZGdnC9L+lStX8PjxY2zevBkNGjTAmTNnqtzG/fv30aBBA/z2228CJCRdxa7mREREpFVMTEzQt29fxMTEYODAgZBIJPjPf/6DAwcOiB2NiDREgwYNMG7cODRp0kTsKDV24cIFJCQkiB2Dakjnznj7+PhgypQpYseos+Lj4xEeHo4ePXpg5syZYschIqI6ytjYGB988AG2bt0KpVKJX3/9FX5+ftXqVkpEdc8bb7yBn3/+Gfb29mJHqbGkpCvRWoMAAAyiSURBVCRMmjRJ7BhUQzpXeDdr1gzt2rUTO0addfPmTWRnZ8PW1hbOzs5ixyEiojrM0NAQ/fv3R0xMDAAgLi4OAwYMQHFxscjJiEhIP//8M8LCwsSOQVQlOld479u3D4sXLxY7RgUhISHo37+/2DFqLD4+vtY/27CwMKSnpwMAZsyYAXd391rdPhERicvAwACBgYHYsmULACA2NhZBQUF4+PChyMmISCguLi5o3bq14NsxNzdH48aNBd9OZXI0atRI7BhUQzp3jXdOTg5Onz4tdowKnJ2d4ejoKHaMGrt69SouXrwIADh06BAWLVqEL774QtBtJiYmorCwUHXfz88P1tbWgm6zOiZPnoy///5b7BjPYZdMepUrV64gLCwM4eHhYkdBamoqlixZInaMSnF1dcXEiRPxxx9/YM6cORWea9y4MRYuXChSMvWaMGEC8vLyxI7xQjt27IBUKoWRkVGlX5OUlCRgIiLSRjExMfDx8RE7Bj766CP4+/ujQYMGYkehGtC5whsoLwqHDx8udowKUlNTYWBggKysLLGjVFtGRobqfm5uLn744QfBD3JkZmaq7p84cQKhoaFo0aKFoNusjm3btrHrI2mdR48eISIiAnfu3BE7Ci5fvowjR46IHaNSDh48iEuXLiEnJwf79++v8JyBgQEePHggUjL1ioqKQmlpqdgxXmrr1q1iRyAiIlLRycL75s2b2Lhxo9gxXujSpUuvfN7Z2fm1gyvk5eVh4sSJkEqlWL16NZRKJUJCQgAAy5cvh5GREcaMGYPw8HB8++23KCgoUFv+p+Xm5qrlc166dCm++OILyOVyzJs3r0KXH29v7xq3Xxs0PaepqanYEUiDODg4YNmyZWLHqMDNzQ1DhgwRO0aVffDBB2JHEIybm5vYEQTRrVs3sSMQEVEdpDOFt7e3N1asWCF2jBqzt7d/7XylRUVFqFevHgwMDDBy5EgolUrI5XIA5deT6+vrQyqVIiAgAE2bNtX4sy8jR46Eubk5Hj16hCFDhsDCwkLsSER1mrW1NcaOHSt2DCIiIqI6Q2cKbxcXF7i4uIgdo1bUq1cPo0ePVj2WSCQVHgNQdbUfPHhwrWarLk27NICIiIiIiKiydG5UcyIiIiIiIqLaxMKbiIiIiIjoGevXr9e4gRqjoqJU0yeSdmHhTURERERE9IytW7di+/btYseoYPv27Rp3MIAqR2eu8SYiIiIiIqqsdevWwdfXV+wYVEfwjDcREREREdEz3njjjQrT2BLVBAtvIiIiIiIiIgGx8CYiIiIiIiISEAtvIiIiIiIiIgGx8CYiIiIiIq0ybNgw3LlzR+wYtaZ+/fq4d+8eevfuLXYUqiaOak5ERERERFrFyMgIRkZGYseoNRKJBA0bNtSp91zX8Iw3ERERERERkYBYeBMRERERkdZRKBQYOXIkfv/9d0Hanz9/PpYtWyZI26R7WHgTEREREZHWUSgUiIqKwtWrVwVpPykpCUlJSYK0TbqHhTcREREREdG/rKysUFJSgvfff1/sKFSHsPAmIiIiIiKtI5FIEBgYCDs7O7W3bWBgAD09lkqkPhzVnIiIiIiItI5UKsX27dvFjkFUKSy8iYiIiIhIY40bNw5eXl7o3r07Ro8e/cp1161bh/j4eGzbtq3CchMTE/zyyy8AgLS0NMyZM+e12/39998hlUrh7+9f/fBqduLECUgkEo3KpOmKiorEjgCAhTcREREREdUCQ0NDSKVSlJWVobi4GI8fP67U6/bs2YNGjRqhQ4cOiI2NfeW6EREROHv27HPrGRgYYO3atQCA69evv7adp1Vl3dqiiZno1SRKpVIpdggiIiIiIqr70tLS8NZbb4kdg3TMwoULERoaKmoGnvEmIiIiIqJa0ahRI4SEhIgdg3SMs7Oz2BF4xpuIiIiIiIhISBwjn4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLyJiIiIiIiIBMTCm4iIiIiIiEhALLxJCyhQmH0YO9dORY9WC3C6VOw8REQ6ojAbidsXINhWAomk/GYbvADbd5+GTCF2OCIiHfCy7+HEbBSKnY2qRKJUKpVihyB6EYXsNPaeSMLOCZMRLft3ocN8pGV9ic76okYjIqrjFCjM2oBPvUb+//fvM2xGLEHs3FF428awdqMREekIhSwB04cFI/zwi7+IbUJ24NSqADTlqVStwD8TaSZFFtZP34F7em/CL3QEbMTOQ0SkQxS3YvG/ryi6AUAW/Rnchy3F6UKe+iYiUrvCVPw4LAy3fJcgLacYSqUSSuUD/HFoDaZ0L98zlq39DB/+mMoz31qChTdpJj0nhKz5HiEBARgQGobverP0JiKqHXdxOPJ7rJX1xpQ1e5/a4StGTtoOzB/h/P+rHp6PL5encaePiEitHiN76wpkfr4D674MQGdVzyILtPEKQfjGJQixAQAZDv8Yi9R8HgDVBiy8SfPpmcLSup7YKYiIdILi1lFs2mCN+Wkx+CGk71M7fIaw6RyAL9cdwKGw3v8uk+Hw8qP4g2NvEBGpT/7v2PNgDH4KsH9hsabXtA+mfjew/IHsPvIesvDWBiy8iYiI6F8KFP5xFv/9bgFCO1u+eBW9pvD6aiqmPOmIdOUy/r7DypuISG0s3sHYUZ1g9tIV9GFu2bD8rk1DWJqypNMG/CsRERHRv4rw57kGCB3Q5tU7CBYd8P7wzrUViohIxxjDzKwyIwnboPd3I9DdgiWdNuDY0ERERPQvM3SeOLES6xmjfmPz8rsOrWDfmLsTRES1Jw+ZKWmwGRGOnwa95kApaQz+UhIREVEVPcaDOwUAAJvATmjNvQkiolqiQGHWPkSd9cPG9UPhZMayW1vwp5KIiIiqRnEX187mAPBF6KBOsBA7DxGRTlCgMDsWs8fFwmXBOnipBr8kbcDCm4iIiKpAgcL0/dhwUAabkBAMdX3JIGxERKQmJZCd/g0nkmIwYXI0ZADgdhkXflyOuf/bFTY86a0VWHgTERFRFdxH6tZNOGzzKXbM6oum3OEjIhLQDewM7oHA6CvPLL+I6FBPJFzcgVOrAvhdrAX4JyIiIqJKUqDw9AbMnleMkCWT0b8puzkSEQmrOQKiLkOpLEZO2j5smz8CNk89K1s7E9/E/g3O5K35WHgTERFR5RSmYfmXS4GwH/Fdf3vuRBAR1RpD2HTugwFfrkP2HzswpfuT8vsi1q44hMusvDUefzOJiIioEvJwevks/Gg3A8umefOaQiIiUejBrE1/zFgwGd2fLLpwGTcLWXlrOv5sEhER0WuU4NbO6fDb5429S4dz+hoiIlHpwczVB8N7/3vWW3YfeQ9ZeGs6/nISERHRK5RAlhiODxc3xsZfPkVnFt1EROLTawHPwZ7l9x1awb4xx8zWdPwLERER0UsoUHh6KYZ9eAefn/qRc8YSEWkMfZhbNgQA2AR2QmtWdRqPh62JiIjoBRQozNqATwdfxPDE7xHw0hHMFSg8vQoLEu/WajoiIt1WioK8+wA6Y/j7HWAhdhx6LRbeRERE9Ix/i+6+R/FeXARCnF62S5eP7ISf8Ongv9DJrWGtJiQi0mmKazgecxw2IdMwoXsjsdNQJbDwJu1SdB8Pijh4BBGRcEogS12GT71GIvrKWnzctj4kEslLbvXh2DsUCYE94WbBXQoioppToPB0BHpIJLANjkBCdv4L1inBrdglmF4yBhu/64um/PrVCvwzkYZToDArEbsTrpQ/lO1F1PYMFIobioiojiofSG2Y+2eIllX2NezmSESkPiXIOXcShwHIokPR23EgpkalQvbkvFNhNhIWjENIihcO753BsTe0iESpVCrFDkH0vFLIdn4G28AVL19lxA7kRAXApvZCERHVbbKdCLYNRHRVXmMThkNZ38GLZ7yJiNRDIcPpDYvw5ch5OPz08u5TsObzLmjh3ANebXi4U9uw8CYiIiIiIiISEA9PExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgFh4ExEREREREQmIhTcRERERERGRgP4PwwUMk71kkfwAAAAASUVORK5CYII=" alt="" width="487" height="179" vspace="0" hspace="0" border="0" style="width:487px;height:179px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL">&nbsp;خذ زجاجة عقار فيجاموكس وقِف أمام المرآة.</p><p dir="RTL">&bull; قم بغسل يديك.</p><p dir="RTL">&bull; أدر الغطاء لنزعه.</p><p dir="RTL">&bull; بعد نزع الغطاء، إذا كان عنق غطاء العبوة غير محكم، قم بإزالته قبل استخدام المنتج.</p><p dir="RTL">&bull; أمسك الزجاجة؛ بحيث يكون الطَّرف لأسفل، بين إبهامك وأصابعك.</p><p dir="RTL">&bull; قم بإمالة رأسك إلى الخلف. اجذب جفنك لأسفل بإصبع نظيف، إلى أن يتشكل &quot;جيب&quot; بين جفنك وعينك. ستدخل القطرة هنا (الصورة 1)</p><p dir="RTL">&bull; قَرِّب طرف الزجاجة من العين. استخدم المرآة إذا كان هذا سيُساعدك.</p><p dir="RTL">&bull; لا تلمس عينك أو جفنك أو المنطقة المحيطة بهما أو الأسطح الأخرى بالقطارة. فقد يلوث هذا القطرة.</p><p dir="RTL">&bull; اضغط برفق على الجزء السفلي من الزجاجة؛ لإخراج قطرة واحدة من العقار في المرة الواحدة (الصورة 2).</p><p dir="RTL">&bull; بعد استخدام عقار فيجاموكس، اضغط بإصبعك على زاوية العين المجاورة للأنف لمدة تتراوح من دقيقتين إلى 3 دقائق (الصورة 3).</p><p dir="RTL">&nbsp;يُساعد هذا على منع الدَّواء من الوصول إلى باقي أجزاء الجسم، وهذا مهم في الأطفال الصغار.</p><p dir="RTL">&bull; إذا كنت تستخدم القطرة في كلتا العينين، اغسل يديك قبل تكرار هذه الخطوات بالعين الأخرى. سيُساعد هذا على منع انتشار العدوى من عين لأخرى.</p><p dir="RTL">&bull; أغلق غطاء الزجاجة بإحكام فورًا بعد الاستخدام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا لم تدخل إحدى القطرات في عينك،</strong> فكرر المحاولة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا استخدمت كمية أكثر مما يجب من العقار، </strong>قم بشطفه بالكامل بماء دافئ. لا تضع المزيد من القطرات حتى يحين وقت الجرعة المعتادة التَّالية الخاصة بك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا ابتلعت عقار فيجاموكس عن طريق الخطأ،</strong> فاتصل بطبيبك أو الصيدلي الخاص بك لاستشارته.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا أغفلت </strong>استخدام الدَّواء<strong>، </strong>استكمل العلاج بتلقي الجرعة التَّالية حسب الموعد المحدد. لا تستخدم جرعة مضاعفة لتعويض جرعة أغفلتها.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حال استخدام قطرات عين أخرى</strong>، اترك فاصلًا زمنيًّا لا يقل عن خمس دقائق بين وضع عقار فيجاموكس والقطرات الأخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كانت لديك أية أسئلة إضافية حول استخدام هذا الدَّواء، فاسأل طبيبك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل كافة الأدوية، قد يُسبب عقار فيجاموكس آثارًا جانبية، على الرَّغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكنك عادة مواصلة استخدام القطرة، ما لم تكن آثارها خطيرة أو ما لم تكن تعاني من تفاعلات حساسية شديدة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا أصبت بتفاعلات حساسية شديدة وحدث لك أي مما يلي، فتوقف عن استخدام عقار فيجاموكس فورًا، وأخبر طبيبك على الفور: تورم باليدين، أو القدمين أو الكاحلين أو الوجه أو الشفتين أو الفم أو الحلق والذي قد يسبب صعوبة في البلع أو التَّنفس وطفحًا جلديًّا أو شرى (أرتكاريا) وبثورًا كبيرة مليئة بالسوائل وقرحًا وتقرحات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية الشَّائعة</strong></p><p dir="RTL"><em>(قد تُؤثر فيما يصل إلى شخص 1 من كل 10&nbsp;أشخاص)</em></p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong>التأثيرات في العين</strong>: ألم بالعين، تهيُّج العين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبيَّة غير الشَّائعة</strong></p><p dir="RTL"><em>(قد تؤثر فيما يصل إلى شخص 1 من كل 100&nbsp;شخص)</em></p><p dir="RTL">التأثيرات في العين: جفاف العين، أو حكة بالعين، أو احمرار العين، أو التهاب بسطح العين أو تندب، أو تلف في الأوعية الدَّموية بالعين، أو شعور غير طبيعي بالعين أو اضطرابات بالجفن، أو حكة أو احمرار أو تورم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;الآثار الجانبية العامَّة</strong>: صُداع ومذاق سيء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبيَّة النَّادرة</strong></p><p dir="RTL"><em>(قد تؤثر فيما يصل إلى شخص 1 من كل 1000&nbsp;شخص) </em></p><p dir="RTL">التَّأثيرات في العين: اضطرابات بالقرنية، عدم وضوح الرؤية أو ضعفها، التهاب أو عدوى بالملتحمة، إرهاق بالعين، تورم بالعين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية العامَّة</strong>: قيء، شعور بالضيق في الأنف، شعور بوجود كتلة في الحلق، نقص الحديد في الدَّم، نتائج غير طبيعية لاختبارات الكبد بالدَّم، شعور غير طبيعي في الجلد، ألم، تهيج بالحلق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروفة</strong></p><p dir="RTL"><em>(لا يمكن تقدير معدل التكرار من واقع البيانات المتاحة)</em></p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong>التَّأثيرات في العين</strong>: عدوى بالعين، يصبح سطح العين غير صافٍ، تورم القرنية، ظهور رواسب على سطح العين، ارتفاع الضغط داخل العين، حكة بسطح العين، حساسية بالعين، إفرازات من العين، زيادة إفراز الدُّموع، حساسية تجاه الضوء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية العامَّة</strong>: ضيق النفس، اضطراب النَّظم القلبي، دوخة، تزايد أعراض الحساسية، حكة، طفح جلدي، احمرار الجلد، غثيان وشرى (أرتكاريا).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ هذا الدَّواء بعيدًا عن رؤية ومُتناوَل الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستعمل هذا الدَّواء بعد انتهاء تاريخ الصلاحية المدون على الزجاجة والعبوة الكرتونية بعد كلمة &quot;EXP&quot;. يُشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يُحفَظ في درجة حرارة أقل من 30 درجة مئوية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تخلَّص من الزجاجة بعد مرور أربعة أسابيع على فتحها لأول مرة؛ للوقاية من العدوى، واستخدم زجاجة جديدة. اكتب تاريخ فتح الزجاجة على المُلصَق الموجود عليها ومُلصَق العبوة الكرتونية في المكان المُخَصص لذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلص من الأدوية عن طريق إلقائها في مياه الصَّرف أو مع المخلفات المنزلية. استشر الصيدلي الخاص بك عن كيفية التَّخلص من الأدوية التي لم تعد تستخدمها. ستُساعد هذه الإجراءات في الحفاظ على البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي: موكسيفلوكساسين. يحتوي كل مللي لتر من محلول قطرة العين على 5 مجم من موكسيفلوكساسين (في هيئة موكسيفلوكساسين هيدروكلوريد، 5.45 مجم).</p><p dir="RTL">تحتوي كل قطرة عين على 190 ميكروجرام من موكسيفلوكساسين.</p><p dir="RTL">المكونات الأخرى هي: كلوريد الصوديوم، حمض البوريك والماء المنقى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يتم إضافة كميات صغيرة من هيدروكسيد الصوديوم وحمض الهيدروكلوريك؛ للحفاظ على مستوى حمضية العقار (مستويات درجة الحموضة) عند المستوى الطبيعي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL" style="text-align:right">هذا الدَّواء عبارة عن سائل (محلول صافٍ ذي لون أصفر مائل إلى الأخضر) متوفر في موزع بلاستيكي (دروب-تينر) يحتوي على 5 مللي لتر.</p><p dir="RTL" style="text-align:right">العبوة الكرتونية تحتوي على زجاجة واحدة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مالك حق التسويق لهذا المنتج هي شركة نوفارتس فارما إيه جي.<br />www.Novartis.com&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            د. آخر تاريخ اعتماد لهذه النَّشرة هو 02/17
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                VIGAMOX 0.5% w/v eye drops, solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 ml of solution contains 5.45 mg moxifloxacin hydrochloride (equivalent to 5 mg moxifloxacin).
Each eye drop contains 190 micrograms of moxifloxacin.
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye drops (solution).
Clear, greenish-yellow solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-indent:50px">Topical treatment of purulent bacterial conjunctivitis, caused by moxifloxacin susceptible strains (see<br />sections 4.4 and 5.1). Consideration should be given to official guidance on the appropriate use of<br />antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For ocular use only. Not for injection. VIGAMOX 0.5%w/v eye drops, solution should not be injected<br />subconjunctivally or introduced directly into the anterior chamber of the eye.<br /><u>Use in adults including the elderly (&ge; 65 years)</u><br />The dose is one drop in the affected eye(s) 3 times a day.<br />The infection normally improves within 5 days and treatment should then be continued for a further<br />2-3 days. If no improvement is observed within 5 days of initiating therapy, the diagnosis and/or treatment<br />should be reconsidered. The duration of treatment depends on the severity of the disorder and on the<br />clinical and bacteriological course of infection.<br /><u>Paediatric patients</u><br />No dosage adjustment is necessary.<br /><u>Use in hepatic and renal impairment</u><br />No dosage adjustment is necessary.<br />To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids,<br />surrounding areas or other surfaces with the dropper tip of the bottle.<br />In order to prevent the drops from being absorbed via the nasal mucosa, particularly in new-born infants or<br />children, the nasolacrimal ducts should be held closed for 2 to 3 minutes with the fingers after<br />administering the drops. After cap is removed, if tamper evident snap collar is loose, remove before using<br />the product.<br />If more than one topical ophthalmic medicinal product is being used, the medicinal products must be<br />administered at least 5 minutes apart. Eye ointments should be administered last.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to other quinolones, or to any of the excipients listed in section
6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In patients receiving systemically administered quinolones, serious and occasionally fatal hypersensitivity<br />(anaphylactic) reactions have been reported, some following the first dose. Some reactions were<br />accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal,<br />pharyngeal or facial oedema), airway obstruction, dyspnoea, urticaria, and itching (see section 4.8).<br />If an allergic reaction to VIGAMOX occurs, discontinue use of the medicinal product. Serious acute<br />hypersensitivity reactions to moxifloxacin or any other product ingredient may require immediate<br />emergency treatment. Oxygen and airway management should be administered where clinically indicated.<br />As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms,<br />including fungi. If superinfection occurs, discontinue use and institute alternative therapy.<br />Tendon inflammation and rupture may occur with systemic fluoroquinolone therapy including<br />moxifloxacin, particularly in older patients and those treated concurrently with corticosteroids. Following<br />ophthalmic administration of VIGAMOX plasma concentrations of moxifloxacin are much lower than after<br />therapeutic oral doses of moxifloxacin (see section 4.5 and 5.2), however, caution should be exercised and<br />treatment with VIGAMOX should be discontinued at the first sign of tendon inflammation (see section<br />4.8).<br />Data are very limited to establish efficacy and safety of VIGAMOX in the treatment of conjunctivitis in<br />neonates. Therefore use of this medicinal product to treat conjunctivitis in neonates is not recommended.<br />VIGAMOX should not be used for the prophylaxis or empiric treatment of gonococcal conjunctivitis,<br />including gonococcal ophthalmia neonatorum, because of the prevalence of fluoroquinolone-resistant<br />Neisseria gonorrhoeae. Patients with eye infections caused by Neisseria gonorrhoeae should receive<br />appropriate systemic treatment.<br />The medicinal product is not recommended for the treatment of Chlamydia trachomatis in patients less than<br />2 years of age as it has not been evaluated in such patients. Patients older than 2 years of age with eye<br />infections caused by Chlamydia trachomitis should receive appropriate systemic treatment.<br />Neonates with ophthalmia neonatorum should receive appropriate treatment for their condition, e.g.<br />systemic treatment in cases caused by Chlamydia trachomitis or Neisseria gonorrhoeae.<br />Patients should be advised not to wear contact lenses if they have signs and symptoms of a bacterial ocular<br />infection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No specific interaction studies have been performed with VIGAMOX 0.5%w/v eye drops, solution. Given<br />the low systemic concentration of moxifloxacin following topical ocular administration of the medicinal<br />product (see Section 5.2), drug interactions are unlikely to occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u><br />There are no adequate data from the use of VIGAMOX in pregnant women. However, no effects on<br />pregnancy are anticipated since the systemic exposure to moxifloxacin is negligible. The medicinal product<br />can be used during pregnancy.<br /><u>Breastfeeding</u><br />It is unknown whether moxifloxacin/metabolites are excreted in human milk. Animal studies have shown<br />excretion of low levels in breast milk after oral administration of moxifloxacin. However, at therapeutic<br />doses of VIGAMOX no effects on the suckling child are anticipated. The medicinal product can be used<br />during breast-feeding.<br /><u>Fertility</u><br />Studies have not been performed to evaluate the effect of ocular administration of VIGAMOX on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>VIGAMOX has no or negligible influence on the ability to drive and use machines, however, as with any<br />eye drops, temporary blurred vision or other visual disturbances may affect the ability to drive or use<br />machines. If blurred vision occurs at instillation, the patient should wait until their vision clears before<br />driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the safety profile</u></p><p>In clinical studies involving 2,252 patients, VIGAMOX was administered up to 8&nbsp;times a day, with over 1,900 of these patients receiving treatment 3&nbsp;times daily. The overall safety population that received the medicinal product consisted of 1,389 patients from the United States and Canada, 586 patients from Japan and 277 patients from India. No serious ophthalmic or systemic undesirable effects related to the medicinal product were reported in any of the clinical studies. The most frequently reported treatment-related undesirable effects with the medicinal product were eye irritation and eye pain, occurring at an overall incidence of 1&nbsp;to&nbsp;2%. These reactions were mild in 96%&nbsp;of those patients who experienced them,<em> </em>with only 1&nbsp;patient discontinuing therapy as a result.</p><p>&nbsp;</p><p>The following adverse reactions are classified according to the following convention: very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000) or not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in decreasing order of seriousness.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Classification</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reactions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>haemoglobin decreased</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Hypersensitivity</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Uncommon</p><p>&nbsp;</p><p>Rare</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>headache</p><p>&nbsp;</p><p>paresthesia</p><p>&nbsp;</p><p>dizziness</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p><p>Uncommon</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>eye pain, eye irritation</p><p>&nbsp;</p><p>punctate keratitis, dry eye, conjunctival haemorrhage, ocular hyperaemia, eye pruritus, eyelid oedema, ocular discomfort,</p><p>&nbsp;</p><p>corneal epithelium defect, corneal disorder, conjunctivitis, blepharitis, eye swelling, conjunctival oedema, vision blurred, visual acuity reduced, asthenopia, erythema of eyelid</p><p>&nbsp;</p><p>endophthalmitis, ulcerative keratitis, corneal erosion, corneal abrasion, intraocular pressure increased, corneal opacity, corneal infiltrates, corneal deposits, eye allergy, keratitis, corneal oedema, photophobia, eyelid oedema, lacrimation increased, eye discharge, foreign body sensation in eyes</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>palpitations</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>nasal discomfort, pharyngolaryngeal pain, sensation of foreign body (throat)</p><p>&nbsp;</p><p>dyspnoea<u> </u></p><p><u>&nbsp;</u></p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestional disorders</p></td><td style="vertical-align:top"><p>Uncommon</p><p>&nbsp;</p><p>Rare</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>dysgeusia</p><p>&nbsp;</p><p>vomiting</p><p>&nbsp;</p><p>nausea</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>alanine aminotransferase increased, gamma-glutamyltransferase increased</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>erythema, rash, pruritus, urticaria</p><p>&nbsp;</p></td></tr></tbody></table><p><u>Description of selected adverse reactions </u></p><p>Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal, pharyngeal or facial oedema), airway obstruction, dyspnoea, urticaria and itching (see section 4.4).</p><p>&nbsp;</p><p>Ruptures of the shoulder, hand, Achilles, or other tendons that required surgical repair or resulted in prolonged disability have been reported in patients receiving systemic fluoroquinolones. Studies and post marketing experience with systemic quinolones indicate that a risk of these ruptures may be increased in patients receiving corticosteroids, especially geriatric patients and in tendons under high stress, including Achilles tendon (see section 4.4).</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>&nbsp;</p><p>In clinical trials, VIGAMOX has shown to be safe in paediatric patients, including neonates. In patients under 18 years old, the two most frequent adverse reactions were eye irritation and eye pain, both occurring at an incidence rate of 0.9%.</p><p><u>&nbsp;</u></p><p>Based on data from clinical trials involving paediatric patients, including neonates (see section 5.1), the type and severity of adverse reactions in the paediatric population are similar to those in adults.</p><p>&nbsp;</p><p>--To reports any side effect(s):</p><p>Saudi Arabia:</p><p>--The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p><p>Other GCC States:</p><p>-- Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The limited holding capacity of the conjunctival sac for ophthalmic products practically precludes any overdosing of the medicinal product.</p><p>The total amount of moxifloxacin in a single container is too small to induce adverse effects after accidental ingestion.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Ophthalmologicals; anti‑infectives, other anti-infectives, ATC code: S01A E07.</p><p>&nbsp;</p><p><u>Mode of Action:</u></p><p>Moxifloxacin, a fourth-generation fluoroquinolone, inhibits the DNA gyrase and topoisomerase IV required for bacterial DNA replication, repair, and recombination.</p><p><u>&nbsp;</u></p><p><u>Resistance:</u></p><p>Resistance to fluoroquinolones, including moxifloxacin generally occurs by chromosomal mutations in genes encoding DNA gyrase and topoisomerase IV.&nbsp; In Gram-negative bacteria, moxifloxacin resistance can be due to mutations in <em>mar</em> (multiple antibiotic resistance) and the <em>qnr</em> (quinolone resistance) gene systems. Resistance is also associated with expression of bacteria efflux proteins and inactivating enzymes. Cross-resistance with beta-lactams, macrolides and aminoglycosides is not expected due to differences in mode of action.</p><p>&nbsp;</p><p><u>Susceptibility Testing Breakpoints</u></p><p><u>&nbsp;</u></p><p>There are no pharmacological data correlated with clinical outcome for moxifloxacin administered as a topical agent. As a result, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) suggests the following epidemiological cut-off values (ECOFF mg/l) derived from MIC distribution curves to indicate susceptibility to topical moxifloxacin:</p><p><u>&nbsp;</u></p><p><em>Corynebacterium</em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ND</p><p><em>Staphylococcus</em> <em>aureus&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.25 mg/l</p><p><em>Staphylococcus</em>, coag-neg.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.25 mg/l</p><p><em>Streptococcus</em> <em>pneumoniae</em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.5 mg/l</p><p><em>Streptococcus pyogenes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.5 mg/l</p><p><em>Streptococcus, viridans </em>group<em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>0.5 mg/l</p><p><em>Enterobacter </em>spp.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.25 mg/l</p><p><em>Haemophilus</em> <em>influenzae</em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.125 mg/l</p><p><em>Klebsiella</em> spp.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.25 mg/l</p><p><em>Moraxella</em> <em>catarrhalis</em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.25 mg/l</p><p><em>Morganella</em> <em>morganii</em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.25 mg/l</p><p><em>Neisseria gonorrhoeae&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.032 mg/l</p><p><em>Pseudomonas</em> <em>aeruginosa</em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4 mg/l</p><p><em>Serratia</em> <em>marcescens</em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 mg/l</p><p>&nbsp;</p><p>The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of moxifloxacin in at least some types of infections is questionable.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top"><p><strong>COMMONLY SUSCEPTIBLE SPECIES </strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Aerobic Gram‑positive micro‑organisms:</strong></p><p><em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>Corynebacterium </em>species including</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Corynebacterium diphtheriae</em></p><p><em>Staphylococcus aureus</em> (methicillin susceptible)</p><p><em>Streptococcus pneumoniae</em></p><p><em>Streptococcus pyogenes</em></p><p><em>Streptococcus viridans </em>Group</p><p><strong>Aerobic Gram‑negative micro‑organisms<em>:</em></strong></p><p><em>Enterobacter cloacae</em></p><p><em>Haemophilus influenzae</em></p><p><em>Klebsiella oxytoca</em></p><p><em>Moraxella catarrhalis</em></p><p><em>Serratia marcescens</em></p><p><strong>Anaerobic micro-organisms:</strong></p><p><em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>Proprionibacterium acnes</em></p><p><strong>Other micro‑organisms:</strong></p><p><em>Chlamydia trachomatis</em></p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top">&nbsp;<p><strong>SPECIES FOR WHICH ACQUIRED RESISTANCE MAY BE A PROBLEM</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Aerobic Gram‑positive micro‑organisms:</strong></p><p><em>Staphylococcus aureus</em> (methicillin resistant)</p><p><em>Staphylococcus,</em> coagulase-negative species (methicillin resistant)</p><p><strong>Aerobic Gram‑negative micro‑organisms<em>:</em></strong></p><p><em>Neisseria gonorrhoeae</em></p><p><strong>Other micro‑organisms:</strong></p><p>None</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>INHERENTLY RESISTANT ORGANISMS</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Aerobic Gram‑negative micro‑organisms<em>:</em></strong></p><p><em>Pseudomonas aeruginosa</em></p><p><strong>Other micro‑organisms:</strong></p><p>None</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Following topical ocular administration of VIGAMOX, moxifloxacin was absorbed into the systemic circulation. Plasma concentrations of moxifloxacin were measured in 21&nbsp;male and female subjects who received bilateral topical ocular doses of the medicinal product 3&nbsp;times a day for 4&nbsp;days. The mean steady‑state C<sub>max</sub>&nbsp;and AUC were 2.7&nbsp;ng/ml and 41.9&nbsp;ng&middot;hr/ml, respectively. These exposure values are approximately 1,600&nbsp;and 1,200&nbsp;times lower than the mean C<sub>max</sub>&nbsp;and AUC reported after therapeutic 400&nbsp;mg oral doses of moxifloxacin. The plasma half‑life of moxifloxacin was estimated to be 13&nbsp;hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure following administration to the eye indicating little relevance to clinical use.</p><p>&nbsp;</p><p>As with other quinolones, moxifloxacin was also genotoxic <em>in vitro</em> in bacteria and mammalian cells. As these effects can be traced to the interaction with bacterial gyrase and in considerably higher concentrations to the interaction with topoisomerase II in mammalian cells, a threshold level for genotoxicity can be assumed. In <em>in vivo</em> tests, no evidence of genotoxicity was found, despite high doses of moxifloxacin. The therapeutic doses for human use therefore provide adequate safety margin. No indication of a carcinogenic effect was observed in an initiation promotion model in rats.</p><p>&nbsp;</p><p>Unlike other quinolones, moxifloxacin showed no phototoxic or photogenotoxic properties in extensive <em>in vitro</em> and <em>in vivo</em> studies.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride</p><p>Boric acid</p><p>Hydrochloric acid and/or sodium hydroxide (to adjust pH)</p><p>Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.

Discard 4 weeks after first opening.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p><p>Do not use this medicine after the expiry date which is stated on the packaging.</p><p>Keep this medicine out of the sight and reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Low density polyethylene (LDPE) bottle that contains 5 ml with a LDPE dispensing plug and polypropylene closure.</p><p>Carton containing 1 bottle.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Marketing Authorization Holder for this Product is Novartis Pharma AG. 
www.Novartis.com  

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                05/17
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>